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Abstract 
Metabolomics data provides complementary information to proteomics, genomics, and transcriptomics, 
in addition to enabling the tracking of the dynamic reactions in living systems. Metabolomics is widely 
used in various areas of study such as human diseases, drug discovery, plant analysis, and human 
nutrition. In metabolomics, the workflow for quantitative and comprehensive metabolic mapping of 
cellular metabolites can be a very challenging undertaking. Sampling and sample preparation play an 
important role in untargeted analysis as they influence the final composition of the analyzed extract, 
which can consequently influence the obtained metabolome. The choice of sample preparation method 
for metabolomics is based on factors such as non-selectivity, high reproducibility, integration of 
metabolism quenching, and extraction of a wide range of metabolite polarities. It should provide a good 
representation of the sample under study and obtain high sample clean-up so as to reduce matrix effects, 
especially when liquid chromatography coupled mass spectrometry (LC-MS) instrumentation is used for 
analysis. Solid phase microextraction (SPME) has already been demonstrated as a suitable technique for 
metabolic profiling of various biological matrices. This noninvasive and solventless extraction 
technique eliminates the need for metabolism quenching steps, as the coating selectively extracts 
metabolites, eliminating the co-extraction of interfering biomacromolecules such as proteins or 
enzymes.  
One of the main objectives of the currently presented research was the development of a new extraction 
phase that is compatible with complex food matrices and that provides high extraction recovery for a 
wide range of metabolites. For this purpose, initial research involved the preparation of a silica-based 
ionic liquid coating as a stationary phase for a 96-blade SPME system for the extraction of polar 
metabolites from grape juice without any further sample pretreatment. The lab-made polymer 
demonstrated high physical and chemical stability, and results indicated that the properties of the 
coating could be changed by changing the functional groups during the synthesis procedure.  Chapter 3 
presents different SPME coating chemistries that were developed and applied to provide simultaneous 
extraction of a wide range of both hydrophobic and hydrophilic cellular metabolites produced by a 
model organism, Escherichia coli (E.coli). This research reports the first successful application of the 
developed 96-blade SPME method coupled to LC-MS for bacteria and plant metabolomics. Three 
different LC-MS methods were also evaluated for the analysis of extracted metabolites. The Orbitrap 
system provided a powerful platform for metabolomics due its high resolution and mass accuracy. 
Among different coating chemistries applied for analysis, polystyrene–divinylbenzene–weak anion 
exchange (PS-DVB-WAX), hydrophilic–lipophilic balance particles (HLB), and their mixtures 
demonstrated the highest extraction recovery and a wide range of metabolite coverage. A mixture of PS-
DVB-WAX and HLB particles with 50:50 weight ratio (PS-DVB-WAX: HLB 50:50 [w/w]) was 
applied successfully for extraction of a wide range of metabolites, while the pentafluorophenyl Kinetex 
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column coupled to an Orbitrap mass spectrometer method provided the widest metabolomics coverage 
for the investigated system. The method separated and detected over 200 cellular metabolites with 
widely varying hydrophobicities, ranging from -7 < log P < 17, including amino acids, peptides, 
nucleotides, carbohydrates, polycarboxylic acids, vitamins, phosphorylated compounds, and lipids such 
as hydrophobic phospholipids, as well as glycerolipids, and fatty acids at the stationary phase of the 
E.coli life cycle. Moreover, the 96-blade SPME system provided a high throughput platform, which 
surpassed sample throughput requirements for a typical metabolomics study whereby ~100 samples/day 
are processed.  
Chapters 4, 5, and 6 present the obtained results of applications of the optimized method towards 
evaluations of environmental stresses on biological systems. Essential oils, as natural plant products 
with a complex mixture of constituents, are comprised of multiple antimicrobial properties related to 
oxygenated terpenoids, particularly phenolic terpenes, phenylpropanoids, and alcohols. This thesis 
presents an investigation into the mechanisms of bactericidal action of cinnamaldehyde and clove oil 
against E.coli during bacterial growth, applying 96-blade SPME in direct immersion mode coupled to 
ultra performance liquid chromatography-mass spectrometry (UPLC-MS). Statistical analysis 
demonstrated alteration in the metabolic pathway during different time points of the E.coli growth 
curve, via the up-regulation of saturated fatty acids and amino acids, as well as the down-regulation of 
unsaturated fatty acids, glycolysis, and TCA cycle metabolites for E.coli treated by cinnamaldehyde, 
below and above the minimum inhibitory concentration. The presented 96-blade SPME-LC/MS method 
was developed using multivariate design, and applied to evaluate the synergistic effect of major 
components of clove oil as an antibacterial agent to E.coli. SPME provided clear separation between 
different sample treatments, and valuable information regarding the mechanisms of antibacterial action 
of the two naturally occurring compounds, suggesting different metabolic pathways for samples treated 
with the active agents. As opposed to the utilization of traditional univariate optimization methods, the 
current study employs the application of multivariate experimental designs for optimization of 
extraction-influencing parameters. Based on the obtained results, eugenol, as the major component of 
clove oil, produced the characteristic features of an antimicrobial agent. There is no synergistic effect 
between the components of clove bud oil in the actual weight percent of its constituents. Evaluation of 
discriminating metabolites in treated samples indicated eugenol as a lead compound for the 
development of an active agent through the control of glycolysis in anticancer cells, as this compound 
demonstrated glycolysis inhibition of E.coli as a model organism. 
The optimized SPME-LC-MS method was applied for high-throughput analysis of complex apple 
matrices without a sample pretreatment step. Untargeted metabolic profiling coupled with multivariate 
statistical analysis indicated metabolic alterations happening prior to scald development. The obtained 
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results could be applied towards an improvement in the nutritional stability of foodstuffs as well as 
allow for shelf-life expansion, in addition to increasing their potential market value.  
The developed 96-blade SPME-LC-MS method is promising for global metabolomics applications, in 
particular in terms of extraction of unstable and short-lived metabolites in comparison to traditional 
techniques. SPME has also demonstrated high reproducibility and sample clean-up, which is a top 
requirement in metabolomics investigations. 
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Chapter 1 
Introduction 
 
1.1 Metabolomics and biomarker discovery 
Metabolomics is the scientific study of chemical processes involving metabolites, which are defined as 
molecules that weight more than 1 kDa in mass [1]. The term metabolome refers to the full complement 
of metabolites, which are intermediates and products of metabolism present in cells, tissues, or organisms. 
As the end products of genomics, transcriptomics, and proteomics (Figure 1.1), metabolomics can provide 
an instantaneous snapshot of the physiology of the cell [2,3]. Providing a comprehensive understanding of 
cellular biology requires integration of all complementary data obtained using the different “omics” 
methodologies [4,5,6]. Genome, transcriptome, and proteome analyses are based on targeted chemical 
analyses of biopolymers, involving four different nucleotides in the case of genome and transcriptome 
analyses, and 22 amino acids in proteome analysis. These compounds are highly similar in chemical 
composition. The metabolome is associated with metabolism and interactions with the environment, 
whereas real and potential functional information of living systems is produced by genomes [7]. 
The concept of metabolic patterns was first introduced by Williams in 1951. He applied paper 
chromatography to compare urine samples of 200,000 patients from mental hospitals [8,9]. Concurrently, 
Horning et al. and Robinson et al. applied gas chromatography (GC) towards the analysis of urine, 
making their work the first research papers to be published on metabolomics in 1971 [10,11,12]. The 
terms used in metabolomics were coined for the first time by Oliver et al. in analogy with genomics and 
transcriptomics, derived from the words genome and transcriptome [7]. 
The metabolome is composed of a large number of metabolites with different chemical and physical 
properties, such as non-ionic inorganic compounds, hydrophilic carbohydrates, amino and non-amino 
organic acids, hydrophobic lipids, complex natural products, volatile alcohols, and ketones [13,14]. 
Metabolites are synthesized to complete a set of biological functions; they are the end product of a chain 
of chemical reactions, called a pathway. A collection of pathways is referred to as metabolism [15]. 
Considering all other “omics” studies, metabolomics is one of the most challenging investigations to 
undertake due to the unique characterization of each compound in comparison with other metabolites in a 
pathway. The chemical and physical properties of metabolites and the dynamics of metabolite conversion, 
which are connected to the environment at any time, determine the evidence of metabolites in metabolism 
[16]. In a living system, the metabolic network is composed of a complex multitude of related reactions. 
A small perturbation in the proteome, such as enzymatic alterations, may cause a significant change in the 
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level of metabolites present within a given system. For example, the decreased activity of a specific 
enzyme may cause a biological response increase in the level of its substrate. Metabolites play a very 
important role in connecting various biological pathways operating in living systems [17]. Metabolomics 
and metabonomics are often applied for unbiased global (untargeted) or holistic analyses of biological 
samples, such as animal/human biofluids, tissue and cell extracts, in vitro incubation media, or plant/food 
extracts. These techniques have the potential to discover new biomarkers by identifying differentiation 
patterns between metabolic profiles of test samples and matched control groups [18]. Both metabonomics 
and metabonomics are multidisciplinary research areas that apply various fields of expertise, including 
analytical chemistry, statistical analysis, biochemistry, medicine, life sciences, as well as nutritional, 
agricultural, or environmental sciences. Technological evolution in instrumentation has ignited a burst of 
research in this field towards the development of methods capable of describing whole metabolomes 
using a particular platform [19,20]. Biomarker discovery is the most important area within metabolomics 
studies for medical and life sciences, as well as for plant/food and environmental sciences [21,22]. In 
medical science, metabolomics/metabonomics are applied in the identification of early biomarkers of 
disease (diagnostic markers) or in drug efficacy prediction, biomarkers of disease progression, and drug 
toxicity (safety assessment). Plant and food sciences utilize metabolomics for taxonomic studies and 
quality or source assessment [23,24]. 
 
                               
     
  
      Genomics           Transcriptomics               Proteomics                             Metabolomics 
 
                                               
 
     DNA                               RNA                      Protein                                  Metabolites 
 
Figure 1.1 Interaction of different “omes” in a cell: Genomics conduct the exploration of all the sequences in the full 
genome of a distinct organism. The genome can be defined as the complete set of genes inside a cell. 
Transcriptomics is the study of the complete set of RNAs (transcriptome) encoded by the genome of a specific cell 
or organism at a specific time or under a specific set of conditions. Proteomics is defined as protein “expressiom 
profiling”. Metabolomics can be defined to determine differences among the levels of thousands of molecules in 
control vs. treated samples.  
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Microbial metabolomics is a newly emerging field utilized to investigate changes in metabolic profiles 
under various environmental conditions, metabolic changes in a mutant strain or microorganism, or 
identification or differentiation through the generation of metabolome profiles of various microorganism 
species [25].  
Metabolomics research can be classified as targeted or untargeted analysis. The first focuses on a specific 
group of metabolites in a sample that needs a high level of purification and selective extraction of 
metabolites, whereas untargeted metabolomics refers to identification of as many metabolites present in 
the sample as possible to obtain the metabolome pattern or fingerprint [26]. 
Metabolomics includes sample preparation, sample analysis, and data analysis; in order to obtain as much 
information as possible, each metabolome study requires evaluation and optimization of its sampling, 
sample preparation, and extraction procedures [26]. Figure 1.2 demonstrates the metabolomics workflow 
regularly used in scientific labs. 
   Targeted or untargeted                                    
                                                                 analysis                                        LC-MS analysis 
                                                    
           Sample collection 
           Sample storage 
           Sample preparation                           
    Targeted analysis                                                                                                                                                                      
Confirmation identification         Data processing (peak alignment, detection and normalization) 
                                                                          Multivariate statistical analysis 
                            
 
 
Metabolite database (tentative identification) 
Understanding of biological processes responsible for the change 
in biomarkers 
Biomarker Discovery 
 
Figure 1.2 Global metabolomics workflow (targeted and untargeted analysis). 
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1.2 Analytical approaches for global metabolomics studies 
Due to the broad range of chemical diversity that exists for metabolites, which can range from sugars to 
lipids, it is often challenging to perform a complete metabolome analysis with a single technique [13,14]. 
The two analytical techniques most widely used in metabolomics are mass spectrometry (MS) and nuclear 
magnetic resonance (NMR). NMR is a nondestructive, rapid, and robust technique that forgoes the need 
of chromatography and ionization; however, the main advantage of MS over NMR lies in the former’s 
sensitivity and its ability to perform quantitative and targeted analyses [27-30]. 
Direct infusion MS has been utilized in conjunction with high-resolution instrumentation such as Fourier 
transform ion cyclotron resonance (FT-ICR) and Orbitrap in metabolomic determinations; however, 
imperfections in overcoming matrix effects and isobaric metabolite analysis limit the application of this 
technique [31].  
Matrix-assisted laser desorption ionization (MALDI) was developed to overcome some of the weaknesses 
of traditional analytical techniques in regards to metabolomics determinations. The main advantages of 
this technique consist of the use of very small sample volumes, in addition to its suitable performance in 
the analysis of matrices containing salt [32-33]. As signals produced by the matrix can cause the detection 
of lower masses in the sample and a high relative standard deviation (RSD), other MS technologies such 
as graphite-assisted laser desorption ionization (GALDI), desorption ionization on silicon (DIOS), 
nanostructure initiator mass spectrometry (NIMS), secondary ion mass spectrometry (SIMS), direct 
analysis in real time (DART), desorption electrospray ionization (DESI), and extractive electrospray 
ionization (EESI), which can provide analyte ionization from a surface, have been developed [34-38]. 
However, the current number of reports in metabolomics literature involving the abovementioned 
approaches is limited; further research needs to be conducted to ensure the progress of these 
methodologies. Inspite of the progress in the metabolomics field, more efficient separation methodologies 
are still needed to lessen the complexity the final extract and improve the chromatographic resolutions of 
the overlying metabolites. Although direct infusion MS has been successful in this regard in some cases, 
MS is often coupled with high-resolution separation methods such as GC, liquid chromatography (LC), 
ultra performance liquid chromatography (UPLC), and capillary electrophoresis (CE) so as to improve 
these factors. These separation methods enhance the real potential of MS as well as the sensitivity of MS 
detection while decreasing the complexity of the samples introduced to the MS, which in turn aids in the 
reduction of background noise. While GC can be applied for the analysis of volatile, nonpolar, and 
thermally stable metabolites, most metabolites are polar and nonvolatile, and as such, must be derivatized 
prior to GC analysis. Derivatization, in turn, generally produces artifacts and complex chromatograms. 
LC offers analysis of a broader range of metabolites in varying concentrations [39-43]. As the 
metabolome is composed of a diverse array of compounds with various physicochemical properties, there 
	   5 
is no single retention mechanism that is sufficient to separate complex sample mixtures with widely 
varying analytes in terms of their polarity, charge, and stability [44]. In the metabolomics area, more than 
90% of the published studies utilizing chromatographic methods were conducted with the use of reversed 
phase liquid chromatography (RPLC) [45]. However, a major limitation of RPLC lies in its poor retention 
of polar metabolites due to their co-elution within a void volume. One of the strategies to solve this 
problem is chemical derivatization; as reported by Shortreed et al. [46] and Santa et al. [47], chemical 
derivatization can be used to improve retention of amino acids and amines, or, as shown by Horvath et al, 
utilized with the application of an ion pairing reagent in the mobile phase. However, it is important to 
note that these reagents are not compatible with ESI interfaces [48]. Another way to increase the 
identification of polar metabolites involves the use of Hydrophilic interaction chromatography (HILIC) 
columns ranging from unmodified silica to bonded-phase particles with non-ionics such as polyol, ionics 
like amine, as well as zwiter ionics such as sulfoalkylbetaine fuctional groups [49,50]. In comparison to 
RPLC, HILIC columns are characterized by an enhancement in retention times, poor separation, and 
longer equilibrium times. Despite these shortcomings, HILIC is the LC-MS separation method of choice 
for polar metabolites [51,52]. CE is particularly applicable for polar and ionizable metabolites such as 
amino acids, which cannot be adapted with metabolomics approaches [53]. 
The high selectivity and low detection limits of mass spectrometry, alongside its compatibility with 
various separation techniques and applicability for quantitative analysis together function to make this 
technique a powerful tool for metabolomics studies [27]. In addition, efficient sample introduction and 
ionization of all metabolite classes assist in the attainment of superior mass spectrometry data [28,30]. 
LC, in comparison to direct infusion, can reduce the complexity of mass spectra as well as reduce or 
eliminate matrix effects produced by co-eluted compounds and interferences produced in low-resolving 
mass analyzers, assisting to separate isomers. Suitable MS quality of data and lower detection limits can 
be obtained by powerful separation techniques [45-52]. However, mass spectrometry-based techniques 
usually require a sample preparation step prior to analysis. Various MS-based techniques have been 
previously applied for metabolomics studies. Further identification and compositional analysis of 
metabolite species can be obtained with the use of MS/MS, while the identification of fragmentation 
patterns can be accomplished with CID spectra [16]. The use of ESI in both positive and negative modes 
can aid in adduct ion identification of different metabolites. In order to distinguish between isobars, high-
resolution mass spectrometers can be applied in conjunction with empirical formula calculations towards 
accurate mass measurements of ion signals. In past research, the use of Fourier transform ion cyclotron 
mass spectrometers (FT-ICR-MS) has been reported to yield very high resolutions up to 1000000, with 
the highest obtained mass accuracy of 0.1-1 mamu [31]. The FT-ICR-MS instrument provides very low 
detection limits in the attomole to femtomole range, with an MSn range being easily achievable with this 
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type of instrument [16]. In contrast, TOF-MS instruments have been reported to offer high mass 
resolutions of 6000-17000, with a 3-5 mamu mass accuracy in cell media samples. Hybrid instruments 
such as the quadrupole-TOF-MS (Q-TOF-MS) have also been applied for analysis of cell and plant 
extracts with high mass accuracy and resolution. High mass accuracy of spectra can assist in the 
identification of the fragmentation process, while allowing for spectra interpretation [16]. 	  
1.3 Sample preparation 
Considering the complexity of the real sample matrices under study in terms of chemical diversity and 
broad dynamic range, sampling and sample preparation are generally considered as the limiting steps in 
metabolomics, as they induce an important source of variability. The choice of sample preparation 
method plays an important role in the final content of the obtained metabolome profile, as well as the 
quality and reliability of the final results. In addition, matrix interferences and metabolite losses are most 
likely to happen during these stages. Accordingly, an ideal sample preparation method for metabolomics 
studies should be non-selective, simple, reproducible, impartial towards metabolome coverage, and able 
to minimize biases for various metabolite classes without metabolite loss or degradation. It should enable 
high-throughput analysis, and integrate a metabolism-quenching step. In addition, the extract should be 
compatible for further analysis; the combination of sample preparation with a suitable chromatographic 
protocol provides insight into the biological system [54]. The main objective of sample preparation is the 
production of an extract that is well suited to the analytical technique, isolating metabolites from a 
complex matrix, and overcomes low sensitivity. A recent trend in sample preparation also includes the 
development of methods that can significantly reduce or omit the need of organic solvents, thus creating 
greener and environmentally friendlier techniques [55]. 
One of the goals of metabolomics is to connect metabolite levels with the response of biological systems 
to genetic or environmental variations. Therefore, the first step of sample preparation is quenching of 
whole biochemical processes concurrently or instantaneously [56]. The sample introduced for analysis 
should be a proper representative of the biological system; thus, the metabolic processes taking place in a 
given sample should be interrupted during sampling, allowing for a reliable snapshot of the metabolome. 
Quenching helps to reach this goal by stopping the metabolic processes occurring in real time through 
enzyme inhibition; an ideal quenching step should be able to inactivate metabolism faster than the rate of 
metabolic changes happening in the sample. Sample integrity should also be conserved during sampling, 
without any variations in the physical or chemical properties of the metabolites under study. Finally, the 
quenched sample should be usable for further stages of the metabolomics workflow [57]. 
Various quenching techniques can be used on samples from biological systems such as microbial and cell 
culture, plant and animal tissues, and body fluids; in such cases, quenching is accomplished through rapid 
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changes in temperature or pH, as these processes can cause rapid inactivation of metabolism and 
enzymatic activities. Quenching is usually performed by putting the biological system in a cold (-40°C) or 
hot (>80°C) solution, or into an acidic (pH < 2.0) or alkaline (pH > 10) solution [56]. In the case of 
bacterial cells, the use of organic solvents at extreme temperatures is the most commonly used quenching 
method. In such quenching methods, disruption of the cell envelope happens during quenching; 
commonly used solvents include percholric acid, trichloroacetic acid, boiling ethanol, boiling water, and 
liquid nitrogen. However, it is important to note that these types of disruptions can result in a reduction in 
the reliability of the obtained results. For example, loss of metabolites has been reported in the application 
of freezing procedures, while metabolite degradation, poor metabolome coverage, and lack of 
compatibility with MS have been reported as drawbacks of applying extreme pH conditions for quenching 
[56-61]. 
In order to analyze the metabolites by instrument without physical loss due chemical degradation or 
biochemical transformation, it is mandatory that metabolites are extracted from the disrupting cell 
envelope and consequent separation of metabolites from the biological matrix [56]. In addition to being 
the most time consuming step, the quenching requirement makes it so that it is practically impossible to 
avoid analyte loss, mainly because of the high chemical diversity present in the matrix as well as the 
broad dynamic range [54]. Indeed, due to the diversity and dynamic range of metabolites, most research 
in metabolomics has focused on a specific group or class of compounds. For example, sometimes a group 
of metabolites are sacrificed in favor of identification of another class with higher reproducibility. The 
relevant literature also reports the application of multiple extraction procedures in order to achieve wide 
metabolome coverage [62]. 
The extraction of metabolites in the metabolomics workflow is one of the most important steps to be 
undertaken; accordingly, optimizations need to be conducted to allow for minimal matrix interference and 
maximum sample recovery, which is associated with sample types and is among the aims of study. An 
ideal extraction method applied for metabolomics should efficiently release metabolites from the sample, 
eliminate interferences such as salts and proteins causing matrix effects, produce an extract compatible 
with the analytical technique, and concentrate metabolites for analysis [63-67]. The physical and chemical 
properties of each metabolite are determined by its molecular weight, molecular size, polarity, volatility, 
solubility, pKa, and stability. Metabolites are small molecular weight compounds weighting less than 
1000 Da, in comparison with polymers such as proteins and starch. The special volume and 
tridimensional structure of a given metabolite determine its molecular size. The molecular structure and 
the number of water molecules involved in non-covalent binding on the surface of the molecule are in 
turn affected by its molecular size. The polarity of the metabolites is related to the formation of polar 
interactions with water molecules and other polar compounds [68].  
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The natures of the polar and nonpolar functional groups presenting in the molecule build the polarity of 
the molecule. Depending on the functional groups positioned at the molecule and the pH of the 
environment, polarity can increase as follows: Acid > Amide > Alcohol > Ketone ≈ Aldehyde > Amine > 
Ester > Ether > Alkane. Based on this classification, lipids, fatty acids, waxes, terpenes, carotenoids, 
chlorophylls, steroids, and flavonoids are considered to be highly nonpolar metabolites; phenolics and 
alcohols are classified as midpolars; while amino acids, organic acids, organic amines, alkaloids, 
nucleosides, sugars, nucleotides, phosphates, metals, and salts are categorized as highly polar metabolites 
[68]. 
Volatility is strongly correlated with the polarity of molecules. More volatile metabolites have less 
polarity. The solubility of a compound is the maximum quantity of solute that can dissolve in a certain 
quantity of solvent or solution at a specific temperature; solubility is a function of polarity, pKa, 
temperature, solvent type, and analyte size. Partition coefficient (P), the ratio of concentration of a 
compound in a mixture of two immiscible phases at equilibrium state, measures differences in the 
solubilities of compounds in these two phases. Normally, one solvent is octanol, as a hydrophobic, and 
the other, which is hydrophilic, is water. The stability of a compound is described by its resistance to 
chemical reactions, changes, or degradation, all which are affected by thermodynamics and kinetics. 
Temperature and light, as well as oxidative or reductive conditions can all affect metabolite stability [68]. 
The appropriate extraction conditions of cellular metabolites must be carefully selected in regards to all of 
the abovementioned factors. 
Different extraction protocols are applied in metabolomics; generally, these are determined based on the 
type of sample matrix to be studied. For solid samples, solid-liquid extraction methods such as Soxhlet 
extraction, Folch extraction, supercritical fluid extraction, ultrasound-assisted extraction, and microwave-
assisted extraction are used, while for liquid samples, liquid-liquid extraction (LLE), solid phase 
extraction (SPE), and solid phase microextraction (SPME) have been reported as the sample preparation 
methods of choice for metabolomics. In addition, various solvent extraction techniques have been 
reported in this area, such as the use of cold solvents, (50% methanol, 100% methanol, ethanol, 
methanol/chloroform and acetonitrile), hot solvents (80% methanol, ethanol, H2O), alkaline solvents 
(KOH), and acidic solvents (perchloric acid). Each method has its own advantages and disadvantages, 
which will be discussed in the next sections. The choice of solvent is generally dependent on the chemical 
properties of the metabolites under study; in many cases, multiple solvent extractions are required to 
enhance metabolite extraction [69-79]. 
SPE is mostly applied in sample clean-up prior to chromatographic analysis. When analysis of a large 
number of samples is required, the use of commercialized robotics or automation devices can provide 
faster, superior results by reducing sample handling and increasing reproducibility. SPE is widely used in 
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metabolomics; however, its selectivity for just one class of compounds limits this method to targeted 
analysis. SPE has been applied to metabolomics investigations in various studies, such as metabolite 
profiling in biofluids, animal tissue, and plant samples [16]. Dilution, incomplete extraction of 
metabolites, chemical modification or degradation of labile metabolites, production of artifacts released 
during the extraction procedure such as chemical contaminants from solvents, and polymer degradation 
are some of the drawbacks reported for traditional extraction techniques used in metabolomics studies 
[16]. 
 
1.3.1 Sample preparation for cell metabolomics 
Microorganisms are one of the mandatory entities of the digestive tract of humans and animals; moreover, 
they are used for fermentation processes in food technology and biotechnology [80]. There are more than 
250 microbial pathogens that cause food-borne diseases. In this context, many cases of disease occur due 
to contamination of fresh and processed foods with food-born pathogens [81]. Metabolomics is one of the 
currently available techniques that can be applied towards the evaluation of animal and plant health and 
production, as well as in the tracking of food quality and safety [82]. Data obtained from genomics, 
proteomics, lipidomics, and metabolomics of pathogens in contaminated foods can provide reliable 
insights about disease outbreaks and therapeutic processes. Therefore, in vivo proteomics and 
metabolomics assist further functional analysis [83-85]. Currently, sensitive methods are available for the 
detection of bacteria and their toxins, including DNA microarray technology, GC-MS based 
metabolomics, LC-MS based proteomics, and lipidomics [85-88]. In order to monitor changes during 
food processing, ‘omics’ investigations of model organisms under stress conditions such as cold or heat, 
osmotic pressure, high pressure, nutrient availability, and antibacterial usage are essential in order to 
better understand their adaptation and consequent reactions to extreme conditions [89]. Antimicrobial 
chemicals and naturally occurring compounds are used to disinfect food contact surfaces [90].  
Cell metabolomics consists of quantitative investigations into the full network of cellular metabolism; in 
order to further our current understanding of cell function and drug development, the properties of cells 
need to be further characterized [91]. In comparison to other types of metabolomics research, cell 
metabolomics has various advantages, such as controllable experimental conditions, minimization of 
individual variations, and availability of cell samples through laboratory cell cultures. In addition, 
investigations of drug effects on cells can be undertaken without human or animal ethical concerns. In 
view of these advantages, the field of cell metabolomics has experienced continuous growth, from studies 
on prokaryotes, especially Escherichia coli (E.coli), to eukaryotes such as yeast and mammalian cells 
[92]. 
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The number of identified metabolites in simple microorganisms can range from the 240 in simple bacteria 
such as Mycoplasma pneumonia, to approximately 800 in E.coli. Since many genes in the genomes of 
many organisms have not been determined to date, the actual number of metabolites present in simple 
microorganisms may even be two or three times greater than the currently obtained numbers [93]. 
The metabolites present in main cellular activities, including the glycolysis pathway, TCA cycle, and 
intermediates in nucleotide biosynthesis, are common in all known organisms, making bacteria good 
model organisms for metabolomics studies. NMR and MS techniques are the most commonly utilized 
analytical methods for bacterial metabolomics. Various sample preparation stages need to be applied 
during bacteria metabolomics. Cell culture, quenching, and metabolite extraction are common pre-
analytical procedures in the bacteria metabolomics workflow [94]. Organic solvents are widely used for 
extraction of metabolites; in order to cover all metabolites, more than one solvent is often used in 
extraction procedures. For example, methanol, methanol-water mixtures, or ethanol are utilized for 
extraction of polar metabolites, while chloroform, ethyl acetate, or hexane are applied for nonpolar 
extractions. In metabolomics investigations, De koning et al. applied buffered methanol-chloroform-water 
at low temperatures (-40°C to -20°C) for simultaneous extraction of both polar and nonpolar metabolites 
of bacteria, yeast, animal tissues, and filamentous fungi. High recoveries of organic acids, sugar 
phosphates, and sugar alcohols were achieved by this method, whereas nucleotides were not significantly 
extracted. On the other hand, this method is tedious and time consuming, in addition to relying on the 
consumption of large amounts of toxic organic solvents [95]. The utilization of boiling ethanol for cell 
metabolomics is another popular method for cell metabolomics investigations, although this technique has 
been reported to result in poor extraction recoveries of phosphorylated metabolites, nucleotides, and 
tricarboxylic acids. Methanol, either in pure form (100%) or in the presence of water as a polar solvent, is 
a very powerful organic solvent applied for extraction of intracellular metabolites from a wide range of 
cell cultures. Methanol was first introduced as an efficient solvent for the extraction of intracellular 
metabolites from bacteria and yeast by Maharjan et al. [96], and Villas-Bôas et al. [56]. Methanol is less 
toxic than chloroform, and applying extraction at -20°C avoids biochemical reactions and degradation of 
thermo labile metabolites; in addition, methanol can be easily evaporated from the final extracts. Acidic 
and alkaline extractions of intracellular metabolites from animal and plant tissues, filamentous fungi, and 
migroorganisms have been conducted through application of acidic and alkaline extraction methods. For 
metabolite extractions, the most commonly used acidic and alkaline solutions are perchloric acid, 
trichloroacetic acid, hydrochloric acid, potassium hydroxide, and sodium hydroxide. In order to eliminate 
the degradation of thermally labile metabolites, extractions are conducted at low temperatures (0-4°C). 
One of the drawbacks reported for this technique is the presence of large amounts of salts that precipitate 
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during pH neutralization, which cause co-precipitation of metabolites. Substantial nucleotide losses have 
been reported by researchers applying this method for extraction of metabolites [57]. 
 
1.3.2 Sample preparation for plant metabolomics 
Plants play an important role in the cycle of nature, and are counted as a critical source of food and 
metabolic energy for organisms that cannot generate their own supply of food. Several thousand different 
metabolites are produced within the plant kingdom, with an observed diversity in concentration that 
ranges within six orders of magnitude. The number of metabolites found in plant species is higher due to 
the generation of secondary metabolites, which are more varied than primary metabolites [97]. 
Metabolomics applications assist in investigations of plant metabolism and phenotype analysis of various 
plant species following environmental and genetic perturbations. In addition, application of metabolomics 
investigations can aid in the discovery of novel pathways. Moreover, plant metabolomics applied to the 
field of nutrigenomics, in which the role of nutrition in human metabolomics and different diseases is 
investigated [98].  
Plant metabolomics was first investigated by Twsett, who identified components in leaf extracts using 
chromatographic techniques. Other chromatographic techniques such as GC-MS, LC-MS, and NMR have 
been subsequently used in this area. The first study on plant metabolic profiling, conducted by Sauter et 
al., investigated different herbicides on barley plants using GC-MS [99]. Different works in this area have 
demonstrated that GC-MS is not applicable to cover the expanse of chemical diversity of metabolites 
present in plants. Accordingly, many studies have focused on LC-MS, which provides higher selectivity 
and impartial detection for analysis of a wide range of metabolites in plant tissue. Von Roepenack-Lahays 
et al. [100] reported detection of 1400 metabolites in Arabidopsis extract by quadrupole time of flight 
(QTOF) mass spectrometer, and Aharoni et al. [101] identified 5000 metabolites from a single plant by 
FT-ICR-MS. In order to increase the spatial resolution of single cell or tissue-specific investigations when 
only small sample sizes are available, various designation techniques have been developed, such as 
capillary electrophoresis coupled to laser-induced flouresence (CE-LIF) or mass spectrometer (CE-MS). 
Sato et al. [102] identified more than 80 metabolites related to glycolysis, an oxidative phosphate pathway 
in rice leaf extract. This study reported the identification of low-concentration, unstable metabolites, such 
as fructose-1,6-biphosphate, and ribulose-1,5-biphosphate. However, due to the complexity of plant 
matrices and the objective of a given investigation, different sample preparation techniques may need to 
be applied prior to analysis; for example, a step may need to be undertaken to extinguish plant enzyme 
activity at the time of sampling, while another technique may need to be applied to separate metabolites 
from the insoluble components of the cell, which include protein, starch, cell wall, pigments, as well as 
other macromolecules such as high molecular weight carbohydrates [103]. 
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Metabolomics is affected by the type of sample preparation technique chosen. Plant metabolomics can be 
subdivided into the following four steps: 1) harvesting of plant materials, 2) processing prior to 
extraction, 3) extraction, and 4) pre-analytical sample preparation [103]. The selected analytical 
technique, together with physical chemical properties of the metabolites under study, determine the 
necessity of each step. Time or place of harvest, as well as environmental conditions, may change plant 
metabolome [104-106]. These changes may occur within seconds up to a few minutes; accordingly, 
harvesting should be carried out in a rapid fashion and any further metabolic changes should be prevented 
from continuing immediately after harvesting. Freezing in liquid nitrogen is the most popularly applied 
technique to stop metabolic changes in plant samples [105]. As cells are vulnerable during freezing, in 
order to remove water, freezing-drying based on lypophilisation and cryodesication can be applied [107]. 
Additional processing prior to extraction, such as grinding, helps improve extraction [108].  
Extraction of metabolites from plant tissue is labour intensive, lacks reproducibility, and is generally not 
available as an automated procedure, in addition to being expensive and time-consuming. The techniques 
applied for metabolite extraction in the plant metabolomics workflow include solvent extraction, vapour 
phase extraction, steam distillation, superficial fluid extraction, and ionic liquids. To date, LLE is the most 
frequently used method in plant metabolomics [106,108,109,110,111]. However, the use of this technique 
during extraction may produce metabolite degradation, modification, or loss, as well as artifact formation 
[104-106]. As a large variety of metabolites is present in the plant metabolome, including nonpolars such 
as terpenoids, fatty acids, midpolars such as secondary metabolites, and polars such as sugars and amino 
acids, this highly diverse metabolome cannot be covered by single solvent use [106,109]. The ratio of 
solvent and plant matrix, type of solvent, extraction time, temperature, as well as the applied methods 
need to be determined prior to analysis. Parameters in solvent selection, summarized as its selectivity, 
inertness, polarity, boiling point, toxicity, in addition to environmental considerations, can interfere with 
the analytical techniques applied towards determinations [106]. The use of methanol coupled to a mixture 
of solvents, followed by applications of an acidified solution for extraction of polars and chloroform for 
extraction of nonpolars, is the most utilized solvent extraction procedure reported for plant metabolomics 
[108,109,112]. Past research has demonstrated that mixing water with organic solvents decreases the 
extraction of nonpolar metabolites such as chlorophyll and fatty acids, causing problems in RPLC-MS. 
On the other hand, water is problematic in GC-MS applications that include the extraction of both polar 
and nonpolar compounds. A protocol involving the use of chloroform/methanol/water (2:2:1 v/v/v) has 
been developed [109] and applied successfully by Yuliana et al. [112] with NMR analysis. In other work, 
Moritz et al. used a mixture of solvent and nonpolar solvent accompanied by shaking for extraction of 
polar and nonpolar metabolites from homogenized plant tissue, respectively [105]. In order to expedite 
the solvent extraction technique, various methods such as ultrasonic extraction, microwave, and 
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pressurized solvent extraction have been developed [113,108,114,115,116]. These types of extraction 
methods are mostly efficient for targeted analysis; an ideal method is still needed for untargeted analysis. 
SPE, another technique often used in plant metabolomics in order to sample clean up, offers a reduced 
matrix effect. C2, C8, C18, ion exchange cartridges, and polymeric adsorbents have been developed and 
applied in this area [108,109,117-124]. However, some of the drawbacks reported for SPE in this area are 
reduced metabolite coverage and metabolite loss. 
Environmental stress in plants and any other organisms is defined as any change in growth conditions that 
interrupts the metabolic pathways. Application of metabolomics could contribute to the study of stress 
biology of plants and other organisms by assisting in the identification of various metabolites, such as by-
products of stress metabolism, as well as stress signal transduction molecules, which are part of the 
acclimation response of plants. Metabolic profiling and fingerprinting, a combination of different ‘omics’ 
platforms, can assist in the capture of holistic features of plant response stress, as well as aid in the 
characterization of other metabolic pathways [125].  
1.4 Introduction to solid phase microextraction (SPME) 
Solid-phase microextraction (SPME) is a non-exhaustive sample preparation method that integrates 
sampling and sample preparation steps. Historically, SPME was mostly applied in combination with GC 
and GC-MS. However, SPME coupled to GC or GC-MS is unresponsive, and thus unable to analyze non-
volatile and thermally labile compounds; therefore, scientists have tried to develop SPME in direct 
coupling with LC-MS. The first format of SPME to be introduced was fiber geometry, in which small 
amounts of extracting phases (SPE sorbents) are immobilized on a solid support (Figure 1.3). In order to 
improve extraction recovery, SPME was developed in other formats, such as thin film, coated stir-bars, 
and coated capillaries. SPME is comprised of consequent steps, which include extraction of the analytes 
of interested by SPME coating from the sample matrix, and desorption of the extracted analytes from the 
coating. Extraction of analytes can be done by setting the fiber above the sample in the case of volatile or 
semi-volatile analytes, or by direct immersion (DI). Desorption of extracted analytes from the surface of 
the coating occurs through thermal desorption for GC or solvent desorption for LC. The currently 
presented work is focused on the analysis of non-volatiles by LC and direct immersion SPME-LC-MS. 
The amount extracted by the fiber is achieved via Equation 1.1:  
 𝑛! = !!"!!!!!!!!!"!!!!!                                                               Equation 1.1                                                 
 
Where n is the amount extracted in moles, C0 is the initial analyte concentration in the sample, Vs is the 
sample volume, Vf is the fiber volume, and Kfs is the distribution constant between the sample matrix and 
SPME fiber, stated as the proportion of analyte concentration in the coating to that in the sample at 
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equilibrium conditions. Kfs (in Equation 1.2, 𝐶!! and 𝐶!! are the analyte concentrations in the fiber and in 
the sample at equilibrium time, respectively) is dependent on the type of analyte under investigation, 
sample matrix properties such as pH and temperature, in addition to the type an organic solvent used and 
the ionic strength.  
 𝐾!" = !!!!!!                                                                                Equation 1.2 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure 1.3 SPME procedure scheme using direct extraction mode: SPME coating is exposed directly to the sample 
solution, and analyte of interest is extracted into the coating. After extraction coating exposed into the desorption 
solvent, and after desorbing analyte into the desorption solvent, solution is ready for further analysis. 
 	  
 
As the technique is non-exhaustive in nature, only small amounts of analyte can be extracted, as opposed 
to exhaustive extractions that occur in LLE and SPE applications. Coatings are classified as either solid or 
liquid; the choice of coating significantly impacts the performance of the method. For liquid coatings, 
such as polydimethylsiloxane (PDMS), analytes are absorbed by the liquid coating through a partitioning 
mechanism. When the coating is thinly applied, extraction will likely occur within a reasonable amount of 
time. However, for solid coatings with a glassy or crystalline structure, such as 
divinylbenzene/polydimethylsiloxane (DVB)/(PDMS), Carboxen/PDMS, and Carbowax (CW)/DVB, the 
extraction mechanism is based on physical interactions or adsorption; in such cases, the analytes are 
	  
	  
	  
	   	  
Coating support 
Coating 
Sample 
	   15 
adsorbed only on the pores of the coatings, not inside the coatings. Small or mid-sized analytes are 
retained in the pores of micropore (<20 Å) or mesopore (20–500 Å) coatings. When energy or solvents 
are applied, the adsorbed analytes are displaced. The mechanism of action is different for macroporore 
coatings (> 500 Å), which can adsorb larger analytes through hydrogen bonding, pi-pi bonding or van der 
Waals interactions. Long extraction times can cause analytes with poor adsorption affinity to be displaced 
by those that have high adsorption affinity or are high in concentration in the sample matrix. To remediate 
this limitation, pre-equilibrium extractions can be carried out for solid coatings. Equation 1.1 is valid for 
liquid coatings, while Equation 1.3 is applicable for solid coatings:  
 
ne=
!!"#!!!!!!!(!!"#$!!!!)!!!!!"#!!(!!"#$!!!!)                                                                  Equation 1.3 
 
where Cfmax represents the maximum concentration of active sites on a solid coating, 𝐶  !!represents the 
equilibrium concentration of a given analyte on the fiber, and KAfs represents the analyte’s adsorption 
constant at equilibrium. The adsorption constant is defined as the ratio of the surface concentration of the 
adsorbed analyte on a porous solid extractive phase to the concentration of the analyte in the sample at 
equilibrium (KAfs = 𝑆!"!  /𝐶!! ). Equation 1.3 demonstrates that when the equilibrium concentration of the 
analyte is significantly lower than the concentrations on the active sites on the coating (𝐶  !!<< Cfmax ), the 
amount of analyte extracted is linearly proportional to the initial sample concentration, while for higher 
concentrations, coating behavior will be nonlinear due to the saturation of active sites. Since the time 
required for analytes to reach equilibrium is infinite, equilibrium is expressed as the time required to 
extract 95% of analyte, theoretically obtained by Equation 1.4. 𝑡! = 𝑡!"% = !!!"!  !!!                                                                                   Equation 1.4 
 
 In this equation, δ represents the thickness of the boundary layer, Ds represents the diffusion coefficient 
of the analyte in the sample matrix, b represents the coating thickness, and Kfs represents the distribution 
constant. Based on this equation, equilibrium time is controlled by factors such as agitation conditions, 
which affects the thickness of the boundary layer; the distribution constant, determined by the affinity of 
the analytes for the coating; the thickness of the SPME coating; and the physiochemical properties of the 
analyte, which determines the diffusion coefficient. When time is of importance, for example, for analysis 
or extraction of unstable metabolites, extraction can be conducted at pre-equilibrium conditions, 
determined by Equation 1.5. In this equation, a is the time constant, which is determined by the mass 
transfer coefficients, distribution constant, sample volume, and extraction phase surface area. 
 
n= (1-𝑒!!")𝑛!= (1-𝑒!!")  𝑛! = !!"!!!!!!!!!"!!!!!                                               Equation 1.5 
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 At equilibrium conditions, Equation 1.5 can be transferred into Equation 1.1, demonstrating that 
equilibrium time is determined by initial concentrations. At Vs >> VfKfs, (large sample volumes), both 
equations (Equation 1.1 and 1.5) change to Equation 1.6.  
 𝑛! = 𝐾!"𝑉!𝐶!!                                                                             Equation 1.6 
 
In this condition, the extracted amount is independent from the volume of the sample. This equation can 
be applied for direct on-site sampling or in vivo sampling, which is very appealing in metabolomics 
studies. In the case of Vs << VfKfs, Equation 1.1 is revised to Equation 1.7, indicating the equality of the 
amount extracted to the product of analyte concentration by sample volume. 
 𝑛! = 𝑉!𝐶!!                                                                          Equation 1.7 
 
SPME calibration, a measurement of analytical signal versus analyte concentration, may be required for 
SPME analysis. Various calibration methods have been applied based on the type of application and 
instrumentation, including external, internal, standard addition, equilibrium extraction, exhaustive 
extraction, pre-equilibrium extraction, and diffusion-based calibration [54]. 
Sampling and sample preparation are the most time-consuming parts of the analytical process; indeed, 
studies have indicated that more than 80% of analysis time is currently spent on these steps. As in most 
cases, when a large number of samples need to be processed, enhancing the speed of these processes to 
improve sample throughput is mandatory. This can be achieved in two ways: decreasing the time of the 
sampling procedure, or sampling from a large number of samples simultaneously. Significant research 
attention has been paid to improving these steps [54]. SPME has not been excepted from these efforts, as 
various designs have been applied to improve sample throughput for SPME. An automation system 
provides numerous advantages such as speed enhancement, higher reproducibility, human error 
minimization, as well as a reduction in labor. Commercial autosamplers have been applied for GC 
applications from the 1990s, and the first coupling of SPME to an LC system was conducted through an 
injection tee for solvent desorption in 1995 [126,127]. In 1997, Eisert applied in-tube SPME as a proof-
of-concept design for automated SPME coupled to an LC, although this system did not provide high-
throughput [128]. The recent development of robotic autosamplers has effectively provided high-
throughput. In 2005, the first methodology for SPME in a 96-well format was introduced [126]. The first 
stationary phases for the system were PDMS-DVB SPME coatings, which were used for bioanalysis 
[129]. Although previous designs were expensive, they provided higher accuracy and repeatability in 
comparison to LLE in 96-well format. In order to provide a more cost-effective design, 96 stainless steel 
pins coated with PDMS hollow fiber membranes were used [129]. The Concept 96 autosampler, designed 
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by Professional Analytical System (PAS) Technology, was first introduced for bioanalysis applications 
using an octadecyl silica-based 96-fiber SPME coating [130]. Following, the Concept 96-SPME system 
was designed with different geometries in the format of rod fibers, disks, and thin films. Different coating 
chemistries have since been developed for these systems, especially for biological applications [131-135].  
One of the limitations of the SPME fiber is its low extraction efficiency due to the small volume of the 
extraction phase used as a coating. Based on Equation 1.1, the extracted amount of analyte could be 
increased by enhancing the volume of the extraction phase. This enhancement can be achieved in two 
ways: by increasing the surface area of the extraction phase, or by increasing its thickness. As previously 
mentioned, increasing the thickness of the coating limits the extraction speed, whereas surface area 
enhancement can be achieved either by increasing the diameter of the coating or through the use of thin 
film geometry. While fiber diameter enhancement is limited due to the format of the commercial 96-well 
plate, the use of thin film geometry does not suffer from the same limitations. As can be seen in Equation 
1.8, extraction rates can be increased through an increase in the surface area or a decrease in coating 
thickness. 
 !"!" = !"!! 𝐶!!                                                                                Equation 1.8 
 
Previous reports indicated that the use of thin film geometry in comparison to the traditional rod fiber 
configuration improved extraction rates by 2-fold [136]. For this purpose, Mirnaghi et al. tried to improve 
the 96-SPME system using thin film geometry and a commercial 96-blade device designed by PAS 
technology. The Concept 96-blade SPME device is composed of eight rows with twelve flat pins coated 
with sorbents 2 cm from the end. In this design, the eight rows of stainless steel blades are held together 
by nine inter-blade holders. The robotic Concept 96-autosampler controlled by Concept software is 
designed to directly place the 96-blade device into the 96-well plate that contains samples or solvents for 
each step of preconditioning, extraction, wash, and desorption. The 96-blade SPME coatings must have 
high extraction recovery, reusability, reproducibility, physical and chemical stability, cost efficiency, and 
be easily automated. In addition, the coatings should also be biocompatible and reach equilibrium within 
a short period of time. Mirnaghi et al. evaluated different extraction phases for the above-mentioned 
system for targeted analysis of biological matrices such as blood and plasma, as well as for food samples 
such as wine and grape. In different works, coatings such as PBA, PS-DVB-WAX, C18, and silica gel 
were developed as well; however, this system had yet to be developed and applied towards extraction of a 
wide range of metabolites or for untargeted analysis [137,138,139]. In the current research, different 
coatings are evaluated and applied as the stationary phase for the 96-blade system for untargeted analysis. 
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1.4.1 SPME and metabolomics 
SPME is a technique that assists in rapid and solvent-free sample preparation; its small sample amount 
requirements and automation compatibility contribute to high-throughput qualitative and quantitative 
determinations. Accordingly, SPME has been frequently utilized in the area of metabolomics [140-142]. 
This technique has the potential to acquire previously unreported information by providing metabolome 
snapshots at the time of sampling. SPME also provides high spatial resolution, making on-site sampling 
and in vivo extraction comparatively easier processes, in addition to allowing for the extraction of 
unstable metabolites [143].  
Since SPME was originally developed for GC applications, most of its coatings were also originally 
designed for GC applications. PDMS, polyacryl (PA), and CARBOWAX (CW) are some of the coatings 
used in GC analysis, but rarely applied for targeted analysis due to their tendency to mostly extract polar 
metabolites, which in turn results in poor metabolome coverage [144-145]. DVB/Car/PDMS is a coating 
applied for the extraction of a wide variety of metabolites. This coating has been utilized for metabolic 
profiling of skin, pepper, cocoa, and banana [147-151]. The first reports using SPME were for extractions 
from the headspace (HS) of samples. The use of direct immersion SPME for analysis of complex matrices 
has been controversial; the adsorption of macromolecules on the surface of the coatings has been reported 
to produce artifacts, while non-volatiles and thermally labile extracted components were described to 
decompose in the injector [54]. PDMS-modified coatings have since improved solid coatings to be more 
biocompatible for direct immersion SPME and in vivo sampling [152]. In LC applications, fiber and thin-
film SPME were utilized for bioanalysis. Vuckovic reported evaluation of 42 different SPE particles 
(silica, polymer, and carbon) immobilized with Loctite 349 adhesive on stainless steel fiber, and applied 
them for the extraction of metabolites from plasma with a wide polarity range (-7.9 < Log P< 7.4). The 
results demonstrated that mixed-mode (C18 or C8), phenylboronic acid (PBA), and polystyrene-
divinylbenzene (PS-DVB) provide the widest metabolome coverage. In the same study study, SPME 
methodology was compared with protein precipitation and ultrafiltration, with results demonstrating that 
SPME could provide a complementary metabolome snapshot for the other two methods. For example, 
carnitine, gangaliosides, fatty acids, and lysophospholipids were successfully solely extracted by SPME, 
whereas application of microdialysis allowed for extraction of hydrophilic metabolites such as peptides 
and amino acids, which could not be extracted by SPME for in vivo sampling [153]. In addition, 
polyacrylonitrile, as a biocompatible binder, was shown to assist in the reduction of matrix effects for in 
vivo and in vitro LC applications [137-139].  
Other attempts have been made to optimize the stationary phases of SPME coatings so as to provide wide 
metabolome coverage for different complex matrices such as biofluids, tissues, plants, microorganisms. 
The majority of works conducted in the plant metabolomics area using SPME were performed by GC-MS 
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in order to extract the volatile organic compounds originating from different biosynthesis pathways 
produced by plants. HS-SPME was used for pre-concentration of volatiles in bioanalysis approaches. To 
date, HS-SPME coupled to GC-MS has been used for comprehensive metabolic profile characterization 
of volatile metabolites in plant materials such as cocoa, coffee, herbs, fruits, and vegetables. 
Differentiation of cocoa beans related to geographical origins and storage conditions based on changes 
occurring in their volatile profiles was reported by Humston et al [154]. Risticevic et al. implemented 
direct immersion in vivo SPME in apple metabolomics, with results that demonstrated that the type of 
SPME coating selected for extraction affects the quality and reliability of the obtained metabolome 
coverage [155]. This mode of SPME provides extraction of high molecular weight metabolites as well as 
polar ones. In related work, volatilomics analysis was conducted by Apera et al. for four types of apple 
samples with application of HS-SPME-GC-TOF-MS; this analysis demonstrated the importance of 
sample collection and storage, as a large decrease in volatile metabolites in apple samples was observed 
in respect to freshly-processed samples. In addition, application of multivariate data analysis has been 
shown to also aid in the differentiation of samples stemming from different apple types related to their 
volatile alcohol and ester derivative profiles [156].  
SPME has also been applied for the extraction of metabolites with a wide range of polarities from 
biological fluids such as blood, plasma, serum, urine, and saliva. In vivo sampling using SPME-LC-MS 
was successfully performed in this area; unstable metabolites such as AMP, gluthathione, and β-NAD 
were identified by this technique, which had not been previously reported with the use of traditional 
techniques [143]. DI-SPME-LC-MS was recently utilized to provide a plasma metabolome profile of 
patients under cardiac surgery. In this study, SPME demonstrated differentiation between metabolic 
pathways induced by the surgery and the applied pharmacotherapy. Lysophospholipids, triglecerols, 
linoleic acids, and mediators of platelet aggregation were listed as potential biomarkers in this study. 
Different changes in the metabolic patterns of different patients were also identified [154]. In other work, 
DI-SPME-LC-MS was applied for simultaneous extraction of approximately 400 metabolites in different 
classes with a wide range of polarities (-3.5 < Log P < 10) from saliva. In this study, SPME showed good 
discrimination between the metabolic patterns of male and female volunteers [142]. HS-SPME-GC-MS 
has also been applied for detection of potential cancer biomarkers through comparisons of urinary 
metabolic profiles. Volatile global metabolome profiling from skin in the early stages of melanoma 
differed from that of healthy skin and benign naevus samples, demonstrating an increase in three volatile 
hydrocarbons as secondary metabolites of membranes produced through lipid peroxidation or oxidation 
stress [157]. Silva et al. reported the presence of 82 volatile organic metabolites related to three different 
cancers in the headspace of urine samples. Benzene derivatives, terpenoids, and phenols have been 
indicated as differential metabolites in oncological samples [158]. 
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Tissue metabolomics is another area in which SPME has been used as a noninvasive sample preparation 
method. In tissue sampling studies, the metabolic coverage of the mixed-mode SPME coating was shown 
to be comparable with results obtained from solvent extraction procedures [159]. In work conducted by 
Cudjo et al., in vivo SPME and microdialysis were applied for brain analysis in response to external 
stimuli, and results indicated that in comparison to microdialysis, SPME was more successful in 
providing a comprehensive metabolic pattern, in addition to yielding a higher pre-concentration of 
samples. In this research, Cudjo et al. reported the high affinity of SPME for the extraction of nonpolars; 
conversely, microdialysis was shown to extract mostly polar metabolites [160]. In other work, on-site 
application of in vivo SPME during lung and liver surgery towards discovery and monitoring of 
metabolic pathways, as well as identification of potential biomarkers, has offered potential real time data 
[159]. In vivo SPME in thin film format has also been reported for metabolic profiling of volatiles 
emitted from skin [161]. SPME has also been successfully applied for metabolic fingerprinting of the 
headspace of cell cultures from different tissues and cell lines, such as lung, stomach, and colon; SPME 
demonstrated clear separation between volatile organic compounds obtained from healthy and cancerous 
stomachs [162]. For example, Buszewski et al. introduced Helicobacter as a gastric cancer pathogen 
through a comparison of obtained metabolic profiles with pathogen headspace composition [163].  
SPME has also been shown to be a suitable technique for identification of pathogenic contamination in 
foodstuffs. HS-SPME was applied for metabolic fingerprinting of volatile compounds from different 
bacteria species. Siripatrawan et al. reported contamination in packed food with Salmonella typhimurium 
with SPME-GC-MS with chemometrics applications in order to predict the number of bacteria in 
unknown samples [164]. The SPME-GC-MS metabolic platform of volatiles from Pseudomonas 
aeruginosa identified 28 new compounds [165]. In another study, Zakir et al. reported the application of 
the automated SPME-GC-MS method for investigations of cinnamaldehyde as an antibacterial agent 
against E.coli bacteria growth at various stages of the growth curve [166].  
LC-MS plays an important role in the identification of a large number of metabolites that cannot be 
identified by GC-MS. In the present study, the potential of coatings developed for SPME-LC-MS targeted 
analysis was tested for both bacteria and plant metabolomics. To that end, evaluation of environmental 
stresses such as cold temperature on apple samples, as well as antibacterial agent effects on E.coli bacteria 
metabolome profiles were investigated in further applications using multivariate analysis. 
1.5 Data processing tools for metabolomics  
As metabolomics provide a large amount of data, the currently presented work relied on the use of 
statistics for data processing as well as application of multivariate analysis for concomitant processing of 
a large number of variables. Figure 1.4 illustrates the data analysis workflow of the presented research 
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work. First, raw data obtained with Xcalibur software (.raw) was converted to (mzXML) with MS 
conversion software. Next, the XCMS R-package (Scripps Center for Metabolomics, California, USA) 
was applied for data processing. The software output consisted of tables containing retention time, m/z, 
and intensity of features. Figure 1.5-A demonstrates the output of the software after peak detection, 
retention time correction, and peak alignment. The CAMERA R-package (Bioconductor Version 2.10) 
was applied to provide ion annotation on the list of features so as to identify detected isotopes, adducts, 
and in-source fragments ions. The obtained data from table 1.5 was then used for tentative identification 
by submitting the exact masses of the unknown metabolites obtained from chromatograms to the 
METLIN database using a 5 ppm mass window. Further selection of metabolites was based on the 
detection of at least two adducts with the same nominal mass at a given retention time; if available, 
authentic standards were then used towards the identification of metabolites through a comparison of 
accurate mass and retention time. In the next step, SIMCA-P+ software v.13.0.3 (Umetrics, NJ, USA) was 
used for multivariate statistical analyses. Principle component analysis (PCA) and partial least square-
discriminant analysis (PLS-DA) were used in this regard. PCA is a linear transformation applied to 
dimensionality reduction that preserves data; it builds a new co-ordinate system describing variations 
within the data. Application of PCA on large tables of data obtained by R package software yielded two 
plots: score plots and loading plots. Score plots demonstrate patterns, trends, clusters, and outliers; it 
summarizes observations, and separates signals from noises. Loading plots, on the other hand, explain the 
position of observation in scores plot while summarizing the obtained variables. Figure 1.5 demonstrates 
the score and loading plots obtained for a set of data; as can be seen, the principal components are 
orthogonal to each other and uncorrelated. The first component is representative of the largest variance in 
the dataset, while consequent ones are orthogonal to the first one, demonstrating the highest remaining 
variance. Figure 1.5-B illustrates two clusters related to two observations in the score plot, while the 
loading plot (Figure 1.5-C) demonstrates how the original variables correlated to each set of clusters. In 
these plot scores, ti, are new variables summarizing the original variables, ordered in a downward fashion: 
t1, t2, and so forth.  
PLS is a supervised dimension reduction methodology that supervises forms of discriminant analysis, 
such as PLS-DA used in classification studies and biomarker identification. Figure 1.6-A demonstrates a 
PLS score plot that indicates the degree of separation between four sets of observations, based on 
treatment and incubation time. The S-plot, the output of PLS (figure 1.6-B), is a useful tool in biomarker 
identification; in this plot, statistically significant variables are discovered through comparisons of control 
and treated samples. The p1-axis represents the magnitude of each variable on the X-axis, while the 
p(corr)1-axis describes the reliability of each variable in X. Variables with high magnitude and high 
reliability are counted as statistically significant variables; in other words, ideal biomarkers. For 
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metabolite confirmations, retention time and fragmentation patterns of authentic standards are then 
compared to those obtained from samples, and pathway analysis can be explored. 
 
 
         
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Data analysis workflow for metabolomics using R and SIMCA softwares 
Supervised modeling: PLS, OPLS, S-plot, discriminating metabolites, potential biomarkers 
identification, MS/MS fragmentation 
Data processing: XCMS R-package (peak detection, retention time correction, peak alignment): 
Table containing m/z, t
R
, and intensity of features 
Metabolite identification: Camera R-package (identify isotopes, adducts, in- source fragments ions) 
METLIN database 
Multivariate statistical analysis: PCA, data overview, outliers, clusters, important metabolites, 
pattern, trends 
Experimental design: Raw data (.raw) obtained by Xcalibur software changed to mzXML with MS 
convert software 
Pathway representation: Mechanistic interpretation 
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Figure 1.5 A) Excel file obtained from XCMS R-package and CAMERA R-package softwares, PCA converts table 
into score plot related to observations and loadings plot related to variables: B) observations score plot and C) 
variables loadings plot obtained from SIMCA-P+ software 
 
 
                       
Figure 1.6 A) PLS score plot demonstrates discrimination between experimental groups (control and treated samples 
at two different time points), and B) S-plot (comparison of two sets of data (control and treated samples at two 
different incubation times: 12 hours) for extraction of putative biomarkers. 
 
 
1.6 Research objective  
The main objective of this body of work was the development of a 96-blade SPME-LC/MS method that 
can provide full metabolome coverage of biological system. Currently, there are no methods available that 
can provide extraction and detection of a wide variety of analytes in a single run. To this purpose, 
different stationary phases for the automation system were developed and evaluated, then coupled to LC-
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MS analysis. Next, the developed coatings were applied for targeted analysis of E.coli bacteria as a model 
organism, and grape and apple samples as plant matrices. Accordingly, Chapter 2 focuses on the 
development of a silica-based ionic liquid coating suitable for the extraction of amino acids from complex 
matrices (grape matrix) without any further sample pretreatment. The obtained results demonstrated that 
changes in precursors during synthesis of the silica-based ionic liquid coating, which impact the polarity 
of the coating, allowed for suitable extraction coverage of metabolites from the sample under study. 
Chapter 3 includes an evaluation of various coating chemistries for the extraction of different classes of 
metabolites with different physical and chemical properties. Identified metabolites are classified as high 
polarity metabolites (central carbon metabolism such as the glycolytic pentose phosphate pathway and 
citric acid cycle intermediates, as well as biosynthetic metabolites such as amino acids, nucleotides, 
vitamins, and their precursors) to nonpolars, including lipids from E.coli culture. Chapter 4 applies the 
method developed in Chapter 3 for bacteria metabolomics towards an investigation of E. coli bacteria 
affected by cinnamaldehyde, both below and above the minimum inhibitory concentration (MIC) during 
bacterial growth. Chapter 5 includes the development of the 96-blade SPME method through application 
of multivariate analysis. This chapter details how the developed method was used to investigate bacteria 
affected by clove oil, as well as clove oil major constituents. The method successfully investigated 
environmental fluctuations leading to rapid adjustment of bacteria treated by different naturally occurring 
antibacterial agents such as cinnamaldehyde, clove oil, and other essential oils during bacteria growth, 
necessitating changes to the cellular network and metabolic pathway. The obtained results indicated 
potential biomarkers related to changes in the metabolic pathway of control samples in comparison with 
matched treated samples. In chapter 6, the 96-blade SPME method was evaluated for targeted and 
untargeted apple metabolomics studies; in this work, the developed method was applied towards further 
exploration into the physiological processes that lead to cell death as well as the ripening processes that 
affect the flavor, appearance, and overall quality of stored apple samples with superficial scald. This work 
used a combination of univariate and multivariate data analysis to characterize changes occurring in the 
metabolic profiles of “honey crisp” apples induced by cold stress, resulting in novel evidence of changes 
in the metabolic profile of stored apple samples in comparison with healthy ones. Finally, Chapter 7 
summarizes the main research findings of this current work and proposes future directions and challenges 
for this field of study. 
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Chapter 2 
Silica-based ionic liquid coating for 96-blade system for extraction of 
amino acids from complex matrixes 	  
2.1 Preamble and introduction  
2.1.1 Preamble  
This chapter has been published as a paper: Fatemeh Mousavi, Janusz Pawliszyn, Silica-based ionic liquid 
coating for 96-blade system for extraction of aminoacids from complex matrixes, J. Analytica Chimica 
Acta, 2013, 803, 66-74. The materials of the current chapter are reprinted from this publication with the 
permission of Elsevier (Copyright Elsevier 2013). All of the work reported within this chapter has been 
performed solely by the author. 
 
2.1.2 Introduction 
Ionic liquids (ILs) are organic/inorganic salts with a melting point below 100°C. These compounds have 
some special properties, such as negligible vapor pressure, high thermal stability (~250-400°C), variable 
viscosity, and capability of undergoing multiple solvation interactions [167]. The popularity of ILs is due 
to their applications in green chemistry; however, their usage also has been extended to other research 
areas. ILs are also used in different areas of separation techniques, including: GC, LC, and electrophoretic 
methods. In LC, ILs are used as the mobile phase additives to eliminate the destructive effect of stationary 
phase on the retention of basic analytes. Moreover, ILs have been applied as the stationary phase for LC 
columns through using synthesized silica based ionic liquid (SiIL) particles [168-175].  
Four various methods have been reported in the literature for synthesizing silica-based ionic liquid (SiIL). 
The first method begins with the attachment of bromoalkyl-1-trichlorosilane to silica; followed by the 
synthesized compound being endcapped with chlorotrimethyl silane. Finally, the reaction between the 
endcapped modified silica and ionic liquid produces SiIL [176-182]. The second method uses 3-
mercaptopropyltrimethoxysilane (MPS), to modify activated silica; afterwards, the reaction of the product 
with the allyle group of imidazole is utilized in the presence of azodiisobutyronitrile (AIBN) as an 
initiator [182-186]. The third method uses a silane-coupling agent, such as 3-
chloropropyltrimethoxysilane, for the modification of activated silica. The reaction is completed through 
the reaction of the product by imidazole [187-193]. The fourth method synthesizes ionic liquid via the 
reaction of 3-bromopropyl-triethoxysilane and 1-alkylimidazole. Finally, the reaction of synthesized ionic 
liquid with silica produces SiIL [194]. In the current work, the second method was used for synthesizing 
SiIL. 
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SPME, a popular sampling technique introduced by Pawliszyn in the early 1990s, is a simple, quick, cost 
effective and solventless technique, which integrates sampling and sample preparation into one step [195-
197]. Automated high-throughput analysis is necessary to provide fast and precise sample preparation for 
analysis in various fields of clinical, pharmaceutical, food, and environmental sciences. In-house 96-
coated SPME fiber using automated robotic unit was used to access high-throughput analysis via 
automation of SPME coupled with LC-MS/MS for parallel analysis of drugs in human blood and plasma 
by Pawliszyn’s group in 2008 [198]. 
To eliminate the limitation of the previous design [198], a 96-blade system coated with thin film 
geometry was developed, and commercial SPE particles including C18, PS-DVB-WAX, and PBA were 
used as the stationary phase on the stainless steel blade for 96-blade system using polyacrylonitrile (PAN) 
as a biocompatible binder [137,138]. These extractive phases provide high extraction recovery in the case 
of extraction of nonpolar compounds, but it is needed to introduce new extraction phase for extraction of 
polar compounds. 
Based on the author’s knowledge, until now ionic liquids immobilized on silica have not been applied to 
the stationary phase for SPME as the sample preparation technique for HPLC. According to references 
[199-201], molecular interactions such as strong hydrogen bonding, hydrophobic, ion-dipole, and strong 
ion-pairing exist in ionic liquid, which provide sufficient interaction with polar compounds. Due to these 
considerations, we synthesized a new stationary phase based on N-methylimidazolium cation group 
attached on the silica surface, and then immobilized it on the stainless steel blade with PAN glue; finally, 
the new extraction phase was applied for direct extraction of amino acids as a group of polar compounds 
from complex food matrix.  
An essential active compound available in food and beverages is amino acids, which affect the food 
quality through taste, aroma, and color. Since these compounds are considered vital elements of human 
diet, their determination has an important role in food industry [202]. Most methods for analysis of this 
group of compounds usually require derivatization by derivatization agents to increase their detectability. 
However, these methods have some disadvantages, such as instability of derivatives, side reactions, 
reagent interferences, and significant time consumption. Thus, a reliable, rapid, and accurate method of 
analysis is needed for performing qualitative and quantitative analysis of amino acids to investigate food 
quality for nutritional and regulatory purposes and overcome the drawbacks of determined in amino acid 
analysis techniques based on pre- or post-column derivative methods [203].  
The objective of this study is to introduce a new coating for SPME coupled with LC-MS/MS for 
extraction of amino acids as the high polar compounds from grape pulp without sample pretreatment. The 
chemical structure of understudied amino acids is shown in Figure 2.1. 
 
	   27 
2.2 Experimental 
2.2.1 Chemicals and materials 
1-vinylimidazole (99%), 3-mercaptopropyltrimethoxysilane, 2,2-Azobisisobutyronitrile (AIBN) (98%), 
and Polyacrylonitrile (PAN) were purchased from Sigma-Aldrich (MO, U.S.). 1-Bromooctadecane, 
(96%) was purchased from Fisher Scientific (ON, Canada). Silica gel with 60 Å average diameter was 
purchased from SiliCycle Inc (Quebec, Canada). Arginine, aspartic acid, glutamic acid, isoleucine, 
histidine, luecine, lysine, phenylalanine, proline, thereonine, tryptophan, tyrosine L-(+)-Tartaric acid and 
potassium-L-tartrate monobasic were purchased from Sigma-Aldrich (MO, U.S.). Acetonitrile (HPLC 
grade), methanol (HPLC grade), and N,N-dimethylformamide (DMF) were purchased from Caledon 
Laboratories (ON, Canada). Polypropylene Nunc U96 Deep Well plates were purchased from VWR 
International (ON, Canada).  
  
                                    
          Arginine                               Aspartic acid                             Glutamic acid                       Histidine      
       
  
                                             
          Isoleucine                                  Leucine                                       Lysine                               Phenylalanine 
 
                                                    
       
              Proline                                    Threonine                                      Tryptophan                       Tyrosine 
  
Figure 2.1 Chemical structures of understudied amino acids. 
 
 
2.2.2 Liquid chromatography and mass spectrometry conditions  
Chromatographic separation was performed by Discovery HS F5 column, 2.1mm×15cm, 3µm particle 
size (Supelco, Bellefonte, PA, USA) using gradiant condition. Flow rate was 200 µL/min, and mobile 
phases A and B consisted of water/formic acid (99.9/0.1, v/v) and acetonitrile/formic acid (99.9/0.1, v/v). 
The chromatographic elution and a 40 min gradient program was optimized for separating the model 
compounds as follows: 100% A (0-3 min), linear gradiant from 100 to 10% A (3-25 min), linear gradient 
held at 10% A from (25-34 min), the column reached to equilibrium for 6 min by applying gradient 10% 
A to 100% A. Quantitative analyses of compounds were performed using an API 4000 triple quadrupole 
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mass spectrometer (Applied Biosystems, California, U.S.) equipped with TurboIonSpray source. A CTC 
PAL autoinjector from Leap Technologies (CTC Analytics, NC, U.S.) was used for the injection of 
samples into the LC-MS/MS system (20 µL injection volume). The MS/MS analysis was performed in 
positive mode under multiple reaction monitoring (MRM) conditions. The summary of MS/MS 
parameters is given in Table 2.1, and extracted ion chromatograms of amino acids are shown in Figure 
2.2.  
Table 2.1 Optimized mass spectrometry condition of understudied aminoacids 
Compromised ionization source values: Ion source gas 1 (GS1)= +20, curtain gas= +10, collision gas= 12, spray 
ionization voltage= 5000 V, and temperature= 400 °C. 
Analyte Q1 mass (amu) Q3 mass (amu) DP (V) EP (V) CE (V) CXP (V) 
Arginine 175.1 70.1 59 14 36 19 
Aspartic acid 134.1 74.0 49 10 25 6 
Glutamic acid 148.1 84.1 47 10 25 6 
Histidine 156.1 110.0 47 15 25 20 
Isoleucine 132.0 86.1 60 10 16 15 
Luecine 132.1 86.1 47 10 25 6 
Lysine 147.1 84.1 46 15 26 6 
Phenylalanine 166.2 120.0 51 15 25 26 
Proline 116.1 70.0 22 14 27 14 
Threonine 120.1 74.0 40 14 25 15 
Tryptophan 205.1 188.3 44 11 25 8 
Tyrosine 182.1 136.1 61 10 20 14 
 
2.2.3 SPME procedure using automated Concept 96-blade SPME 
The Concept 96-blade SPME device and autosampler prepared by Professional Analytical System (PAS) 
Technology (Magdala, Germany) controlled by concept software was used to provide reproducibility and 
high-throughput for the analysis. The detailed description of automated 96-blade SPME system is 
reported in the references [137,138]. This system has 4 stations: preconditioning, extraction, wash, and 
desorption steps. Red seedless grapes, purchased from a local market in Waterloo (ON, Canada), were 
manually stemmed, washed with deionized water, dried, and crushed using a blender. The extraction was 
performed from 1 mL of sample for 90 min (1000 rpm agitation speed, 2.5 mm amplitude), which is the 
equilibrium time for all compounds. The optimized condition for wash was 10 seconds without agitation 
in the case of real sample analysis. Desorption was performed into 1 mL of acetonitrile/water 1:1 (v/v) as 
the optimized desorption solvent (1500 rpm agitation speed, 1 mm amplitude) for 60 min.  
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Figure 2.2 Chromatograms of aminoacids with developed LC-MS/MS method. 
 
2.2.4 General procedure for IL synthesis 
The procedure of synthesizing IL was performed based on literature [204]. In brief, 1-vinyl-3-
octadecylimidazolium bromide was produced through reaction of 4.7 g 1-vinylimidazole (0.05 mol) and 
18.3 g bromooctadecane (0.055 mol, 10% excess) at 60°C under agitation with a magnetic stirrer for 36 h. 
The IL product was separated as a precipitate through filtration process. By three consequent extractions 
with ethyl acetate, the remainder of liquid product was separated. After recrystallization from ethyl 
acetate in order to purification of the product, white solid was dried under vacuum at 60°C for 24 h.  
1-Vinyl-3-octadecylimidazolium bromide was obtained as the white powder with efficiency of 75% and 
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73°C melting point. Avance 300 MHz Bruker (Bruker, Germany) was used to take 1H NMR spectra of 
synthesized [C18VIm]Br. 1H NMR (CDCl3, ppm): δ 0.9 (t, 3H), 1.3 (m, 30H), 1.9 (qi, 2H), 4.4 (t, 2H), 5.4 
(dd, 1H), 6. 0 (dd, 1H), 7.5 (dd, 1H), 7.6 (s, 1H), 7.9 (s, 1H), 10.8 (s, 1H). 
 
2.2.5 Synthesis of the N-methylimidazolium functionalized silica  
Imidazolium functionalized silica was synthesized based on the procedure in reference [205]. First, 
activated silica was obtained by immersion of silica in hydrochloric acid for 24 h. Next, silica was washed 
with deionized water until the pH of eluted water reached 5.5, and was then dried under vacuum for 8 h at 
120°C. Mercaptopropyl modified silica (Si-MPS) was prepared through the reaction of activated silica 
(6.0g) and 3-mercaptopropyltrimethoxysilane (3.0g) in 30 mL of dry toluene under nitrogen atmosphere 
while stirring mechanically and refluxing for 68 h. After cooling to room temperature, the product - Si-
MPS- was obtained followed by successive washing with large volumes of toluene and methanol–water. 
SiIL was synthesized through surface radical chain-transfer polymerization of the synthesized 1-Vinyl-3-
octadecylimidazolium bromide monomers with Si-MPS based on the procedure used in reference [205]. 
6.1 g of Si-MPS was added to a 100 mL three-neck round-bottomed flask. Then, the same amount of 
synthesized IL was dissolved in 30 mL of chloroform and added to the flask. After 20 min of bubbling N2 
through the solution, 1% AIBN was added, and the mixture was stirred at 60°C for 32 h under N2 
atmosphere. The obtained SiIL, octadecylimidazolium-modified silica (SiImC18), was filtered and washed 
with chloroform, ethanol, ethanol–water, methanol, and diethyl ether, and dried under vacuum 
atmosphere. The structure of synthesized compound is shown in Figure 2.3. 
 
 
Figure 2.3 Chemical structure of silica-based 1-vinyl-3-octadecylimidazolium bromide ionic liquid and different 
types of possible molecular interactions. 
 
2.2.6 Immobilization of silica based ionic liquid on the 96-blade system 
Immobilization of the synthesized silica on the stainless steel blade system using PAN glue, and dipping 
technique was completed based on the previous works reported on commercial particles (C18, PBA, PS-
DVB-WAX) [138,139]. In brief, stainless steel blades were sonicated in concentrated HCl solution for 1 
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hour.  The blades were then washed thoroughly; and kept at 150°C for 30 min. In order to produce PAN 
glue solution, 0.5 g PAN was dissolved in 7.5 mL DMF; and kept at 90°C for 1 hour. 1.5 g of synthesized 
SiImC18 was added in PAN glue solution and sonicated for 30 min to disperse particles homogenously. 
Two cm length at the ends of the stainless steel blades were dipped into the prepared suspension for 2 
min, taken out, then dried for 2 min at 100°C. The dipping and drying steps were repeated 10 times until 
reaching the homegenous coverage of blades by the particles.  
 
2.2.7 Preparation of standards, buffers, and spiked solution 
1 mg/mL of stock solution of analytes in nanopure water was prepared and maintained at -30°C. Lower 
concentration standards were prepared daily from stock solution and diluted by acetonitrile/water (50:50 
v/v). Tartaric buffers were formed from determined molar ratios of potassium tartarate monobasic and 
tartaric acid in 1 L of water, and the pH of the buffers was adjusted to pH=5.0 using hydrochloric acid or 
sodium hydroxide solution if needed. The concentration of organic solvents in buffers and real samples 
was always maintained at less than 1%. In order to achieve the equilibrium of amino acids with the 
sample matrix, after spiking the standard of analytes in grapes, solutions were stirred for 1 h (2400 rpm 
agitation) before extraction. 	  
2.2.8 Solvent extraction (SE) procedure 
To compare the performance of SPME versus traditional extraction method, SE was performed for 
extraction of analytes from grape pulp. 1 g of grape sample was weighed in to a 15 mL centrifuge tube 
with cap. 10 mL of 0.2 mM acetic acid was added to the samples. After mixing by the vortex for 2 min, 
the mixture was centrifuged at 5000 rpm for 10 min at -5°C. The clear supernatant was quantitatively 
transferred into a vial, and filtered through 0.45 µm nylon syringe filter prior to LC/MS analysis [202].  
2.3 Results and discussions 
2.3.1 Characterization of developed SiImC18-PAN coating  
2.3.1.1 Thermogravimetric analysis (TGA) 
TA Instruments simultaneous TGA/DSC SDT Q600 (TA Instruments, IL, USA) was used for thermal 
geravimetric analysis. The condition of analysis was performed in static air ranging from 30°C to 800°C 
with a heating rate of 10°C/min. TGA, which measures the amount and rate of change in the weight of a 
material as a function of temperature or time in a controlled atmosphere showing thermal stability and 
verification of the amount of immobilized compounds, was performed for unmodified silica, synthesized 
Si-MPS, and SiImC18. As presented in Figure 2.4, weight loss for MPS was between 200°C and 600°C, 
and mass loss was approximately 12%. For SiImC18, weight loss was between 200°C and 600°C, and 
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mass loss was approximately 35%. The obtained results show that after forming covalent bonding 
between ionic liquid and Si-MPS, there is a higher mass loss for SiImC18 than Si-MPS. The weight loss at 
the temperatures less than 100°C occurs because of elimination of physically adsorbed water. The weight 
loss between 250-600°C is attributed to dehydroxylation of silica surface. Enhancement of weight loss in 
the case of SiImC18 compared with Si-MPS represents the higher organic content of SiImC18, thus 
verifying the attachment of synthesized [C18VIm]Br to the Si-MPS [194]. 
 
 
Figure 2.4 Thermogravimetric curves of silica, Si-MPS, SiImC18. 
2.3.1.2 Infrared spectroscopy (IR) 
Bruker Tensor 37 FTIR (Bruker, Germany) was used to take the Fourier transform infrared spectra in the 
range of 4000-400 cm-1 for identification of chemical modification of synthesized compounds. Based on 
IR spectra shown in Figure 2.5, differences in wave numbers and intensities of Si-MPS and SiImC18 were 
evident. The peaks at 2854 and 2927 cm-1 are related to the C-H stretching of tetrahedral carbon, and the 
peaks at 1468 and 1563 cm-1 are related to imidazolium group, which verify the attachment of 
imidazolium group onto the silica surface. 
2.3.1.3 NMR spectroscopy 
Avance 500 MHz Bruker (Bruker, Germany) was used to take solid state 13C and 29Si cross-
polarization/magnetic angle spinning nuclear magnetic resonance (CP/MAS NMR) spectra using 4 mm 
VT CP/MAS probe at 4.2 kHz to confirm the attachment of IL to the silica particle surface. Figure 2.6 
demonstrates the 13C NMR and 29Si NMR of the synthesized SiImC18 which provides valuable structural 
information. As shown in Figure 2.6 (a), the signals at -50 and -57 ppm are related to the monofunctional 
Si-O-Si and more stable bifunctional Si-O-Si linkages, respectively. The signals at -95 and -108 ppm are 
related to Si atoms with geminal and free hydroxyl groups, respectively. The signal at -115 ppm is related 
to Si atoms at siloxan network [205]. The signals related to carbons of mercaptopropyl, imidazolium and 
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alkyl groups of [C18VIm]Br are represented in Figure 2.6 (b) investigated by 13C NMR.  
 
 
Figure 2.5 FTIR spectra of Si-MPS and SiImC18. 
 
2.3.1.4 Characterization of SiImC18-PAN SPME coating immobilized on the stainless steel blade 
and scanning electron microscopy  
The topography and morphology of the coated blades was prepared by scanning electron microscopy 
(SEM). SEM images were recorded using an Ultrapure1530 field emission scanning electron microscopy 
(Zeiss NTS GmbH, Germany). Figure 2.7 shows the SEM images of the coating after being sputtered 
with 10 nm of gold on the surface. The SEM was also used to estimate the average thickness of the 
coating, which was approximately 20 µm. The distribution coefficients (Kfs) of the analytes between the 
fiber coating and sample matrix were calculated by Equation 1.1. 
Vf for thin film geometry coatings can be calculated from Equation 2.1, in which (l) is the coating length, 
(w) is the width of the blades, (d) is the depth of the blades, and (b) is the coating thickness [138].  
 𝑉! = 2 𝑙𝑏 𝑤 + 2𝑏 + 2 𝑙𝑏 𝑑 + 2𝑏 + [𝑏 𝑑 + 2𝑏 ]                                                             Equation 2.1 
 
The new extraction phase not only has an octadecyl chain to provide nonpolar interactions, but also has 
functionalized imidazolium groups, which provide additional interactions such as π-π and hydrogen 
bonding to the polar analytes. The information about Vf, Kfs, fiber constant, Kfs.Vf, and absolute 
extraction recovery, % AER, and intra- and inter-blade reproducibility for extraction of analytes from 
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tartaric buffer are summarized in Table 2.2. 
  
 
 
 
Figure 2.6 a) 29 Si CP/MAS NMR and   b) 13CNMR spectra of SiImC18. 
 
 
Figure 2.7 SEM image of SiImC18 -PAN coating using- 28× magnification for surface morphology. 
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2.3.2 SPME method development  
2.3.2.1 Preconditioning 
To investigate the effect of preconditioning step on the extraction of amino acids as the model 
compounds, experiments were performed for extraction of analytes from tartaric buffer for 60 min. In one 
experiment, extraction was performed without any application of preconditioning step. For two other 
experiments, 1 mL methanol:water 1:1 (v/v) was applied to wet the coating for 30 and 60 min before 
extraction step for the assessment of the effect of preconditioning step as the mixture of the two aqueous 
and organic solvents (methanol and water) wet and activate the surface of the coating with different 
functional groups for extraction. Extraction of amino acids was done from 1 mL tartaric buffer (pH=5.0). 
As the understudied grape matrix had the pH=5.0, all the extraction steps for the SPME method 
development were done at pH=5.0 to simulate a similar conditions for pH and ionic strengths in regards 
to real sample analysis. Based on the results (Figure 2.8), applying 30 min preconditioning before 
extraction could provide better extraction efficiency compared with no preconditioning step; however, 
there is no noticeable difference between using 30 min and 60 min time for preconditioning step in the 
range of experimental error, so there was no need for evaluation of this step in higher times. Finally, 60 
min preconditioning in 1 mL methanol:water 1:1 (v/v) was applied for all experiments before extraction.  
 
 
Figure 2.8 Investigation of the effect of preconditioning on the extraction recovery of aminoacids, extraction from 
100 ppb of amino acids in tartaric buffer (pH=5.0). 
2.3.2.2 Extraction 
When the change in the amount extracted is less than the experimental error during extraction, the system 
reaches equilibrium, which provides extraction of 95% of an analyte from sample matrix. At equilibrium 
time, the highest sensitivity and extraction efficiency is achieved [54]. Extraction time profile of amino 
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acids was evaluated for 30, 60, 90 and 120 min of extraction from 1 mL tartaric buffer and grape pulp in 
different experiments. The concept 96-autosampler system provided 1000 rpm agitation speed. The 
results are shown in Figure 2.9. Based on the extraction time profile, the minimum time required for all 
the analytes to reach equilibrium with the coating was approximately 90 min for both matrixes; 
consequently, 90 min extraction time was used for the entire study. 
 
 
Figure 2.9 Extraction time profile for understudied analytes, extraction from 100 ppb of amino acids in tartaric 
buffer (pH=5.0) 
3.2.2.3 Wash 
In the case of real sample analysis, the complexity of the grape matrix is due to high sugar and proteins 
content; therefore interferences must be removed before introduction of coatings into desorption solvent. 
To decrease matrix effect (ion suppression/ ion enhancement) because of co-elution of interferences and 
deterioration of coating, a wash step was needed. Using wash step provides removal of interferences 
caused matrix effect of amino acids; on the other hand, analytes removal should be noticed in this step.  
The optimization of wash step showed that immersing the coatings in 1 mL nanopure water for 20 s 
without agitation after extraction step could remove the analytes during this stage. However, 10 s 
immersion in water under the same conditions could also be effective. The loss of analytes during this 
step was under 1%. Also matrix effect (ion suppression/ ion enhancement) evaluation showed that 
application of this step could help prevention of transferring interferences in to the final extract.  
2.3.2.4 Desorption 
To optimize desorption condition, the optimal desorption solvent must be identified to desorb the highest 
amount of analytes from the coating during shortest time while eliminating or decreasing the potential of 
carry over.  Two mixtures as desorption solvents at the maximum agitation speed of concept 96- 
autosampler system were evaluated: methanol:water 1:1 (v/v) and acetonitrile:water 1:1 (v/v). Based on 
the results shown in Figure 2.10, acetonitrile:water 1:1 (v/v) provided higher extraction recovery and the 
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least carry over for all amino acids. Desorption time profile was also investigated for all the model 
compounds. As is clear from Figure 2.11, approximately 60 min could provide complete desorption of all 
analytes from the coating. Evaluation of carryover as the second desorption step for 60 min using 
acetonitrile:water 1:1 (v/v) showed that the amount of analytes remained on the coating after first 
desorption was negligible (less than 3%). Thus, 1 mL acetonitrile:water 1:1 (v/v) for 60 min was used as 
the optimized desorption solvent and desorption time for the entire study. 
2.3.2.5 Reusability and reproducibility of SiImC18-PAN coating 
Performance of the SiImC18 coatings was evaluated through assessment of physical stability and 
extraction recovery of aminoacids from tartaric buffer (pH=5.0) and grape pulp under optimized 
conditions for 4 sets of coated blades each with 12 coatings. In the case of tartaric buffer, the extraction 
efficiency dropped after 50 times extraction; in the case of grape sample the extraction efficiency dropped 
approximately 30% for all analytes after 20 times extraction. The results of the evaluation of reusability 
and physical stability of the new coating for extraction from tartaric buffer (pH=5.0) and grape pulp are 
shown in Figures 2.12 and 2.13 respectively. This study demonstrated that the washing step after the 
extraction from complex real sample is needed to increase the coating stability. Because of the complexity 
of matrix, some physical changes were observed on the surface of coatings after increasing the number of 
extractions. It seems that lower stability of coating by repetition in the case of extraction from grape pulp 
matrix is because of adsorption of particulates to the unreacted silanol sites of the synthesized compound. 
 
 
Figure 2.10 Investigation of the type of desorption solvent on the extraction recovery of aminoacids, and extraction 
from 100 ppb of aminoacids in tartaric buffer (pH=5.0). 	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Figure 2.11 Desorption time profile for understudied aminoacids, extraction from 100 ppb of aminoacids in tartaric 
buffer (pH=5.0) 
 
2.3.3 Silica based ionic liquid 96-blade SPME-LC-MS/MS method validation 
Evaluation of figures of merit was performed to ensure data quality and reliability. The linear range, limit 
of detection (LOD) and limit of quantitation (LOQ) were investigated for the extraction from tartaric 
buffer (pH=5.0) and grape matrix with the developed SiIL coating. The linear calibration model was 
achieved by performing least square regression of the instrument response versus the concentration of 
analytes. The range of linearity, linear regression coefficient (R2), LOD and LOQ for SPME-LC/MS/MS 
analysis of all amino acids from tartaric buffer (pH=5.0) and grape pulp are presented in Table 2.3. A 
signal-to-noise ratio (S/N) of three is generally accepted for estimating LOD and signal-to-noise ratio of 
ten is used for estimating LOQ. The obtained LOD and LOQ levels for tartaric buffer ranged from 0.1-0.5 
µg/L and 0.3-1.0 µg/L, respectively; and in the case of grape pulp, LOD and LOQ levels were 0.3-2.0 
µg/L and 0.5-3.0 µg/L, respectively. In addition, R2 values were found in the range of 0.9901-0.9962 for 
the understudied analytes with the linearity in the concentration ranges of 1.0-200 µg/L for arginine, 
aspartic acid, lysine, and tyrosine, 0.5-200 µg/L for phenylalanine and tryptophan, 1.5-200 µg/L for 
glutamic acid, histidine, isoleucine, leucine, and threonine, and 3.0-200 µg/L for proline in the case of 
extraction from tartaric buffer, and in the case of extraction from grape pulp, linearity was in the ranges of 
1.0-150 µg/L for arginine, aspartic acid and lysine, and tyrosine, 0.5-150 µg/L for phenylalanine and 
tryptophan, 1.5-150 µg/L for glutamic acid, histidine, isoleucine, leucine and threonine, and 3.0-150 µg/L 
for proline. The new developed SPME-LC-MS/MS showed high sensitivity and reproducibility for grape 
analysis. 
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2.3.4 Evaluation of matrix effect 
Co-elution of sample matrix can decrease or increase ionization efficiency of analytes. Reduction or 
elimination of matrix effects is possible through optimization of chromatographic conditions and use of 
suitable sample clean-up prior to injection to LC-MS/MS regarding the type of matrix. In the present 
study, using a biocompatible SPME coating and wash step after extraction provide selective extraction 
and improved clean-up of the sample which prevented introduction of polysaccharides, proteins, and 
other interferences to analytical instrument.  Furthermore, standard addition calibration was used for 
compensating any possible matrix effects. The new proposed SPME coating was capable of extracting 
polar analytes from complex matrix with the cleaner final extraction in comparison to extraction obtained 
by SE. To evaluate absolute matrix effect for SPME, the signals obtained for the post extraction of tartaric 
buffer extract spiked with the analytes (SA) were compared with those of the standard with the same 
concentration (SB) using (SA/SB×100%). A percentage of absolute matrix effect between 80-120% is 
acceptable; however, the higher amount shows ion enhancement, and the lower amount indicates ion 
suppression [206]. As there is no blank grape matrix for the absolute matrix effect evaluation, tartaric 
buffer was used as the blank solution. Table 2.4 displays the results related to this study. No significant 
matrix effect (ion suppression/ion enhancement) was detected for the analysis of amino acids from tartaric 
buffer in this work. In the case of real sample analysis, sample extract dilution was done for both extracts 
obtained from SPME and SE. The final sample extract for both SPME and SE were diluted with different 
dilution factors. Comparison between results demonstrated that in the case of SPME, there was no need 
for extra dilution of sample extract; however, the extract of SE needed high dilution levels to reduce 
matrix effect (ion suppression/ ion enhancement) of amino acids. The obtained results showed presence of 
interferences in the sample extract and inefficient separation of analytes from sample matrix in the case of 
SE in compared with SPME. However, using biocompatible coating and removal of interferences during 
wash step helped decrease of matrix effect occurrence for SPME. 
Table 2.2 SiImC18 –PAN coating parameters, %AER (absolute extraction recovery), % inter- intra-blade RSD in 
tartaric buffer and grape pulp matrixes. 
	  
Analyte LogP Vf  (mL) Kfs Kfs. Vf 
(mL) 
% AER Tartaric buffer 
% intra-blade 
RSD (n=12) 
Tartaric buffer 
% inter-blade 
RSD (n=4) 
Grape pulp 
% intra-blade 
RSD (n=12) 
Grape pulp 
% inter-blade 
RSD (n=4) 
Arginine -4.20 2.6×10-3 381 1.00 50 4 9 6 8 
Aspartic acid -3.89 2.6×10-3 42 0.11 10 5 8 8 8 
Glutamic acid -3.83 2.6×10-3 33 0.09 8 4 7 7 9 
Histidine -3.32 2.6×10-3 57 0.15 13 10 13 12 14 
Isoleucine -1.59 2.6×10-3 67 017 15 6 11 9 10 
Luecine -1.52 2.6×10-3 52 0.14 12 7 10 13 13 
Lysine -2.99 2.6×10-3 29 0.08 7 5 7 6 7 
Phenylalanine -1.38 2.6×10-3 127 0.33 25 4 8 8 10 
Proline -2.15 2.6×10-3 96 0.25 20 7 10 10 12 
Threonine -2.94 2.6×10-3 73 0.19 16 10 12 10 14 
Tryptophan -1.06 2.6×10-3 338 0.88 47 4 8 8 10 
Tyrosine -2.26 2.6×10-3 163 0.42 30 4 12 9 11 
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2.3.5 Quantitation of amino acid compounds in grape samples 
Standard addition was used for quantitative analysis of amino acids applied to 9 different concentration 
points. To achieve better precision, each point was done three times. Plots of response of instrument to 
concentration for each analyte were investigated, and by the extrapolation of the response to zero, the 
original concentration of analytes in the sample can be obtained.  Before LC-MS/MS analysis, final 
extracts were diluted whenever needed to fit the response of instrument in the linear range of calibration 
curves and prevention of matrix effect. Table 2.5 displays presented amount of amino acids in grape pulp 
sample through SPME-LC-MS/MS and SE-LC-MS/MS analysis. In some cases, the results are matched 
in respect to the standard deviation ranges; however, in most cases, the obtained results for SE are higher 
than those of SPME. The reason for this observation is discussed in the following paragraph. SPME can 
provide free and active concentration of analytes; on the other hand, SE is an exhaustive method able to 
extract total concentration of analytes. The understudied analytes have some bindings towards 
macromolecules such as proteins and polysaccharides in grape matrix, which could be released under 
severe conditions of using acidic or basic conditions. In the case of SE, grape sample and all 
concentration points of standard addition calibration were centrifuged (5000 rpm for 10 min). Thus, the 
bonded fraction of analytes in the sample was precipitated. In this case, free amount of analytes in the 
supernatant could be separated by SE, and after required dilution to fit the linear response of instrument 
also prevention of matrix effect be injected to LC–MS/MS for analysis. The extract obtained from SE was 
not as clean as desorbed solution of SPME, which indicates the stronger capability of SPME to produce 
cleaner sample extract. Otherwise, in some cases, the extracted amount obtained by SE was higher than 
that of obtained by SPME, which is probably due to the presence of a part of the bounded analytes as 
there were some tiny colorful particulates, which could be seen in the supernatant and final extract used 
for analysis; also, high matrix effect was resulted in the case of SE compared to SPME. In fruit samples, 
there are interactions and bindings between the analytes and macromolecules and particulates of the 
sample matrix. These adsorption and conjugation of analytes is variable for different analytes based on 
different binding sites and analyte interaction with the matrix surfaces. SPME can extract the free 
concentration of analytes in the sample matrix. In order to extract the total (free and unbound) 
concentration of analytes, it is needed for enzymatic, acidic or basic hydrolysis to release the binding part 
of analytes before extraction. 
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Table 2.3 Figure of merits evaluation for the SiImC18–PAN SPME-LC-MS/MS. 
 Tartaric buffer Grape pulp 
Analyte LOD 
(µg/L) 
LOQ 
(µg/L) 
R2 Linear range 
(µg/L) 
LOD 
(µgL) 
LOQ 
(µg/L) 
R2 Linear range 
(µg/L) 
Arginine 0.1 0.3 0.9911 1.0-200 0.3 1.0 0.9924 1.0-150 
Aspartic acid 0.1 0.3 0.9907 1.0-200 0.3 1.0 0.9907 1.0-150 
Glutamic acid 0.2 0.7 0.9932 1.5-200 0.4 1.5 0.9912 1.5-150 
Histidine 0.1 0.3 0.9946 1.5-200 0.4 1.5 0.9961 1.5-150 
Isoleucine 0.2 0.7 0.9953 1.5-200 0.4 1.5 0.9933 1.5-150 
Leucine 0.2 0.7 0.9918 1.5-200 0.4 1.5 0.9902 1.5-150 
Lysine 0.1 0.3 0.9910 1.0-200 0.3 1.0 0.9905 1.0-150 
Phenylalanine 0.1 0.3 0.9913 0.5-200 0.1 0.5 0.9915 0.5-150 
Proline 0.5 2.0 0.9962 3.0-200 1.0 3.0 0.9913 3.0-150 
Threonine 0.3 1.0 0.9953 1.5-200 0.5 1.5 0.9932 1.5-150 
Tryptophan 0.1 0.3 0.9942 0.5-200 0.1 0.5 0.9901 0.5-150 
Tyrosine 0.1 0.3 0.9948 1.0-200 0.3 1.0 0.9921 1.0-150 
 
 
Figure 2.12 Evaluation of reusability of SiImC18-PAN, and extraction from 100 ppb of amino acids in tartaric buffer 
(pH=5.0). 	  
 
Figure 2.13 Evaluation of reusability of SiImC18-PAN, and extraction from 100 ppb of amino acids in grape pulp 
(pH=5.0). 
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Table 2.4 Evaluation of % absolute matrix effect 
Analyte % Absolute matrix effect (±SD) 
Arginine  115 (±4) 
Aspartic acid  100 (±8) 
Glutamic acid                               81(±2) 
Histidine   83 (±6) 
Isoleucine                            101 (±7) 
Leucine  102 (±7) 
Lysine                           105 (±10) 
Phenylalanine                              106(±9) 
Proline    89 (±6) 
Threonine    99 (±8) 
Tryptophan  117 (±4) 
Tyrosine    85 (±7) 
 
Table 2.5 Concentrations of aminoacids using SPME (standard addition calibration method) and the comparison 
with that of solvent extraction 
    Analyte Concentration with SPME µg/g (±SD) Concentration with SE µg/g (±SD) 
Arginine                               18 (±2)  42 (±8) 
Aspartic acid 19 (±1)  25 (±2) 
Glutamic acid 25 (±1)  77 (±8) 
Histidine 41 (±3)              62 (±7) 
Isoleucine 18 (±2)                            22 (±4) 
Leucine 20 (±3)                            23 (±5) 
Lysine                            87 (±10)                        127 (±13) 
Phenylalanine 15 (±1)                            61 (±7) 
Proline 13 (±1)                            61 (±5) 
Threonine 24 (±4)                            31 (±3) 
Tryptophan 13 (±1)                                          44 (±5) 
Tyrosine 28 (±2)                            43 (±3) 
2.4 Conclusions and future directions 
One of the challenges SPME faced with is the lack of potential extractive phase for extraction of high 
polar compounds from complex matrixes. The current work introduces a new type of polymer as an 
extraction phase for 96-blade thin film SPME providing hydrophobic, π-π, electrostatic, hydrogen 
bonding and ion dipole interactions. Precursor selection during synthesis can determine the type of 
interaction between analytes and metabolites under study. The new developed coating was successfully 
used for the direct analysis of amino acids in grape pulp with significant reduced matrix effect compared 
to solvent extraction. Silica based ionic liquid is a promising coating for extraction of polar amino acids, 
sugars, vitamins and other polar compounds. Moreover, the application of SiImC18–PAN 96-blade SPME 
system provides high throughput analysis of up to 96 samples simultaneously without any extra needs to 
sample pretreatment. Consequently, this system could be applicable for the highly automated analysis of 
unprocessed samples in the areas of food, biological, pharmaceutical, environmental, clinical and 
metabolomics studies through changing functional groups in synthesized silica based ionic liquid 
polymers. 
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Chapter 3 
Development of high throughput 96-blade Solid Phase 
Microextraction-Liquid Chromatrography-Mass Spectrometry protocol 
for metabolomics 
 
3.1 Preamble and introduction  
3.1.1 Preamble  
This chapter has been published as a paper: Fatemeh Mousavi, Barbara Bojko Janusz Pawliszyn, 
Development of high throughput 96-blade solid phase microextraction-liquid chromatrography-mass 
spectrometry protocol for metabolomics, Journal of Analytica Chimica Acta, In press. 
(doi:10.1016/j.aca.2015.08.016). The materials of the current chapter are reprinted from this publication 
with the permission of Elsevier (Copyright Elsevier 2015). All of the work reported within this chapter 
has been performed by the author. Co-author Barbara Bojko provided comments on the manuscript. 
 
I, Barbara Bojko, authorize Fatemeh Mousavi to use the material for her thesis. 
 
 
3.1.2 Introduction 
Metabolomics is the comprehensive measurement of the end products of biological mechanisms at the 
cellular level [207]. Quenching, metabolite extraction, instrumental analysis of extracted metabolites, 
statistical analysis, and data interpretation are different steps often applied in untargeted metabolomics. 
Currently, no single method is able to detect a whole metabolome, as metabolomes are comprised of a 
wide variety of metabolites with various chemistries, polarities, solubilities, and chemical stabilities, as 
well as with differing ranges of concentration [208,209].  
One of the most important analytical methods widely used in metabolomics is LC-MS equipped with an 
electrospray ionization (ESI) mode. Previously, different LC columns were used for separation of 
metabolites extracted from bacteria, with results indicating the need for both RP and HILIC columns to 
separate a wide range of metabolites [207-213]. One of the probable issues in LC-MS analysis is change 
in the signal intensity of the metabolites in the presence of complex matrix because of ionization 
enhancement or ionization suppression called matrix effect. Choice of sample preparation and 
chromatographic separation before ESI-MS plays an important role in matrix effect reduction resulting in 
more reliable outcomes [207]. 
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Investigations of different methods have shown that the method of sampling and sample preparation can 
affect the metabolic profile of a system under study [214]. As such, an ideal sample preparation technique 
for metabolomics should be nonselective, reproducible, nondestructive, and provides extraction of a wide 
variety of metabolites without metabolite loss, degradation, or transformation and integrated well with 
metabolism quenching step [215]. In metabolomics, quenching is applied to inactivate the metabolism 
and preserve sample integrity through rapid interruption of enzymes. This is accomplished by modifying 
sample conditions such as its pH or temperature [216]. Cold methanol, liquid nitrogen (-196°C), as well 
as acidic and alkali solvents have been commonly used for quenching, causing metabolite and enzyme 
leakages through the cellular membrane and reduced recoveries [217-219]. An extraction step, often used 
in metabolome workflows, should provide efficient separation of metabolites from interferences such as 
salts and proteins, thus making the extract compatible and representative of the sample prior to 
introduction to appropriate analytical instrument. In most cases, solvent extraction is used at very low or 
high temperatures, although changes in temperature result in significant drawbacks, especially for 
unstable metabolites [159,211,220]. There is a need for a sample preparation technique that provides 
efficient separation of broad range of metabolites from interfering matrix components, thus facilitating 
good chromatographic resolution and mass spectrometric quantification and identification.  
SPME, a solventless extraction technique frequently used in a wide range of applications including on site 
sampling and in vivo analysis, was recently applied for global metabolomics studies [142,143,159,166].	  
Using SPME eliminates the need for a separate quenching step, as only small molecular weight species 
are extracted by the coating. Bio-macromolecules such as proteins including enzymes, which could cause 
course conversion of metabolites, are separated from remaining metabolites in the matrix. Therefore there 
is no need for further sample pretreatment to eliminate their activity. In essence the extraction into sorbent 
eliminates need for several steps used in traditional procedures such as quenching, clean up and pre-
concentration steps. In comparison to traditional extraction techniques, SPME provides much cleaner 
sample extract thus decreasing matrix effect [159].  
A few studies have used SPME coupled with GC-MS to study bacteria metabolomics; however, to the 
authors’ best knowledge, bacterial metabolomics by SPME-LC-MS has not been explored to date. 
Hossain et al. applied automated headspace solid phase microextraction (HS-SPME) for quantitative and 
semi-quantitative analysis of E.coli affected by cinnamaldehyde as an antibacterial agent [166]. In other 
work, Bean et al. used SPME in combination with GC×GC-TOFMS to identify volatile metabolites in the 
HS of Pseudomonas aeruginosa PA14 [221]. These methods are able to cover compounds characterized 
by high Henry constant, but a comprehensive LC-MS method is needed to cover determination of widest 
range of chemical property compounds.  
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In the present study, the development of a high throughput 96-blade SPME-LC-MS approach for in vivo 
global metabolic profiling of E.coli as a model organism was evaluated. At first, nine different types of 
polymer and silica-based particles were evaluated for targeted metabolomics. Then, the ones showing 
high stability and reusability, and uppermost extraction recovery, for both polar and nonpolar metabolites 
were applied to in vivo determination. SPME method optimization was performed considering efficient 
enrichment of extracted metabolites into different coatings. The isolated bacterial metabolites were 
characterized using three different chromatographic columns. Finally, the optimum protocol providing the 
identification of a maximum number of metabolites with highest peak intensity was determined. Also, the 
stability test was performed to determine how long coatings could be stored after in vivo sampling in 
addition to matrix effect investigations to propose the optimum protocol. Previously, Vuckovic et al. [28] 
evaluated number of biocompatible SPME coatings for untargeted metabolomics profiling of metabolites 
with a wide range of polarities in biological fluids by LC-MS. The current study provided a wider polarity 
range with higher sensitivity due to the higher amount of sorbent in the 96-blade system in comparison to 
the previously utilized commercially available SPME fibers. Moreover, concept 96 autosampler provided 
advantages such as reduced analysis time, sample high-throughput, and good reproducibility. 
3.2 Experimental section 
3.2.1 Chemical and materials 
LC-MS grade solvents and LC-MS grade formic acid (1 mL glass ampules) were obtained from Fisher 
Scientific (Ottawa, Canada). N,N-dimethylformamide (DMF) was purchased from Caledon Labs 
(Georgetown, Canada). Polypropylenes deep 96-well plates (Nunc) and easily modified polystyrene–
divinylbenzene (Macherey-Nagel) particles were purchased from VWR International (Mississauga, 
Canada). Phenylboronic acid particles were purchased from Varian Inc. Discovery silica-based-C18 
particles, silica-based weak cation exchange, and Diol bonded silica particles were obtained from Supelco 
(PA), and StrataX was provided by Phenomenex. All metabolites, peptone, yeast extract, and NaCl were 
purchased from Sigma–Aldrich. The E. coli BL21 was obtained from Professor John Brennan’s lab at 
McMaster University (Hamilton, Ontario, Canada) as a gift. The Concept 96-SPME-blade unit and 
robotic Concept 96 autosampler were purchased from Professional Analytical Systems (PAS) Technology 
(Magdala, Germany) for SPME sample preparation. 
 
3.2.2 Bacterial strain and culture condition 
E.coli BL21 was used as non-pathogenic bacteria for a microbial metabolomics study in the present work. 
Standard Luria Bertani (LB) media (10 g trypton, 5 g yeast extract, and 5 g NaCl in 1 L nanopure water) 
was used as the media for growth of bacteria, and LB agar media (10 g trypton, 5 g yeast extract, and 5 g 
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NaCl; 15 g Agar in 1 L nanopure water) was used to count the number of colony forming units per mL 
(CFU mL-1) in bacterial suspensions. Cells were grown in nutrient media at 37°C and 125 rpm for 24 
hours. To provide the countable number of colonies on the agar media, cultures were serially diluted with 
sterile media. Next, 100 µL of diluted media were distributed on the warm agar plate, and incubated at 
37°C for 24 hours. The growth curve of E.coli culture was obtained by counting the CFU mL-1 from the 
first moment of adding bacteria to the LB media up until 18 hours. Sampling of the whole study with all 
coatings were conducted from a culture containing 2×105 CFU mL-1 at the stationary phase of bacterial 
growth (after 14 hours incubation).  
 
3.2.3 Coating preparation 
The main objective of this research was the development of a coating for the 96-blade SPME system with 
thin film geometry that provided the best coverage for a wide variety of metabolites. For this purpose, 
different polymer chemistries were selected for testing. These include the commercially available SPE 
particles: C18, polystyrene-divinylbenzene-weak anion exchange (PS-DVB-WAX), hydrophilic-
lipophilic balance (HLB), phenylboronic acid (PBA), silica based-reversed phase-weak cation exchange 
(Si-RP-WCX), surface modified styrene divinylbenzene with pyrrolidone group (StrataX), as well as the 
lab made silica based ionic liquid (Si-IL), and tris-amide functionalized porous silica (HILIC) particles. 
All particles were immobilized on the stainless steel blade surfaces of the 96-blade system by spraying 
method, using polyacrylonitrile as a biocompatible binder. All coatings were prepared with approximately 
the same thickness (120 µm). Both the coating preparation procedure, as well as information pertaining to 
the 96-blade SPME system, have been reported in previous works [138,139,222]. In brief, polymer 
particles (20% of total volume) were added in 10% w/w PAN in DMF (heated in the oven at 90°C for 60 
min) solution. A flask type sprayed was used for spraying the slurry on the thin film steel surface using 
nitrogen gas flow. After spraying, in the case of each layer the coatings were immediately cured in the 
oven at 150°C for 5 min. This process was continued until reaching an appropriate thickness and 
robustness. In the current study, the new coatings were prepared by mixing various particles with 
different weight ratios (PS-DVB-WAX:HLB 50:50 [w/w], PS-DVB-WAX:HLB 80:20 [w/w], PS-DVB-
WAX:Si-IL 80:20 [w/w]) to determine the interaction effect of multi-particle coatings on metabolome 
coverage. Figure 3.1 shows the structure of the particles used as stationary phases for the 96-blade SPME 
system.  
 
3.2.4 Preparation of targeted metabolites mixtures 
A SPME sample preparation method using different commercially available SPE particles and lab made 
polymers was developed for extraction of different classes of targeted metabolites having various 
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chemical properties, such as: amino acids (tyrosine, valine, asparagine, histidine, arginine, isoleucine, 
citrulline, cysthationine, S-adenosyl-L-methionine, and taurine); nucleotides (adenosine, cytidine); 
vitamins (nicotinamide and riboflavin); carboxylic acids (citric acid and Fumaric acid); carbohydrates 
(allantion, D-ribose-5-phosphate, and D-glucose-6-phosphate); redox-electron carries and precursors 
(FAD and NAD); nucleosides phosphates (CMP, AMP, dUMP, and ADP), and CoA’s (CoA hydrates). 
Stock standard solutions were prepared in water/methanol, stored at a temperature of -20°C, and left 
unexposed to the light. For instrument calibration, working standard solutions with a known concentration 
of metabolites were prepared by diluting stock standards with a desorption solvent. The extraction 
solution was prepared by spiking the 1µg/mL stock standard solution in sterilized LB media. The 
concentration of organic solvents in samples was always kept at less than 1%. 
 
         Si-IL 
  
  C18 
     
Si-RP-WCX 
 
                                          
                                                           
      HILIC                                                    Diol                                                       HLB 
                                               
                 Strata X                                           PBA                                              PS-DVB-WA 
 
Figure 3.1 Chemical structure of evaluated particles for 96-blade system. 
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3.2.5 Targeted analysis using SPME-LC-MS/MS 
SPME method development was conducted for different coatings by optimizing the preconditioning, 
extraction, washing, and desorption steps using the concept 96-blade SPME device and the robotic 
concept 96-autosampler. The coatings were conditioned prior to extraction for 30, 60, 90, and 120 min in 
1 mL ethanol:water 70:30 (v/v) mixture in 96-well plate along with agitation at 850 rpm to prepare the 
surface of the coatings for extraction. After preconditioning, extractions were carried out for 30, 60, 90, 
and 120 min at an extraction agitation speed of 1000 rpm (2.5 mm amplitude) and direct immersion mode 
from 1 mL 200 mg/mL spiked metabolites in Standard Luria Bertani (LB) media to determine equilibrium 
time. After the extraction, coatings were washed for 10, 20, 30, 40, and 60 s in 1 mL water +0.1% formic 
acid under agitation at 850 rpm in order to remove particulates and salt from the surface of the coatings. 
The experiment was conducted without a washing step as well to evaluate the effect of using wash step 
after extraction. Desorption was performed in 1 mL acetonitrile:water 50:50 (v/v), acetonitrile:water 
80:20 (v/v), and methanol:water 50:50 (v/v) at an optimal 1500 rpm speed for 30, 60, 90, and 120 min. 
Next, the desorption solution was transferred to the LC–MS/MS autoinjector for separation and 
quantitation. In this part of the study, chromatographic separation was performed by a Discovery HS F5 
column, 150×2.1mm, 3µm particle size (Supelco, Bellefonte, PA, USA) along with Luna HILIC Si, using 
gradient elution. For the RP column, flow rate was 200 µL/min, and mobile phases A and B consisted of 
water/formic acid (99.9/0.1,v/v) and acetonitrile/formic acid (99.9/0.1,v/v), respectively. The 40 min 
gradient program was optimized for separation of the model compounds as follows: 100% A (0-3 min), 
linear gradient from 100 to 10% A (3-25 min), linear gradient held at 10% A (25-34 min), and column 
equilibration for 6 minutes by applying gradient 10% A to 100% A. Chromatographic conditions for the 
HILIC column are explained in the following section. Quantitative analyses of compounds were 
performed using an API 4000 triple quadrupole mass spectrometer (Applied Biosystems, California, 
USA) equipped with a TurboIonSpray source. A CTC PAL autoinjector from Leap Technologies (CTC 
Analytics, NC, USA) was used for the injection of samples into the LC-MS/MS system (20 µL injection 
volume). The MS/MS analysis was performed in positive and negative ionization modes under multiple 
reaction monitoring (MRM) conditions. A summary of the MS/MS parameters is presented in Tables 3.1 
and 3.2. 
 
3.2.6 Untargeted cell metabolomics analysis 
The coatings that provided the highest extraction recoveries in the targeted analysis study (PS-DVB-
WAX, HLB, Si-RP-WCX, PBA, and Si-IL) were applied for an untargeted in-vivo metabolomics study. 
Moreover, PS-DVB-WAX, HLB and Si-IL were mixed together with different weight ratios of individual 
particles to produce mixed coatings (PS-DVB-WAX:HLB 50:50 [w/w], PS-DVB-WAX:HLB 80:20 
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[w/w], and PS-DVB-WAX:Si-IL 80:20 [w/w)]) so as to evaluate the interaction of different particles in 
terms of peak intensity and metabolite coverage. Optimized conditions obtained from the targeted 
analysis study were applied for the untargeted microbial metabolomics study (Section S1 to Section S5). 
After preconditioning and sterilizing of the coatings with ethanol:water 70:30 (v/v), extraction was 
conducted from a 1 mL culture containing 2×105 colony forming units per mL (CFU mL-1) of E.coli at 
stationary phase in direct immersion mode inside 96-well plate. Next, washing was conducted for 30 s 
with agitation to remove particulate and macromolecules from the coating surface. Then, extracted 
metabolites were desorbed in an optimized desorption solvent for 120 min, and the desorption solution 
was preserved at -80°C for LC-MS analysis using three different LC-MS methods. An LC-MS system 
consisting of a Thermo Accela autosampler, pumps, and an Exactive benchtop Orbitrap system (Thermo, 
San Jose, California, USA) was used for LC-MS analyses. The extracted analytes using the diverse 
aforementioned SPME coatings were analyzed by three different LC columns to ensure that all extracted 
analytes were retained and detected: Kinetex pentaflourophenyl (PFP), HILIC, and XBridge C18. A 
Kinetex PFP column [100×2.1mm, 1.7µm] (Phenomenex, Torrance, CA, USA) with a guard filter 
(SecurityGuard ULTRA Cartridges UHPLC PFP for 2.1 mm) was applied with a flow rate of 300 µl/min, 
using mobile phase A containing water: formic acid 99.9:0.1%, and mobile phase B composed of 
acetonitrile: formic acid 99.9:0.1%. The starting mobile phase conditions for Kinetex PFP were 90% A 
from 0 to 1.0 min, followed by a linear gradient to 10% A from 1.0 to 9.0 min, and an isocratic hold at 
10% A until 12.0 min. The total run time was 16 min per sample, including a 4 min column re-
equilibration period. A Luna HILIC Si, 100×2mm, 3µm particle size was used with a flow of 400µL/min. 
Mobile phase A consisted of acetonitrile/ammonium acetate buffer (9/1, v/v, effective salt concentration 
20mM), and mobile phase B consisted of acetonitrile/ammonium acetate buffer (1/1, v/v, effective salt 
concentration 20mM). The starting mobile phase composition was 100% A held for 3.0 min, with ramp to 
100% B in 5.0 min. 100% B was held for 4.0 min. The column was re-equilibrated for 8 min prior to the 
next injection, thus making the total run time 20 min per sample. For XBridge C18 (150×4.6 mm, 3.5µm), 
mobile phase A consisted of acetonitrile: water 90:10 with 15mM effective concentration of ammonium 
acetate, and mobile phase B consisted of 0.5% acetic acid in isopropanol with a flow rate of 200µL/min. 
The starting mobile phase conditions for the XBridge C18 column were 90% A from 0 to 6.0 min, 
followed by a linear gradient to 40% A from 6.0 to 8.0 min, then another linear gradient to 30% from 8.0 
to 18.0 min, and finally a linear gradient to 90% from 18 to 18:30 min. An isocratic hold was set at 90% 
A until 22.0 min. The total run time was 22 min per sample. Analyses were performed in both positive 
and negative ESI modes for all three LC methods. The injection volume for all methods was 10 µL. 
Samples were stored and refrigerated (4°C) on the autosampler while waiting for injection. Samples were 
run in randomized order, and a QC sample was run periodically to verify instrument performance. 
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Table 3.1 Optimized mass spectrometry condition of investigated targeted metabolites in positive mode. 
Compromised ionization source values: Ion source gas 1 (GS1)= +20, curtain gas= +10, collision gas= 12, spray 
ionization voltage= 4500 V, and temperature= 350 °C. 
Analyte Q1 mass 
(amu) 
Q3 mass 
(amu) 
DP (V) EP (V) CE (V) CXP (V) 
Tyrosine 182.1 136.1 61 10 20 8 
Allantion 159.0 116.1 75 8 10 20 
Cytidine 244.0 112.1 56 10 17 21 
Isoleucine/leucine 132.0 86.1 60 10 16 15 
Riboflavin 377.2 243.0 131 10 34 24 
Methionine 150.0 60.9 22 10 30 9 
Taurine 147.1 60.9 81 12 15 10 
Histidine 155.9 110.2 78 15 26 12 
Cysteine 121.9 107.1 104 13 30 16 
Arginine 175.1 70.1 59 14 36 19 
Valine 117.9 72.1 65 15 17 14 
Asparagine 133.0 74.0 59 10 22 14 
 
 
Table 3.2 Optimized mass spectrometry condition of investigated metabolites in negative mode. 
Compromised ionization source values: Ion source gas 1 (GS1)= +12, Ion source gas 2 (GS2)=10 curtain gas= +10, 
Ion spray voltage= -4500 V, and temperature= 325 °C. 
Analyte Q1 mass 
(amu) 
Q3 mass 
(amu) 
DP (V) EP (V) CE (V) CXP (V) 
FAD 784.3 437.1 -111 -15 -40 -15 
D-Ribose-5-
Phosphate 
228.9 96.9 -101         -9 -22 -6 
Guanosine-5-
monophosphate 
361.9 79.0 -128 -5 -56 -14 
Coenzyme A 
hydrate 
356.9 79.0 -180 -9 -65 -15 
Thiamine 
hydrate 
336.9 147.0 -68 -10 -38                -11 
D-Glucose-6-
phosphate 
258.7 96.9 -106 -10 -20         -6 
Cystathionine 220.9 133.9 -92 -9 -20 -10 
Biotin 243.0 166.0 -123 -10 -23 -11 
Citrulline 173.9 131.0 -98 -5 -20 -9 
2-deoxy-
uridine-5-
phosphate 
306.9 79.0 -122 -10 -55 -14 
D-trihalose 
dihydrate  
376.0 341.1 -91 -10 -29 -12 
Cytidine-5-
monophosphate 
Beta-
Nicotinamide 
Adenosine 
diphosphate 
Adenosine-5-
monophosphate 
Fumaric acid 
Citric acid 
321.9 
 
662.1 
426.0 
 
345.9 
 
114.8 
190.7 
79.0 
 
602.1 
158.9 
 
79.0 
 
97.9 
110.9               
 
-138 
 
-211 
-132 
 
-135 
 
-74 
-75 
-10 
 
-10 
-10 
 
-10                   
 
-5 
-5 
-60 
 
-46 
-35 
 
-57   
 
-30 
-27 
 
-14 
 
-10 
-11 
 
-15 
 
-5 
-7 
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This QC sample was prepared by mixing 10 µL part of each sample as one sample. MS acquisitions were 
performed using AGC = balanced (1.000.000 ions), 100.000 resolution at m/z of 200, with an injection 
time into the C-trap of 100, and 250 ms for the two RP and HILIC methods, respectively. Sheath gas 
(arbitrary units), auxiliary gas (arbitrary units), ESI voltage (kV), capillary voltage (V), capillary 
temperature (°C), and tube lens voltage (V) were (i) 40, 25, 4.0, 27.5, 275, and 100 for positive ESI RP 
LC-MS; (ii) 50, 25, -2.7, -67.5, 325, and -85 for negative ESI RP LC-MS; (iii) 60, 30, 2.8, 90, 325, and 
155 for positive ESI HILIC LC-MS; and (iv) 50, 25, -2.5, -55, 275, and 100 for negative ESI HILIC LC-
MS. External instrument mass calibrations were performed every 24 h, and found to be within 2 ppm for 
all ions. Separated metabolites were analyzed using Xcalibur software version 2.1 (Thermo) by isolating 
the extracted ion chromatograms (XIC), using a 5 ppm window around the accurate mass of a given 
compound. 
 
3.2.7 Data processing, metabolite identification, and data analysis  
The raw data obtained with Xcalibur software (.raw) was converted to (mzXML) with the MS conversion 
software. The converted data was then processed with the XCMS R-package (Scripps Center for 
Metabolomics, California, USA). The output is a table containing retention time, m/z, and intensity of 
features [142]. Table 3.3 shows the optimum parameters used for peak detection, retention time 
correction, and peak alignment [223]. The CAMERA R-package (Bioconductor Version 2.10) was 
applied to provide ion annotation on the list of features to identify detected isotopes, adducts, and in-
source fragments ions. An Exactive Orbitrap detector was used in this study, providing high mass 
resolution and sensitivity.  
The first step of tentative identification was done by submitting the exact mass of unknown metabolites 
obtained from chromatograms to the METLIN database with a 5 ppm mass window. Further selection of 
metabolites was based on the detection of at least two adducts with the same nominal mass at given 
retention time; in the case of availability of authentic standard identity of the metabolite was confirmed 
based on comparison of accurate mass and retention time [142,223]. According to the analytical 
conditions, for the RP chromatographic column, polar compounds eluted at the beginning of the run, 
while nonpolar compounds eluted later. However, for the HILIC chromatographic column, the separation 
condition was reversed. Th Log P of the metabolites and the retention times of the peaks were also taken 
into account in order to minimize false positive identifications of the compounds when no authentic 
standard was available. SIMCA-P+ software v.13.0.3 (Umetrics, NJ, USA) was used for statistical 
analyses. Principle component analysis (PCA) and partial least square-discriminant analysis (PLS-DA) 
were used to assess the performance of different coating chemistries as the stationary phases for the 96-
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blade SPME system through the identification of the metabolites impacted and the discrimination of the 
metabolomics patterns of E.coli.  
Table 3.3 Parameters settings used for data processing with XCMS R-package 
Method p.p.m Peak width Bw mzwid Prefilter 
Kinetex PFP-Orbitrap 2.5 C(5,20) 2 0.015 C(3,5000) 
Luna HILIC Si-Orbitrap 2.5 C(10,60) 5 0.015 C(3,5000) 
XBridge C18-Orbitrap 2.5 C(10,60) 5 0.105 C(3,5000) 
 
3.3 Results and discussion 
3.3.1 SPME method development for targeted analysis  
Extraction phase optimization was performed by targeted determination of a mixture of amino acids, 
nucleotides, vitamins, carboxylic acids, carbohydrates, redox-electron carriers and precursors, nucleosides 
phosphates, and CoA’s. Nine different silica and polymer-based particles with different functional groups 
(commercially available SPE particles and lab made synthesized polymers) were used in evaluation. 
Samples were extracted from LB broth (pH=6.5) spiked with known concentrations of targeted 
metabolites used to simulate the nutritional media for bacterial growth in the in vivo study. The 96-blade 
development of SPME microbial metabolomics methodology includes optimization of four steps: 
preconditioning, extraction, wash, and desorption. In such investigations important parameters related to 
each step were optimized for all coatings to reach the maximum extraction recovery. Prior to extraction of 
analytes, the surfaces of the coatings were prepared for extraction. The more hydrophilic coatings 
(HILIC, Diol, Si-IL, and PBA) needed a longer preconditioning time in comparison to hydrophobic 
sorbents. Results indicate that application of ethanol:water 70:30 (v/v) solution to the surfaces of the 
coatings for 120 min as a preconditioning step prepared the coatings for extraction better than 
preconditioning with lower preconditioning times, or merely applying the dried SPME surface directly for 
extraction. In addition to preconditioning, ethanol also served to sterilize the surface of the coatings. The 
evaluation of the extraction time profiles for the targeted analytes showed that 120 min extraction of 
targeted metabolites from LB broth at 1000 rpm reached sorption equilibrium for all analytes. 
Optimization of the washing step after the extraction step is important for removal of salts, large 
macromolecules, and other particulates; this produces a cleaner extract and reduces matrix effects related 
to ion suppression or ion enhancement, as well as extending the reusability of the coating. Results showed 
that washing the coating surfaces for 30 s with water + 0.1% formic acid accompanied by agitation 
directly after extraction decreased matrix effects; however, it should be noted that the wash time period 
needs to be limited, as increasing the wash time by more than 30 s may cause a significant loss of polar 
analytes. When washing times were kept at 30 s, metabolite losses were kept at below 20% within three 
replicates for the most polar analytes for all coatings. Percentage of wash loss during 30 s wash step using 
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PS-DVB-WAX:HLB 50:50 [w:w] coupled to Kinetex PFP column is visualized in Figure 3.2. After the 
wash step, extracted metabolites were desorbed through immersion of the coatings in a desorption 
solvent. Desorption solvents and desorption times were optimized for different 96-blade SPME coatings. 
The desorption solution was chosen to perform well in desorption and dissolution of both extracted polar 
and nonpolar metabolites as well as to be compatible with RP and HILIC columns. The obtained results 
showed that a combination of acetonitrile:water 50:50 (v/v) at 1500 rpm vortex agitation for 2 hours 
provided the highest extraction recovery for all target compounds and coatings under study, with less than 
5% carryover as demonstrating during the second desorption. 
  
Figure 3.2 Percentage of wash loss during 30 s wash step using PS-DVB-WAX:HLB 50:50 [w:w] coupled to 
Kinetex PFP column. 
 
 The coatings under investigations were evaluated based on extraction recovery, stability, and 
reproducibility. Results demonstrated that among all nine evaluated coatings, PS-DVB-WAX, HLB, C18, 
Si-RP-WCX, PBA, and Si-IL had good stability, while Diol, HILIC, and strata X coatings showed very 
low stability; particles were detached from the surface of stainless steel blades after 10 extractions, 
consequently causing low reproducibility and unreliable results. Therefore, these coatings were not 
evaluated for further untargeted metabolomics studies. Figure 3.3 shows a comparison of percent absolute 
extraction recoveries (ratio of amount extracted to total spiked metabolites × 100%) of the chosen 
targeted metabolites from LB broth with different 96-blade SPME coatings at optimized SPME 
conditions for each coating. Metabolites with different polarities and functional groups were extracted 
with different absolute extraction recoveries using various SPME coatings. Among the mentioned 
coatings, C18 did not show high extraction recoveries for the polar metabolites under study, while PBA, 
Si-IL, Si-RP-WCX, HLB, and PS-DVB-WAX indicated high extraction recoveries. As the primary 
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objective of this study was to identify the coatings providing high extraction recoveries for both polar and 
nonpolar metabolites, C18 was eliminated from further studies. Comparison results between the absolute 
extraction recoveries of different coatings showed that HLB and PS-DVB-WAX yielded the highest 
extraction recoveries for both polar and nonpolar metabolites. HLB demonstrated higher extraction 
recovery for more nonpolar metabolites while PS-DVB-WAX indicated higher extraction recovery for 
more polar metabolites. In order to investigate interaction effect of SPME made from different stationary 
phases, particles were mixed together in different weight ratios, and SPME method development was 
done for the three developed mixed coatings: PS-DVB-WAX:HLB 50:50 [w/w], PS-DVB-WAX:HLB 
80:20 [w/w], and PS-DVB-WAX:Si-IL 80:20 [w/w)]. 
The optimization of important parameters in SPME method development (desorption solvent type, 
preconditioning time, extraction time profile, and desorption time profile) for PS-DVB-WAX:HLB 50:50 
[w/w] for extraction of targeted metabolites from LB broth is shown in Figure 3.4. The %RSDs for three 
replicates in all experiments were below 13%. Based on the obtained results, 2 hours preconditioning of 
the coatings in ethanol:water 70:30 (v/v) was sufficient to prepare the surface of the coating for extraction 
(Figure 3.4-B). Acetonitrile:water 50:50 (v/v) provided the highest absolute extraction recovery (Figure 
3.4-A). As showed in Figure 3.4-C, after 2 hours of extraction, all metabolites reached equilibrium with 
the surface of the coatings, and a period of 120 min of desorption (Figure 3.4-D) in the acetonitrile:water 
50:50 (v/v) solution was sufficient to desorb all extracted analytes with less than 3% carryover for the 
second desorption. 
 
3.3.2 SPME-LC-MS method development for bacterial cell metabolomics studies  
3.2.2.1 SPME method development 
Eight different SPME coating chemistries (Figure 3.1) under optimized conditions obtained from targeted 
analysis were applied to extract metabolites from the E.coli metabolism life cycle from the same batch 
culture. Metabolite separation was achieved using three different LC columns (Kinetex PFP, HILIC, and 
XBridge C18) to ensure separation and detection of all metabolites extracted using different SPME 
coatings and evaluate the best combination of SPME-LC-MS method for detection of the highest number 
of metabolites. Results showed that the evaluated coatings provided extraction of different metabolites 
varying in chemical functional groups and polarities with different peak intensities. A metabolic profile 
comparison using different SPME coatings was conducted through multivariate data analysis. Clear 
separation in the scattered plots was observed based on thousands of extracted features separated by 
various stationary phases for the 96-blade system and analyzed by three different LC-MS methods. As 
demonstrated by Figure 3.5, there are eight groups of specific clusters related to each developed SPME 
coating, with three microbial replicates for each coating. Data analysis demonstrated that SPME coating 
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type has direct influence on metabolic profiling and metabolite recovery; extraction phases that act 
similarly in terms of features extracted have closer data points. Differentiation between various types of 
coatings is represented both by differences in number of metabolites extracted and peak intensities. 
Different SPME-LC-MS methods demonstrated different recovery yields for various classes of 
metabolites because of various functional groups in evaluated coatings. Table 3.4 demonstrated the 
number of extracted features by each SPME coatings coupled to different chromatographic methods. 
 
Figure 3.3 Comparison of the percent absolute recoveries of targeted metabolites for different 96-blade SPME 
coatings. 
 
An evaluation of the obtained results indicated that PBA, Si-IL, and Si-RP-WCX had similar extraction 
behaviors, as all three coatings showed approximately the same extraction recoveries for the same class of 
metabolites especially polar ones; however, these three coatings did not provide high extraction 
recoveries for nonpolar metabolites. Polar metabolites (-4 < logP < 4) such as amino acids, peptides, 
carboxylic acids, monosaccharides, and sugar acids were extracted better with these types of coatings, 
rather than hydrophobic compounds such as prenol lipids, glycerolipids, glycerophospholpids, fatty acids. 
The diol-containing group in PBA provided covalent bonds and better interaction with hydrophilic 
compounds. Si-IL synthesized in our laboratory acted as a mixed mode type of coating containing an 
alkyl group with an anion exchange group in its structure. The imidazolium group in this coating provided 
extraction of hydrophilic compounds from the sample. Carboxylic acid functional groups attached to the 
alkyl groups in the structure of the Si-RP-WCX coating provided extraction of polar metabolites. 
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Therefore, these types of coatings that are particularly suitable to extract hydrophilic metabolites are 
classified as polar coatings. 
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Figure 3.4 SPME method development for PS-DVB-WAX:HLB 50:50 [w:w] and Kinetex PFP column A) 
Desorption solvent optimization, B) Preconditioning time optimization, C) Extraction time profile, and D) 
Desorption time optimization. 	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Table 3.4 Number of features extracted by different 96-blade SPME coatings from 2×105 CFU/mL bacteria at 
stationary phase grown in LB broth and separated by three different LC columns. 
 
      LC column   Kinetex PFP   Kinetex PFP  Luna HILIC Si  Luna HILIC Si   XBridge C18    XBridge 
C18         
 Ionization mode         ESI (+)         ESI (-)         ESI (+)              ESI (-)                 ESI (+)              ESI (-)    
                         
      Coating                                                          Number of features 
 
    Si-IL   4003     4009  4696  1244  1837  1850 
    PBA   3273     3274  1633  1243  2163      1678 
   Si-RP-WCX  5065         5065  1684  1088  2856  2398 
PS-DVB-WAX  10625      10625           2903                 2285             3466                3414 
       HLB  10420      10420      4232             1791             3956            4204 
PS-DVB-WAX:HLB 13205    12029     4851         2285         4583       4579 
      50:50 [w:w]  
PS-DVB-WAX:HLB 12289     12289   5113          2630          3547       3972 
      80:20 [w:w] 
PS-DVB-WAX:IL 8071        8019       3676           2158             4583           4854 
      80:20 [w:w] 
 
HLB and PS-DVB-WAX demonstrated higher extraction recovery for both polar and nonpolar 
metabolites compared to PBA, Si-IL, and Si-RP-WCX. Polar modified PS-DVB copolymer with weak 
anion exchange provided high extraction efficiency for both polar and nonpolar metabolites (-7 < logP < 
7). The Oasis HLB particle is a macroporous copolymer made from a balanced ratio of two monomers: 
lipophilic divinyl benzene and hydrophilic N-vinylpyrolidone. The HLB coating was shown to exhibit 
mostly nonpolar characteristics (-4 < logP < 15), as the results indicated that it mostly extracted nonpolar 
metabolites with higher peak intensity; however, this coating can also extract polar metabolites as well, 
but with lower extraction recoveries than that of nonpolar metabolites. On the other hand, PS-DVB-WAX 
yielded exactly the opposite result. This coating extracted polar metabolites with higher extraction 
recoveries than nonpolar metabolites. As these two coatings (HLB and PS-DVB-WAX) provided 
metabolite coverage for both polar and nonpolar metabolites, the 96-blade SPME coatings composed of a 
mixture of particles were evaluated. To investigate the effect of interaction of particles, PS-DVB-
WAX:Si-IL 80:20 [w/w], PS-DVB-WAX:HLB 50:50 [w/w], and PS-DVB-WAX:HLB 80:20 [w/w] 
coatings were prepared. As multidimensional scaling plot demonstrated (Figure 1), adjacent clusters in 
PCA score plots indicated correlations and similarities between the mixed coatings (PS-DVB-WAX:Si-IL 
80:20 [w/w], PS-DVB-WAX:HLB 50:50 [w/w], and PS-DVB-WAX:HLB 80:20 [w/w]) and individual 
coatings (PS-DVB-WAX, HLB, and Si-IL) in terms of similarities in extracted metabolites and their peak 
intensities. Data analysis of the obtained results from LC-MS showed that the single extraction method 
using PS-DVB-WAX: HLB 50:50 (w:w) coupled to different chromatographic techniques assists to 
provide broad metabolite coverage which develop untargeted metabolome profiling for both highly polar 
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and nonpolar metabolites. The degree of simultaneous extraction of both polar and nonpolar metabolites 
based on increasing peak intensities using various coatings is ordered as follows: PS-DVB-WAX:HLB 
50:50 [w/w] > PS-DVB-WAX:HLB 80:20 [w/w] > PS-DVB-WAX:SiIL 80:20 [w/w] > PS-DVB-WAX > 
HLB > Si-IL > Si-RP > PBA. As it can be seen, in untargeted metabolomics studies, the number of peaks 
and their intensity corresponding to the extracted features is dependent on the selected SPME coating and 
method of analysis. A S-plot was used for identification of discriminating features between different 
coatings, with PS-DVB-WAX:HLB 50:50 [w/w] used as a reference coating. Results showed that the 
highest overlap of clusters were related to mixed coatings (PS-DVB-WAX:Si-IL 80:20 [w/w]), PS-DVB-
WAX:HLB 50:50 [w/w]), PS-DVB-WAX:HLB 80:20 [w/w]) and coatings prepared with individual 
particles (PS-DVB-WAX, HLB, Si-IL) in comparison with other coatings (PBA, Si-RP-WCX) for both 
positive and negative ionization modes and for all three columns in terms of number of features, extracted 
metabolites, and peak intensities. PS-DVB-WAX: HLB 50:50 (w:w) as the best candidate of 96-blade 
system for untargeted analysis is able to extract a wide variety of metabolites in terms of polarities 
characterized by -7 < log P < 15, and 100 < MW < 1000 such as metabolites related to central carbon 
metabolism (glycolytic, and pentose phosphate pathway like glucose, ribulose-5-phosphate, glucose-6-
phosphate, and intermediates of citric acid cycle such as aconitic acid, succinic acid, malic acid ), and 
biosynthetic metabolites (amino acids such as S-adenosyl-L-methionine, asparagine,  cystathionine, 
betaine, homoserine, etc, and nucleotides including cytidine 3'-triphosphate, nicotinic acid 
mononucleotide, adenosine diphosphate ribose, adenosine 3',5'-bisphosphate, adenosine triphosphate) 
classified as polar metabolites to hydrophobic metabolites such as lipids linolenic acid, hexacosanoic 
acid, and stearic acid, PG(22:0/19:0), PG(16:0/16:0), PC(P-20:0/12:0), which are widely distributed 
within E.coli membrane separated with three different LC columns combined. Tables 3.5 display the list 
of identified metabolites using PS-DVB-WAX: HLB 50:50 (w:w) coupled to three different columns in 
both ionization modes after removal of the parts of the chromatograms related to void volume and re-
equilibration time confirmed with authentic standards. Figure S5 demonstrates Heatmap of metabolites 
extracted by different 96-blade SPME coating (Metabolite levels correspond to the color intensity). The 
lower color intensity indicates reduced levels of the respective metabolites and vice versa. The each box 
color represents the data after calculating the mean of three replicates. 
The obtained results demonstrated that different stationary phases for the 96-blade system could provide 
different metabolites profiles; therefore, the coating should be carefully selected based on the focus of 
study on different classes of metabolites. Using SPME sorbents composed of a mixture of particles with 
different polarities is similar to using a mixture of different solvents for extraction in order to achieve 
wider metabolite coverage. The developed 96-blade SPME technique is more successful for untargeted 
metabolomics in comparison to other extraction techniques such as SPE and LLE. One of the drawbacks 
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of SPE in comparison to SPME is its limitation because of breakthrough volume. Using the same 
extraction phase for both, SPME and SPE experiments, Mirnaghi et al. [224] proved the suitability of 
SPME for untargeted analysis of metabolites in broad range of polarity where the breakthrough volume 
cannot be determined prior to extraction. Additionally, due to its open bed format SPME does not suffer 
from the clogging that is an issue with SPE cartridges. 
 Hye Shin et al. [220] evaluated different solvents for extraction of metabolites from bacterial cells, and 
they found that a mixture of acetonitrile:methanol:water (2:2:1) and water:isopropanol:methanol (2:2:5) 
provided the highest peak intensity, number of extracted metabolites, and reproducibility in comparison to 
pure methanol and acetonitrile:water (1:1). However, as the type of extraction solvent could affect the 
metabolomics profiling, the solvent must be carefully selected in regards to the purpose of the metabolic 
profiling under investigation. Polyamines, amino acids, organic acids, sugar phosphates, and fatty acids 
were detected by the best-nominated solvent. 
In the current study, global metabolomics profiling using PS-DVB-WAX:HLB 50:50 [w/w] provided a 
wider range of metabolite coverage than acetonitrile:methanol:water (2:2:1) and 
water:isopropanol:methanol (2:2:5) evaluated by Hye Shin et al. [220]. The PS-DVB-WAX:HLB 50:50 
[w/w] coating provided wide metabolome coverage (Table 3.5), from highly polar and ionic metabolites 
such as peptides, nucleotides, mono/di/tri/tetrasaccharides, sugar acids, and glycosyl compounds, to 
nonpolar metabolites such as linoleic acid and derivatives, fatty acids, glycerophospholipids, and prenol 
lipids which is comparable with identified metabolites using commercial SPME fibers as well as 
previously developed traditional solvent extraction techniques. Based on the present observation, 
saccharides (mono/di/tri/tetrasaccharides), nucleotides (purine nucleotides, pyrimidine nucleotides), 
imidazole nucleosides, peptides, and diazins are the main class of compounds extracted by SPME, which 
were not reported in extraction with LLE.  Moreover, the SPME technique provided no risk of chemical 
modification, contamination, and analyte loss while in solvent extraction technique consumption of large 
volumes of organic solvent and emulsion formation result in metabolite loss [28]. One of the other 
advantages of SPME is capability of this technique for characterization of short-lived or unstable species 
or biotransformation reaction intermediates [225-230]. Vuckovic et al. applied in vivo SPME procedure 
for direct sampling of the circulating blood of mice and demonstrated that in comparison to ultrafiltration 
and solvent precipitation techniques, SPME has capability of capturing unstable energy metabolites 
displaying an important development in metabolomics [143]. In the present study, the results 
demonstrated that SPME extracted adenosine, adenosine monophosphate, adenosine triphosphate, and 
glutathione as unstable metabolites from E.coli metablome. This technique is also less invasive over 
traditional extraction methodologies [231]. 
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3.3.2.2 LC-MS method development for bacterial cell metabolomics studies  
Most works in the area of nontargeted metabolomics have been conducted with the use of RP C18 
columns, as they have shown to be the columns that provide the highest number of features. However, RP 
C18 columns provide poor separation of polar metabolites eluted in the void volume, which may result in 
ion suppression and low metabolomic coverage [213]. To obtain reliable results in profiling thousands of 
features, it is necessary to optimize chromatographic separation and reduce matrix effects. Detection of as 
many metabolites as possible enhance the chance of capturing up regulated or down regulated metabolites 
in the metabolome.  
In the present work, three different LC columns (HILIC, XBridge C18, and Kinetex PFP) were selected to 
ensure analyte retention and provide metabolome coverage for extracted metabolites with different SPME 
coatings. HILIC columns operate based on hydrophilic interaction chromatography, and are mostly used 
for separation of polar metabolites. XBridge C18 and Kinetex PFP columns were selected as RP columns. 
The XBridge C18 column is modified to retain polar as well as nonpolar metabolites, and the Kinetex 
PFP column acted as a mid-polar stationary phase. Table 3.4 demonstrates the number of features 
extracted using different coatings separated by different investigated columns in both polarization modes. 
The highest number of features represents overall metabolome coverage, and peak intensity of features 
indicates the threshold required for quantification [211]. 
The Kinetex PFP column separated the highest number of features and identified metabolites ranged 
between -7 < log P < 15, and the highest number of identified metabolites were related to carboxylic acid 
and derivatives, peptides, amino acids and derivatives, prenol lipids, glycosyl compounds, 
mono/di/trisaccharides, glycerophospholipids, fatty acids and conjugates. In the case of Kinetex PFP 
column, pentafluorophennyl bonded phase incorporates fluorine atoms on the periphery of the phenyl 
ring, applying multiple retention mechanisms for separation of challenging compounds. These 
interactions include hydrophobic, π-π, dipole-dipole, H-bonding, and shape selectivity. Both polar and 
aromatic compounds can be retained with a PFP column as there are electronegative fluorine atoms 
producing an electron deficient phenyl ring. This highly polar phenyl ring enables highly polar analytes 
and their stereoisomers to also be retained by dipole-dipole and H-bonding interactions. This wide 
separation coverage was not achieved by the amino-based HILIC and the XBridge C18 columns. The 
Kinetex PFP stationary phase with gradient elution provided a higher resolution, decreased run time and 
improved sensitivity compared to regular HPLC. Figure 3.6 shows the chromatogram of the separated 
metabolites using Kinetex PFP extracted by PS-DVB-WAX:HLB 50:50 [w/w] using an Orbitrap mass 
spectrometer in both positive and negative ESI modes. The identified metabolites separated by HILIC 
column were ranged between -8.0 < log P < 9.0, and the majority of the separated metabolites were 
related to glycosyl compounds, peptides, phenols and derivatives, amino acids and derivatives, and 
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mono/disaccharides. The HILIC column with amino bonded functional groups demonstrated good 
retention of highly polar compounds. However, these types of columns need longer equilibration times 
than RP columns, and produce broader peak shapes. According to comprehensive metabolomics studies, 
while the HILIC column does not provide much additional information for global metabolomics profiling, 
it can provide more resolution of polar compounds, which might be useful in some applications [215].  
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Figure 3.5 PCA score plot using Kinetex PFP column in positive ionization mode (A), PCA score plot for Kinetex 
PFP using negative ionization mode (B), PCA score plot using Luna HILIC Si column in positive ionization mode 
(C), PCA score plot using Luna HILIC Si column in negative ionization mode (D), PCA score plot using XBridge 
C18 in positive ionization mode (E), PCA score plot using XBridge C18 in negative ionization mode (F). 
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Figure 3.6 Heatmap of metabolites extracted by different 96-blade SPME coatings (Metabolite levels correspond to 
the color intensity). The lower color intensity indicates reduced levels of the respective metabolites and vice versa. 
The each box color represents the data after calculating the mean of three replicates. 
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Nucleoside di/triphosphate is one of the most important metabolites identified using the HILIC column, 
and the XBridge C18 columns could not separate it. Alternatively, the XBridge C18 column could 
separate mostly prenol lipids, glycerophospholipids. This column used as an RP column in this research 
demonstrated good separation of nonpolar compounds ranged between -3 < log P < 17; however, in terms 
of retaining highly polar and ionic metabolites, this column did not provide high efficiency. 
The metabolome coverage among different evaluated columns HILIC, Kinetex PFP, and XBridge C18 
chromatographic modes was evaluated by using the ion features defined by their exact mass 
corresponding to detected adduct ions. These analyses indicated that the highest number of unique 
features were detected by Kinetex PFP in both ESI modes. Figure 3.8 demonstrated the difference 
between metabolic coverage of different evaluated columns. The difference between Kinetex PFP column 
and HILIC (5 ± 12%) is related to separation of highly polar purine nucleotides with HILIC column while 
5 ± 10% difference between XBridge C18 with Kinetex PFP is related to separation of highly nonpolar 
glycerolipids with XBridge C18. The results obtained in this study are promising for the Kinetex PFP in 
terms of separation of a wide variety of metabolites in one single run; however, for a group of highly 
polar and nonpolar metabolites, there is a need for the HILIC and C18 columns, respectively. Serially 
applying multiple dimension chromatographic methods by using HILIC and XBridge C18 columns in 
parallel could be the solution for retaining and resolving peaks related to highly polar metabolites such as 
phosphorylated nucleotides by HILIC column, and highly nonpolar glycerolipids by XBridge C18 
columns. Ivanisevic et al. reported integration of RP and HILIC chromatography for metabolomics 
coverage of hydrophobic, lipids, hydrophilic, and central carbon metabolites [207]. In this work, the 
authors reported 56,000 features extracted from E.coli for both positive and negative ESI modes using 
HILIC (Luna Aminopropyl) and RP (XBridge C18) columns, and in cases where time and sample sizes 
are limited, the RP in positive mode and HILIC in negative mode can be combined to yield a maximum 
amount of biological information [207].	  
The outcome of the obtained results shows that in order to have comprehensive metabolite coverage, it is 
better to do coupling of RP and HILIC columns. This can be achieved in two ways: off-line coupling 
called heart-cutting or on-line coupling called comprehensive LC×LC. These configurations provide 
advantages such as increase in peak capacity, improvement in separation, especially for co-eluted peaks, 
and decrease in signal suppression [212,232,233]. Edwards et al. [212] applied two-dimensional (2D) 
separation combining SAX and RPLC columns for a complex E.coli cell matrix, providing a metabolomic 
profile with increased peak capacity, resolution and sensitivity. In this study authors addressed that 
compared to RPLC with the same gradient of 2D, 74 more compounds (within experimental error) were 
separated. This study is mostly focused on polar compounds such as glycolysis and TCA cycle 
metabolites, and there is no report about extraction of nonpolars. 
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3.3.3 Matrix effect 
To reduce matrix effect, which is a significant issue in complex sample analyses by ESI-MS, the chosen 
sample preparation technique needs to provide high quality sample clean up. In this study, the use of 
biocompatible coatings and a washing step helped to decrease possible matrix effects. The absolute 
matrix effect for targeted metabolites was calculated based on the procedure developed by Matuszewski 
et al. [206]. Bacteria extract prepared using the optimized SPME protocol was spiked with a known 
concentration of targeted metabolites. The obtained results from the SPME-LC-MS analysis of spiked 
bacteria extract were compared with the results of neat standards at the same concentration. Ion 
suppression and ion enhancement are defined for results less than 80% and more than 120%, respectively 
[206,234]. Figure 3.9 shows that no matrix effects were found for the targeted metabolites characterized 
by wide range of physicochemical properties with the optimized SPME method. For the untargeted 
metabolomics study, the stability of the QC following injection of a large number of samples represented 
by QC clusters in PCA score plots (Figure 3.5, and Figure 3.10) demonstrated good stability of instrument 
function because of the excellent clean up of sample extracts, thereby yielding reliable results and 
minimizing instrument maintenance.  
 
 
Figure 3.7 Chromatogram related to separation of extracted metabolites from bacteria using PS-DVB-WAX:HLB 
50:50 (w/w) 96-SPME blade coupled to Kinetex PFP and Orbitrap mass spectrometer A) positive ESI B) negative 
ESI mode. 
	   71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Metabolome coverage by three different columns based on accurate mass. 	  
Table 3.5 Classes of all identified metabolites extracted and analysed by the optimized PS-DVB-WAX:HLB 50:50 
(w:w) coupled to three different columns for in vivo sampling from bacterial media containing 2×105 CFU/mL cells 
at stationary phase of growth curve at both ionization modes (*: separated by Kinetex PFP, +: separated by HILIC 
column, #: separated by XBridge C18 column). Masses are theoretical mass for the chemical formula and 
experimentally measured masses of hydrogen adduct ions in both positive and negative ESI. 
Alcohols and Polyols  
Metabolite Theoretical mass 
(molecule) 
Exp. mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Choline * + # 104.1075 105.1147 103.0997 C5H14NO 
 
-3.6 
 
Alkylamines 
Metabolite Theoretical mass 
(molecule) 
Exp. mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Spermidine * + # 145.1578 146.1657 144.1500 C7H19N3 
 
-1.1 
Betaine aldehyde * +  102.0918 103.0997 101.0840 C5H12NO 
 
-4.7 
 
Carnitine * +  161.1052 162.1130 160.0973 C7H15NO3 
 
-4.9 
 
Pantothenic acid * + # 219.1106 220.1184 218.1028 C9H17NO5 
 
-1.4 
 
Pentane-1,5-diamine * + #  102.1156 103.1235 101.1078 C5H14N2 
 
-0.4 
 
Amino acids 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Valine * + # 117.0789 118.0868 116.0711 C5H11NO2 
 
-2.3 
 
Tryptophan * + #  204.0898 205.0977 203.0820 C11H12N2O2 
 
-1.1 
 
Threonine * +  119.0582 120.0660 118.0504 C4H9NO3 
 
-3.5 
 
Serine * + #  105.0425 106.0504 104.0347 C3H7NO3 
 
-3.9 
 
Quinolinic acid * + #  167.0218 168.0296 166.0140 C7H5NO4 
 
-0.54 
 
Acetylornithine * + # 174.1004 175.1082 173.0926 C7H14N2O3 -3.6 
Kinetex PFP 5 % 
50% 
Luna HILIC 
XBridge C18 
5 % 
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S-adenosyl-L-methionine  
* +  
399.1450 400.1528 398.1372 C15H23N6O5S 
 
-5.3 
 
Allantoic acid * + # 176.0545 177.0623 175.0467 C4H8N4O4 
 
-2.6 
 
4-aminobutyrate * + # 103.0633 104.0711 102.0555 C4H9NO2 
 
-3 
 
Arginine * +  174.1116 175.1195 173.1038 C6H14N4O2 
 
-3.9 
 
Asparagine * +  132.0535 133.0613 131.0456 C4H8N2O3 
 
-4.3 
 
Aspartic acid * +  133.0375 134.0453 132.0296 C4H7NO4 
 
-3.5 
 
Tyrosine * + # 181.0738 182.0817 180.0660 C9H11NO3 
 
-2.4 
 
Ureidosuccinic acid * + # 176.0433 177.0511 175.0354 C5H8N2O5 
 
-1.7 
 
Cystathionine * +  222.0674 223.0752 221.0596 C7H14N2O4S 
 
-5.8 
 
Cysteine * + # 121.0197 122.0275 120.0119 C3H7NO2S 
 
-2.8 
 
Glutamic acid * +  147.0531 148.0609 146.0453 C5H9NO4 
 
-3.5 
 
Proline * + # 115.0633 116.0711 114.0555 C5H9NO2 
 
-2.7 
 
Glutamine * +  146.0691 147.0769 145.0613 C5H10N2O3 
 
-4 
Betaine * +  117.0789 118.0868 116.0711 C5H11NO2 
 
-4.5 
 
Glutamic acid 5-phosphate * +  227.0194 228.0273 226.0116 C5H10NO7P 
 
-3 
O-phospho-L-homoserine 
 * +  
199.0245 200.0324 198.0167 C4H10NO6P 
 
-3.2 
 
Histidine * +  155.0691 156.0773 154.0616 C6H9N3O2 
 
-3.3 
 
Phenylalanine * +  165.0789 166.0868 164.0711 C9H11NO2 
 
-1.4 
 
Methionine * + # 149.0510 150.0588 148.0432 C5H11NO2S 
 
-2.2 
 
Homocysteine * + # 135.0354 136.0432 134.0275 C4H9NO2S 
 
-2.6 
 
Lysine * +  146.1055 147.1133 145.0977 C6H14N2O2 
 
-3.8 
 
S-Methyl-L-methionine * + 164.0745 165.0823 163.0667 C6H14NO2S 
 
-3.3 
 
Citrulline * +  175.0956 176.1035 174.0878 C6H13N3O3 
 
-3.9 
 
Phosphoserine * +  185.0089 186.0167 184.0011 C3H8NO6P 
 
-3.2 
 
Leucine * + # 131.0946 132.1024 130.0868 C6H13NO2 
 
-1.8 
 
Homoserine * +  119.0582 120.0660 118.0504 C4H9NO3 
 
-3.8 
 
Amino sugars 
Metabolite Theoretical mass [M+H]+ Exp. Mass Formula Log P 
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(molecule) [M-H]- 
5-phosphoribosylamine * + 229.0351 230.0429 228.0273 C5H12NO7P 
 
-3.5 
 
Orotic acid * + # 156.0171 157.0249 155.0092 C5H4N2O4 
 
-1.2 
 
Ornithine * +  132.0898 133.0977 131.0820 C5H12N2O2 
 
-3.3 
 
N-acetyl-glucosamine-1-
phosphate * +  
301.0562 302.0640 300.0484 C8H16NO9P 
 
-3.3 
 
5-phosphoribosylamine * + 229.0351 230.0429 228.0273 C5H12NO7P 
 
-3.5 
 
Azoles 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Histidinol * + # 141.0902 142.0980 140.0823 C6H11N3O 
 
-1.7 
 
Carboxylic acids and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Succinic acid * + # 118.0266 119.0344 117.0187 C4H6O4 
 
-0.4 
 
Aconitic acid * + # 174.0164 175.0242 173.0086 C6H6O6 
 
-0.52 
 
Pimelic acid * + # 160.0735 161.0813 159.0657 C7H12O4 
 
0.94 
 
3-isopropylmalate * + # 176.0684 177.0763 175.0609 C7H12O5 
 
0.16 
 
Malic acid * + # 134.0215 135.0293 133.0137 C4H6O5 
 
-1.1 
 
Porphobilinogen * + # 226.0953 227.1031 225.0875 C10H14N2O4 
 
-2.7 
 
Glutathione 306.0759 307.0818 305.0673 C10H16N3O6S -4.9 
3-isopropylmalate * + # 176.0684 177.0763 175.0606 C7H12O5 
 
0.16 
 
Cyclic alcohols and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Inositol phosphate * +  260.0297 261.0375 259.0218 C6H13O9P 
 
-3.9 
 
myo-inositol * +  180.0633 181.0712 179.0555 C6H12O6 
 
-3.8 
 
Diazins 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Uracil  * + # 112.0272 113.0351 111.0194 C4H4N2O2 
 
-0.86 
 
Cytosine * + # 111.0433 112.0510 110.0358 C4H5N3O 
 
-1.1 
 
Thymine * + # 126.0429 127.0507 125.0351 C5H6N2O2 
 
-0.46 
 
Disaccharides 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Trehalose 6-phosphate * + 422.0825 423.0903 421.0747 C12H23O14P -4.8 
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Lactose * +  342.1162 343.1240 341.1083 C12H22O11 
 
-4.7 
 
Melibiose * +  342.1162 343.1240 341.1083 C12H22O11 
 
-4.7 
 
Trehalose * +  342.1162 343.1240 341.1083 C12H22O11 
 
-4.7 
 
Dithiolanes 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Lipoamide * + # 205.0595 206.0673 204.0516 C8H15NOS2 
 
1.31 
 
Fatty acids and conjugates 
 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Valeric acid * + # 102.0680 103.0759 101.0602 C5H10O2 
 
1.37 
 
Hexacosanoic acid *  # 396.3967 397.4045 395.3889 C26H52O2 
 
10.7 
 
Heptadecanoic acid *  # 270.2558 271.2637 269.2480 C17H34O2 
 
6.7 
 
Stearic acid *  # 284.2715 285.2793 283.2637 C18H36O2 
 
7.15 
 
Eicosapentaenoic acid *  # 302.2245 303.2324 301.2167 C20H30O2 
 
6.23 
 
Oleic acid *  # 282.2558 283.2637 281.2480 C18H34O2 
 
6.78 
 
Palmitoleic acid *  # 254.2245 255.2324 253.2167 C16H30O2 
 
5.89 
 
Eicosapentaenoic acid *  #  302.2245 303.2324 301.2167 C20H30O2 
 
6.23 
 
1-Hexyldecanoic acid *  # 256.2402 257.2480 255.2324 C16H32O2 
 
6.26 
 
Fumaric acid * + # 116.0109 117.0187 115.0031 C4H4O4 
 
-0.041 
 
Fatty acid esters 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Succinyl-CoA * + # 867.1313 868.1390 866.1234 C25H40N7O19P3S 
 
-0.61 
 
Acetyl-CoA * + # 809.1257 810.1336 808.1179 C23H38N7O17P3S 
 
-0.58 
 
Malonyl-CoA * + #  853.1156 854.1234 852.1077 C24H38N7O19P3S 
 
1.39 
 
Fatty acids and conjugates 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Lauric acid * + # 200.1776 201.1854 199.1698 C12H24O2 
 
4.48 
 
Myristic acid * + # 228.2089 229.2165 227.2020 C14H28O2 4.77 
 
3-decenoic acid * + # 170.1306 171.1385 169.1228 C10H18O2 2.99 
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Fatty acyls 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
9,13-dihydroxy-11-
octadecenoic acid * + # 
314.2457 315.2535 313.2378 C18H34O4 
 
4.62 
 
Fatty alcohols 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
1,3,7-Octanetriol * + # 
 
162.1255 163.1334 161.1177 C8H18O3 
 
-0.34 
 
Guanidines 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Agmatine * + # 130.1218 131.1296 129.1140 C5H14N4 
 
-1.2 
 
Glycosyl compounds 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Pseudouridine 5'-phosphate * 
+ #  
324.0358 325.0436 323.0280 C9H13N2O9P 
 
-3.2 
 
Glycerophospholipids 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
PE-
Cer(d14:2(4E,6E)/16:0(2OH)) 
*  # 
618.4372 619.4451 617.4294 C32H63N2O7P 
 
8.73 
 
PG(22:0/19:0)  # 848.6506 849.6584 847.6428 C47H93O10P 
 
15.28 
 
PG(20:5(5Z,8Z,11Z,14Z,17Z)/
15:1(9Z)) *  # 
752.4628 753.4706 751.4550 C41H69O10P 
 
11.60 
 
PG(16:0/16:0) *  # 722.5097 723.5176 721.5019 C38H75O10P 
 
11.77 
 
PG(17:1(9Z)/14:0) *  # 706.4784 707.4863 705.4706 C37H71O10P 
 
11.16 
 
PG(17:2(9Z,12Z)/13:0) *  #  690.4472 691.4550 689.4393 C36H67O10P 
 
10.55 
 
PG(17:2(9Z,12Z)/0:0) *  # 494.2644 495.2722 493.2566 C23H43O9P 
 
5.68 
 
PG(18:3(6Z,9Z,12Z)/0:0)  
*  # 
506.2644 507.2722 505.2566 C24H43O9P 
 
5.68 
 
PC(P-20:0/12:0) *  # 717.5672 718.5750 716.5594 C40H80NO7P 
 
12.63 
 
PG(17:2(9Z,12Z)/0:0) *  # 494.2644 495.2722 493.2566 C23H43O9P 
 
5.68 
 
Hydroxy acids and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
4-hydroxybenzyl alcohol    * + 
# 
124.0524 125.0602 123.0446 C7H8O2 
 
0.9 
 
Imidazopyrimidines 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Hypoxanthine * + # 136.0385 137.0463 135.0306 C5H4N4O 
 
0.048 
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Guanine * + # 151.0494 152.0572 150.0415 C5H5N5O 
 
-0.59 
 
Imidazole nucleosides and nucleotides 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Phosphoribosyl-formamido-
carboxamide 
 * +  
366.0576 367.0654 365.0498 C10H15N4O9P 
 
-4.1 
 
5-aminoimidazole 
ribonucleotide * +  
295.0569 296.0647 294.0491 C8H14N3O7P 
 
-4.3 
 
Lineolic acids and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Linolenic acid * + # 
 
278.2245 279.2324 277.2167 C18H30O2 
 
6.06 
 
Keto-acids and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
2-Ketobutyric acid * + # 102.0316 103.0395 101.0238 C4H6O3 
 
0.77 
 
Prephenate * + # 226.0477 227.0555 225.0399 C10H10O6 
 
0.061 
 
Monosaccharides 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Xylulose * + # 150.0528 151.0606 149.0450 C5H10O5 
 
-2.6 
 
Ribulose-5-phosphate * + # 230.0192 231.0269 229.0113 C5H11O8P 
 
-2.4 
 
Arabinose * + # 150.0528 151.0606 149.0450 C5H10O5 
 
-2.9 
 
Glucose * + # 180.0633 181.0712 179.0555 C6H12O6 
 
-2.9 
 
Glycerol-3-phosphate * + # 172.0137 173.0215 171.0058 C3H9O6P 
 
-2 
 
Mannitol-1-phosphate * +  262.0453 263.0531 261.0375 C6H15O9P 
 
-3.9 
 
Glucose-6-phosphate * + # 260.0297 261.0375 259.0218 C6H13O9P 
 
-3.1 
 
Rhamnose * + # 164.0684 165.0763 163.0606 C6H12O5 
 
-1.9 
 
Organic oxoanionic compounds 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Isopentenyl pyrophosphate * + 
#  
246.0058 247.0136 244.9980 C5H12O7P2 
 
0.2 
 
Carbamoyl phosphate * + # 140.9827 141.9905 139.9748 CH4NO5P 
 
-1.2 
 
Organic phosphoric acids and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Pantetheine 4'-phosphate     * 
+ # 
358.0963 359.1041 357.0885 C11H23N2O7PS 
 
-1.7 
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Glyceric acid 1,3-biphosphate 
* + # 
265.9592 266.9671 264.9514 C3H8O10P2 
 
-2.3 
 
Peptidomimetics 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
4'-phospho-N-
pantothenoylcysteine * + # 
402.0861 403.0940 401.0783 C12H23N2O9PS 
 
-2 
 
Prenol lipids 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Undecaprenyl diphosphate 
  # 
926.6318 927.6396 925.6240 C55H92O7P2 
 
16.89 
 
Octaprenyl diphosphate      *  
# 
722.4440 723.4518 721.4362 C40H68O7P2 
 
11.92 
 
Pteridines and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Tetrahydropteroyltri-L-
glutamate * + # 
703.2561 704.2639 702.2483 C29H37N9O12 
 
-6.1 
 
5,10-methylene-THF * + #  457.1709 458.1788 456.1631 C20H23N7O6 
 
-2 
 
5-Methyltetrahydropteroyltri-
L-glutamate * +  
717.2718 718.2796 716.2639 C30H39N9O12 
 
-5.7 
 
Riboflavin * + # 376.1382 377.1461 375.1304 C17H20N4O6 
 
-0.92 
 
Tetrahydrofolic acid * + # 445.1709 446.1788 444.1631 C19H23N7O6 
 
-2.8 
 
Tetrahydropteroyltri-L-
glutamate * +  
703.2561 704.2639 702.2483 C29H37N9O12 
 
-6.1 
 
Purine nucleotides 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Xanthosine 5-triphosphate * +  523.9746 524.9825 522.9668 C10H15N4O15P3 
 
-4.1 
 
Xanthosine * + # 284.0756 285.0835 283.0678 C10H12N4O6 
 
-1.2 
 
Adenosine diphosphate ribose  
+  
559.0716 560.0795 558.0638 C15H23N5O14P2 
 
-6.7 
 
Adenosine 3',5'-bisphosphate  
+  
427.0294 428.0372 426.0215 C10H15N5O10P2 
 
-6.1 
 
Adenosine * + # 267.0967 268.1045 266.0889 C10H13N5O4 
 
-2.1 
 
Adenosine 3',5'-bisphosphate 
* +  
427.0294 428.0372 426.0215 C10H15N5O10P2 
 
-6.1 
 
Adenosine triphosphate       +  506.9957 508.0035 505.9879 C10H16N5O13P3 
 
-6.2 
 
Deoxyadenosine triphosphate 
* +  
491.0008 492.0086 489.9930 C10H16N5O12P3 -5.3 
 
Deoxyadenosine 
monophosphate * +  
331.0681 332.0759 330.0603 C10H14N5O6P 
 
-3.9 
 
2'-Deoxyadenosine-5'-
diphosphate * +  
331.0682 332.0759 330.0603 C10H14N5O6P 
 
-4.4 
 
Guanosine triphosphate      * +  522.9907 523.9971 521.9828 C10H16N5O14P3 
 
-3.6 
 
Guanosine monophosphate * 363.0580 364.0658 362.0501 C10H14N5O8P -2.9 
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+ #    
Inosine * + # 268.0807 269.0885 267.0729 C10H12N4O5 
 
-2.5 
 
Guanosine * + # 283.0916 284.0994 282.0838 C10H13N5O5 
 
-2.7 
 
5'-methylthioadenosine      * + 
# 
297.0895 298.0973 296.0817 C11H15N5O3S 
 
-0.61 
 
Phosphoribosyl-AMP * +    559.0716 560.0795 558.0638 C15H23N5O14P2 
 
-4.1 
 
Pyrimidine nucleotides 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Uridine triphosphate * +  483.9685 484.9763 482.9607 C9H15N2O15P3 
 
-3.4 
 
Cytidine monophosphate    * +  323.0518 324.0596 322.0440 C9H14N3O8P 
 
-3.3 
 
2'-Deoxycytidine-5'-
triphosphate * +  
466.9896 467.9974 465.9817 C9H16N3O13P3 
 
-3.6 
 
2'-Deoxycytidine 5'-
diphosphate * + # 
387.0232 388.0310 386.0154 C9H15N3O10P2 
 
-3 
 
Cytidine * + # 243.0855 244.0933 242.0776 C9H13N3O5 
 
-2.8 
 
Cytidine 3'-triphosphate      * 
+  
482.9845 483.9911 481.9775 C9H16N3O14P3 
 
-4.3 
 
Thymidine * + # 242.0902 243.0980 241.0824 C10H14N2O5 
 
-1.1 
 
2'-Deoxyuridine 5'-
monophosphate * + # 
308.0409 309.0487 307.0331 C9H13N2O8P 
 
-1.6 
 
Deoxyuridine-diphosphate * + 
# 
388.0072 389.0151 386.9994 C9H14N2O11P2 
 
-2.1 
 
Uridine 5'-diphosphate       * + 
# 
404.0022 405.0100 402.9943 C9H14N2O12P2 
 
-3 
 
Uridine diphosphate glucose * 
+  
566.0550 567.0628 565.0472 C15H24N2O17P2 
 
-5 
 
N-acetylglucosamine * +  221.0899 222.0977 220.0821 C8H15NO6 
 
-3.2 
 
Uridine 5'-monophosphate  * 
+ #  
324.0358 325.0436 323.0280 C9H13N2O9P 
 
-2.5 
 
Uridine * + # 244.0695 245.0773 243.0617 C9H12N2O6 
 
-2.4 
 
Pyrrolines 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
1-pyrroline-5-carboxylate  * + 
# 
113.0476 114.0555 112.0398 C5H7NO2 
 
-2.3 
 
Pyridines and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Pyridoxal 5'-phosphate       * + 
# 
247.0245 248.0324 246.0167 C8H10NO6P 
 
-2.1 
 
Pyridoxine * + # 169.0738 170.0817 168.0660 C8H11NO3 
 
-0.95 
 
Nicotinic acid * + # 123.0320 124.0398 122.0242 C6H5NO2 
 
-0.17 
 
Niacinamide * + # 122.0480 123.0558 121.0401 C6H6N2O -0.39 
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Pyridine nucleotides 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Nicotinic acid mononucleotide 
* +  
337.0562 338.0640 336.0484 C11H16NO9P 
 
-5.5 
 
Sugar acids and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Phosphogluconic acid * +  276.0246 277.0402 275.0171 C6H13O10P 
 
-3.5 
 
Tetrapyrroles and derivatives 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Uroporphyrinogen-III * + #  836.2752 837.2830 835.2674 C40H44N4O16 
 
1.39 
 
Protoporphyrinogen * + # 568.3049 569.3127 567.2971 C34H40N4O4 
 
6.2 
 
Protoporphyrin IX * + # 562.2580 563.2658 561.2501 C34H34N4O4 
 
6.78 
 
Hydroxymethylbilane * + # 854.2858 855.2936 853.2779 C40H46N4O17 
 
0.53 
 
Tetrasaccharides 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Maltotetraose * +  666.2218 667.2296 665.2140 C24H42O21 
 
-8.2 
 
Thiamine pyrophosphate 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Thiamine-pyrophosphate  
* +  
425.0449 426.0527 424.0371 C12H19N4O7P2S 
 
-5.8 
 
Thiamine monophosphate  * +  344.0708 345.0786 343.0629 C12H17N4O4PS 
 
-5.7 
 
Thienoimidazolidines 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Biotin * + # 244.0881 245.0959 243.0803 C10H16N2O3S 
 
0.17 
 
Trisaccharides 
Metabolite Theoretical mass 
(molecule) 
Exp. Mass 
[M+H]+ 
Exp. Mass 
[M-H]- 
Formula Log P 
Maltotriose * +  504.1690 505.1768 503.1612 C18H32O16 
 
-6.5 
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Figure 3.9 Absolute matrix effect for targeted analysis using PS-DVB-WAX: HLB 50:50 [w:w] and Kinetex PFP 
column. 	  
3.3.4 Stability of metabolites on the coating and preservation before analysis 
 The stability of the metabolites after extraction on the surface of coating was investigated to determine 
how long the SPME coatings could be stored after sampling in case there is a need to preserve the 
coatings before analysis. An evaluation was conducted using a PS-DVB-WAX: HLB 50:50 [w/w] coating 
at optimized conditions and the Kinetex PFP as the column for separation. Desorption was completed at 
three time points: immediately after extraction, 5 hours and 10 hours after extraction when stored at room 
temperature. Coatings were also stored for 20 hours after extraction at -80°C. Results were compared with 
those obtained from desorptions performed immediately after extraction. The PCA score plot in Figure 
3.10 shows the differentiation between various clusters related to desorption immediately after extraction 
(0h), 5 hours after extraction (5h), and 10 hours after extraction (10h) while storing at room temperature, 
and desorption after storing coatings for 20 hours at -80°C. A slight difference was observed between 5h 
and 10h clusters. Low differentiation was also observed between clusters related to stored coatings at        
-80°C and immediately desorbed coatings. However, differentiation was noted between 5h and 10h 
clusters with respect to immediate desorption and 20h storage at -80oC. This would indicate that 
metabolite profile changed over time on the surface of the coatings when the coatings were not kept at 
very low temperatures. Thus, storage under low freezing conditions could prevent the change and 
degradation of the extracted metabolites. The identification of the metabolites that altered over time 
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demonstrated that lipids and amino acids are two classes of metabolites that can undergo changes after 
extraction on the surface of coatings if the coating is not preserved at a low temperature immediately after 
extraction. This change can be related to oxidation or degradation of compounds. Unstable lipid 
metabolites that were noted to decrease when coatings were stored at room temperature before desorption 
include fatty acids and conjugates such as 3-decenoic acid, tetradecanoic acid; fatty acyls such as 9,13-
dihydroxy-11-octadecenoic acid, prenol lipids such as undecaprenyl diphosphate; fatty alcohols such as 
1,3,7-octanetriol; glycerophospholipids such as PG(17:1(9Z)/14:0), PG(17:2(9Z,12Z)/0:0). Autoxidation 
of unsaturated fatty acids exposed to air led to formation of hydroperoxides that degraded to secondary 
oxidation products such as ketones and aldehydes. This lipid oxidation is widely detected in the food 
industry, in which the flavor, odour, colour, and nutritional value of foods are negatively affected during 
storage. The lipid oxidation process is initiated under heat or light stress and increases with the degree of 
unsaturation [235]. Amino acids and peptides are other examples of unstable metabolites. Tyrosine, 
glutamine, methionine, proline, aspartic acid, threonine, asparagine, and proline betaine were found to be 
unstable metabolites that decreased by storage at room temperature. Hydrolysis, deamination, oxidation, 
diketopiperazine and pyroglutamic acid formation, and racemization are potential degradation pathways 
for peptides and amino acids. For example, dehydration of aspartic acid to form cyclic imide intermediate 
or deamination of amino acids into aspartic acid or glycine can occur. Oxidation can also occur to amino 
acids by both chemical and photochemical pathways. 
Diketopiperazine and pyroglutamic acid formation can occur to the peptide by cleavage of the first two 
amino acids in the form of diketopiperazine if proline or glycine is in positions 1 or 2. This conversion 
can occur in peptides containing asparagine in the N terminal. Chiral integrity of amino acids and 
peptides can happen as well [236]. In the present study, 2,5-Dioxopiperazine and pyroglutamic acid are 
two differentiate metabolites increased in 10h samples versus 0h ones.  
A decrease in metabolite peak intensities was also indicated for extracted semi-volatiles and volatile 
organic compounds such as volatile aldehydes, alcohols and indols. Time elapsed in storage allows these 
compounds to escape from the surface of the coatings. As such, if coatings need to be 
transferred/transported for further analysis, it suggested that coatings be stored at -80°C and covered with 
aluminum foil so as to protect the extracted metabolites on the surface of the coatings from photo 
degradation. 
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Figure 3.10 PCA sore plot using PS-DVB:HLB 50:50 [w:w] and Kinetex PFP column to evaluate metabolite 
stability on the surface of coating during storage (positive ionization mode). 
 
3.4 Conclusions and future directions 
The objective of this study was to develop a systematic high-throughput metabolomics platform to 
analyze a broad coverage of metabolites from various samples, including cell, body fluids, and tissue. 
This is the first study to comprehensively optimize different coating chemistries for the 96-blade SPME 
system for direct extraction mode of untargeted metabolite profiling studies in combination with LC-MS. 
As previous studies in this area have concluded, different methods are needed to provide a metabolic 
profile for a broad coverage of metabolites. Different types of HPLC columns and SPME coating 
chemistries were applied to identify the best combination of SPME-LC-MS method for metabolomics 
profiling of bacterial cells with relatively high metabolome coverage. This consisted of accurately 
measuring wide ranges of classes of compounds in terms of polarities in untargeted metabolic profiling. 
The proposed and evaluated PS-DVB-WAX:HLB 50:50 [w/w] coating was able to extract the highest 
number of metabolites with a broader log P range than other previously developed coatings.  Moreover, 
the obtained results demonstrated that each type of SPME coating Chemistry has selectivity towards a 
specific class of metabolites. Therefore, an individual coating can be selected in order to focus on the 
specific class of metabolites and do targeted analysis without interferences from other metabolites. The 
investigation of metabolite stabilities indicate that SPME is able to extract unstable compounds; however, 
it is important to either immediately proceed with subsequent steps of the analysis or to preserve the 
coatings with extracted analytes at -80°C freezer in dark. This facilitates to obtain accurate representation 
of the metabolite composition in the living system. The Kinetex PFP column separated the highest 
number of features compared with other investigated columns. Based on the results, 2D-LC by using 
HILIC and RP columns could provide a broader metabolic profile. In the next chapters, the application of 
the optimized SPME-LC-MS method with widest metabolome coverage described above will be applied 
towards discovery of potential biomarkers of bacteria/cells under stress conditions. 
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Chapter 4 
Effect of cinnamaldehyde as an antibacterial agent on E.coli growth 
using 96-blade Solid Phase Microextraction coupled to Liquid 
Chromatography-Mass Spectrometry 	  	  
4.1 Introduction 
In recent times, transcriptomics, proteomics, and metabolomics, as functional genomics techniques, have 
burgeoned investigative fields in different areas of research; however, their challenging methodologies, 
particularly for in vivo analysis, have abated further progress in various areas of research [237]. 
Metabolomics, the newest “omics” science, involves the detection and semi-quantification of low 
molecular weight (<1000 Da) species in biological systems, referred to as metabolites, which result as end 
products of cellular reactions corresponding to direct effects on the cell phenotype. Contrastingly, 
transcriptomics and proteomics are mostly applied to provide extensive information related to genotype 
[238,239]. Metabolites are the building blocks of proteins, RNA, DNA, and cell membranes. They play 
important roles in system metabolism, signaling, and regulation with provision of vital components for 
life. The goal of metabolomics is to investigate the metabolic profiles of biological systems at a specified 
time and under specific environmental conditions. As metabolomics has the closest proximity to the 
phenotype of a given biological system, any environmental perturbation in a given biological system is 
reflected rapidly in its metabolome. For example, studies on stress responses of E.coli as a model 
organism have demonstrated that changes in its metabolic profile are higher than transcript changes. Also, 
in comparison to other ‘omics’ approaches, the high-throughput approach available for metabolic 
analyses of large numbers of samples provides a more cost effective alternative for determinations of 
changes in biological systems [240]. 
Recently, microbial metabolomics has received a lot of scientific attention due to its potential applications 
in a wide range of research areas, for instance, drug discovery and development, food metabolomics, and 
metabolic engineering [25]. Biofilm formation on food as well as exposure of food contact surfaces to 
human pathogens enhances their ability to survive in harsh environments, as well as their resistance in 
response to antibacterial treatments. Biofilm growth inhibition may retard spoilage of edible goods, 
consequently making them safer for human consumption, which in turn benefits both the food production 
industry as well as consumers [241]. In this regard, one of the most important areas of research in 
microbial metabolomics involves investigations into the bactericidal modes of action of antibacterial 
agents against different bacterial strains. 
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Plants, as a rich source of biologically active components, have been prominently used as a basis for drug 
development, contributing to human health [242]. Essential oils, as secondary metabolites produced by 
aromatic plants, are volatile compounds that are characterized by a strong odor, and used as food 
preservers due to their antiseptic, bactericidal, virucidal, fungicidal, and medicinal properties. The 
cytotoxic nature of these compounds is attributed to the presence of phenol, aldehyde, and alcohol 
functional groups in their structures, which have a pro-oxidant effect on proteins and DNA through the 
generation of reactive oxygen species [243-245]. 
The addition of essential oils such as linalool, thymol, eugenol, carvone, cinnamaldehyde, vanillin, 
carvacrol, citral, and limonene in food products has been accepted by the European Commission and the 
United States Food and Drug Administration (FDA). To this extent, essential oils have been used as 
flavors and microorganism growth inhibitors in food products to increase food shelf-life [246]. 
Previous studies have shown that various biologically active components exhibit differing effects on 
bacterial growth, as these compounds have unique functional groups that work through different pathways 
to stop bacterial metabolism. In past work, cluster discrimination between different antibacterial 
components was observed, as each compound was shown to exhibit stress specificity providing various 
metabolic patterns [247]. However, in order to introduce a new active component as an antibacterial 
component, its bacterial resistance mechanism needs to first be characterized. 
Cinnamon is one of the oldest herbal medicines used as a spice and traditional medicine. 
Cinnamaldehyde, as the main component of cinnamon bark extract, produces its distinct cinnamon odor 
and flavor. This compound has been proven to be active against pathogenic bacteria, fungi, and viruses 
[248-250]. The target action of cinnamon is introduced either on cell structure and membrane 
functionality, proteins and enzymes, or other essential processes involved in biosynthesis or energy 
generation [246]. Cinnamaldehyde is also capable of altering the lipid profile of the microbial cell 
membrane [251]. Consequently, tracking biochemical alterations during treatment of the biological 
system by this antibacterial agent could be used to find specific biomarkers or pathway mechanisms 
[159]. 
Metabolomics can been conducted through the use of a variety of analytical platforms, although MS 
coupled to LC or GC has been most regularly applied. Due to the complexity of the biological matrix 
under study, in this case, bacteria media, appropriate sample preparation steps need to be taken prior to 
analysis so as to reduce possible matrix effects [240]. To this extent, different sample preparation 
techniques have been introduced for bacterial metabolomics, each with its own set of advantages and 
disadvantages. In recent times, SPME has been successfully shown as a feasible technique for global 
metabolomics determinations. The use of SPME towards metabolomics applications includes several 
advantages, such as its applicability for in vivo analysis, reduced matrix effects, extraction of a wide 
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variety of metabolites, extraction of unstable or short-lived metabolites, and circumvention of chemical 
modification [252]. 
Recently, qualitative and semi-quantitative analyses of metabolic responses of E.coli to cinnamaldehyde 
were conducted through the use of headspace solid phase microextraction (HS-SPME). This research 
showed that the metabolic profile of E.coli treated by cinamaldehyde changed in comparison to control 
samples. In this research, 25 volatile and semivolatile metabolites were identified in the HS of complex 
biological samples [166]. The most important goal in untargeted analysis is to detect as many metabolites 
as possible so as to enhance the chances of detecting dysregulated metabolites in a biological system, 
which can indicate the metabolic pathways affected by the stimuli. This chapter presents a comprehensive 
study of E.coli bacteria affected by cinnamaldehyde, performed with the recently developed SPME-
LC/MS protocol (Chapter 3) to evaluate potential biomarkers related to the microorganism’s response to 
stress induced by the biologically active component.  
In metabolomics investigations, the method chosen for extraction and separation of metabolites must be 
able provide a comprehensive metabolic profile that reflects the large number of metabolites present in 
biological systems [253]. The developed 96-blade SPME-UPLC-MS method described in Chapter 3 
provides a comprehensive as well as unbiased metabolic profile, ranging from polar metabolites such as 
amino acids and nucleotides, to nonpolar metabolites such as lipids. The method is simple, fast, 
reproducible, and incorporates a metabolism-quenching step while providing high-throughput analysis. 
With the proposed protocol, the extraction of both hydrophilic and hydrophobic metabolites can be 
performed in one experiment, making this method a time-efficient alternative as compared to solvent-
based sample preparation methods. For this series of experiments, The UPLC-MS method was coupled to 
Orbitrap with high mass resolution, excellent analytical sensitivity, signal stability, and mass accuracy 
over long analysis time was applied for comparative global metabolomics profiling. 
The optimized protocol was applied to sets of samples of E.coli harvested at different growth phase time 
points. The samples were treated with cinnamaldehyde at concentrations ranging from lower to higher 
than minimum inhibitory concentration (MIC). Different trends in metabolite concentrations were 
observed over time for each set of experiments, and multivariate analysis was applied towards 
determinations of statistically significant discriminating features between control and test groups. The 
observed changes reflected perturbations in the regular metabolic pathways of E.coli induced by the 
bactericidal effect of cinnamaldehyde. The findings were supported by results previously obtained from 
transcriptomics and proteomics studies.  
	   86 
4.2 Material and methods 
4.2.1 Chemical and materials 
LC-MS grade solvents and LC-MS grade formic acid (1 mL glass ampules) were obtained from Fisher 
Scientific (Ottawa, Canada). Polypropylenes deep 96-well plates (Nunc) and easily modified polystyrene–
divinylbenzene (Macherey-Nagel) particles were purchased from VWR International (Mississauga, 
Canada). All metabolites, peptone, yeast extract, NaCl, and cinnamaldehyde were purchased from Sigma–
Aldrich. E.coli BL21 samples were donated from the laboratory of Professor John Brennan at McMaster 
University (Hamilton, Ontario, Canada). The Concept 96-SPME-blade unit and robotic Concept 96 
autosampler were purchased from Professional Analytical Systems (PAS) Technology (Magdala, 
Germany) for SPME sample preparation. 
 
4.2.2 Bacterial strain, culture condition, and cinnamaldehyde effect on bacterial strain 
growth 
E.coli BL21 was used as non-pathogenic bacteria for the currently presented microbial metabolomics 
study. Standard Luria Bertani (LB) media (10 g trypton, 5 g yeast extract, and 5 g NaCl in 1 L nanopure 
water) was used as media for growth of bacteria, while LB agar media (10 g trypton, 5 g yeast extract, 
and 5 g NaCl; 15 g Agar in 1 L nanopure water) was used to count the number of colonies forming in 
units per mL (CFU mL-1) in bacterial suspensions. Cells were grown in nutrient media at 37°C and 125 
rpm for 24 hours. To provide countable numbers of colonies present in agar media, cultures were serially 
diluted with sterile media. Next, 100 µL of diluted media were distributed on the warm agar plate, and 
incubated at 37°C for a 24-hour period. The growth curve of E.coli culture was obtained by counting the 
CFU mL-1 from the first moment of bacteria addition to LB media up until 24 hours had elapsed. 
Different concentrations of cinnamaldehyde in methanol (0-2000 mg L-1) were added into the 96-well 
plate containing a suspension of bacterial cells grown in different cell tubes with an initial concentration 
of 105 CFU mL-1. Subsequently, growth curves were obtained for each of the E.coli cultures grown on the 
plate with agar gel incubated at 37°C for 24 hours in the presence of cinnamaldehyde. Final and initial 
CFU mL-1 figures were obtained for control cultures and cinnamaldehyde-treated cultures grown under 
the same conditions, and used to obtain a MIC value for cinnamaldehyde.  
 
 4.2.3 Metabolite extraction, and metabolic profiling using 96-blade-SPME-UPLC-MS 
In the present study, for each set of samples, bacteria were cultivated in sterile 96-well plates. 
Subsequently, the 96-thin film (blades) SPME system operated by the robotic Concept 96-autosampler 
was applied for in vivo metabolite extractions. The stainless steel blades were coated with PS-DVB-
WAX:HLB 50:50 [w/w]. The coating preparation procedure as well as information related to the concept 
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autosampler have been reported in previous works [138]. The experimental design consisted of two 
approaches: in the first case, bacteria was treated with cinnamaldehyde (below and above MIC) at the 
beginning of incubation, and extraction was performed at 0, 3, 6, 9, 12, and 15 hours from 1 mL of E.coli 
culture in sterile LB media (initial concentration 5.0 log CFU mL-1). As a control, a sample obtained from 
the same batch of E. coli culture was extracted under identical conditions with no cinnamaldehyde 
addition. In the second case, cinnamaldehyde (above minimum inhibitory concentration) was added every 
three hours after E. coli incubation up to the 15th hour. For each time point, metabolic profiling data was 
obtained in triplicate.  
The SPME procedure conditions for all experiments were as follows: coatings were conditioned for 120 
min in 1 mL ethanol:water 70:30 (v/v) mixture in the 96-well plate with orbital agitation set at 850 rpm. 
Next, extraction from 1 mL 5.0 log CFU mL-1 E.coli (initial concentration) in sterile LB media was 
carried out in direct immersion mode for 60 min with agitation speed set at 1000 rpm (2.5 mm 
amplitude). After extraction, coatings were washed for 30 seconds in 1 mL of distilled water with 0.1% 
formic acid under agitation at 850 rpm in order to remove loosely attached particulates and salt from the 
surface of the sorbent. Desorption was performed in 1 mL acetonitrile:water 50:50 (v/v), at 1500 rpm 
speed for 60 min. Next, the desorption solution was transferred to the autosampler of the LC–MS system 
for separation and quantitation. Optimization of the SPME protocol is described in Chapter 3.  
Chromatographic separation was performed with a Kinetex PFP column [100 × 2.1mm, 1.7µm] 
(Phenomenex, Torrance, CA, USA) with a guard filter (SecurityGuard ULTRA Cartridges UHPLC PFP 
for 2.1 mm). The column temperature was maintained at 25°C, and gradient mobile phase conditions 
were composed of phase A (water containing 0.1% formic acid) and phase B (acetonitrile with 0.1% 
formic acid) with the following set conditions: 0-1 min 90% A; 1-9 min 90-10% A; 9-12 min 10% A; 12-
16 min 10-90% A. All extracts were injected randomly, while blank and QC samples were injected 
throughout the sequence between every 15 extract injections so as to avoid cross contamination, as well 
as verify instrument performance. The QC sample was prepared by mixing 10 µL aliquots of each extract. 
The injection volume was 10 µL. Autosampler temperature was set at 4°C, and extracts were kept at 4°C.  
The high-resolution orbitrap Exactive mass spectrometer (Thermo, San Jose, California, USA) was 
operated in both negative and positive electrospray ionization (ESI) modes and at 100-1000 m/z mass 
range. Optimum sheath gas (arbitrary units), auxiliary gas (arbitrary units), ESI voltage (kV), capillary 
voltage (V), capillary temperature (°C), and tube lens voltage (V) were set at 40, 25, 4.0, 27.5, 275, and 
100 for positive ESI mode, and 50, 25, -2.7, -67.5, 325, and -85 for negative ESI mode. External 
instrument mass calibration was performed every 24 h, resulting in 2 ppm mass accuracy. Compound 
identification was confirmed for discriminant features using a Q-Exactive mass spectrometer (Thermo 
Fisher Scientific, CA, USA) operating in positive and negative ionization modes with the same 
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chromatographic conditions as the primary analysis. Collision energy ranging from 50-100 V was applied 
for MS/MS fragmentation of target ions. 
 
4.2.4 Metabolite identification, data mining, and statistical analysis  
The raw data (.raw) obtained with Xcalibur software version 2.1 (Thermo) was converted to (mzXML) 
with the MS conversion software. The converted data was then processed with the XCMS R-package 
(Scripps Center for Metabolomics, California, USA). The output is a table containing retention times, 
m/z, and intensity of features [142]. Alignment, framing, peak picking, and feature detection were done 
with R software. The CAMERA R-package (Bioconductor Version 2.10) was applied to provide ion 
annotation on the list of features so as to identify detected isotopes, adducts, and in-source fragment ions.  
Putative identification of discriminant compounds was based on comparisons of their accurate masses 
with METLIN online database queries, using a 5 ppm tolerance window. Data from MS/MS METLIN 
and MassBank databases as well as literature surveys were subsequently applied to confirm the 
identification of putative candidates. Moreover, commercially available chemical standards were analyzed 
by UPLC-MS and MS/MS to confirm metabolite identities by retention time and mass spectral matching. 
Ions were targeted by collision energy and the MS/MS fragmentation and retention time of discriminant 
features were compared by those of commercially available chemical standards. Calculations and 
comparisons between expected m/z values of common adducts for common adduct species and observed 
experimental values were done from peaks within spectra.  
Multivariate data analysis was performed with the use of SIMCA-P+ software (Umetrics, NJ, USA) for 
statistical analyses. PCA and PLS-DA were used to assess information regarding variances in metabolic 
phenotypes corresponding to bacteria cultures treated with antibacterial agents at different time points in 
comparison to control samples at the same time intervals. Potential biomarkers for distinguishing treated 
E.coli by cinnamaldehyde from control E.coli cultures were acquired by analysis of S-plots obtained from 
OPLS score plots. The KEGG database was used in the identification of important metabolic pathways 
and subsequent biological interpretations. For this data processing step, abundant dysregulated features 
were filtered according to the following criteria: p-value < 0.01, fold change >1.5, and MS peak intensity 
>10000 ion counts, representing the threshold required to generate high-quality MS spectra on an 
Orbitrap instrument. 
4.3 Results and discussion 
4.3.1 E.coli and effect of cinnamaldehyde on E.coli growth  
In order to investigate the influence of cinnamaldehyde on E. coli growth, the minimum concentration of 
cinnamaldehyde needed for inhibition of E.coli growth was obtained via addition of different 
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concentrations of cinnamaldehyde to media containing the same E.coli concentration (Figure 4.1). As can 
be seen, concentrations of cinnamaldehyde above the 500 mg L-1 threshold resulted in total inhibition of 
E.coli at an initial concentration of 105 CFU mL-1 in LB media.  
The influence of sub-lethal doses of cinnamaldehyde (100 mg L-1) on bacteria growth was also studied 
and compared with control samples. Bacterial growth was observed through lag phase, exponential phase, 
and stationary phase. For the system under study, a slow growth of E.coli was observed for 3 hours after 
incubation.  The bacteria then proceeded to enter its exponential phase for a subsequent 12 hour period. 
Lastly, exponential growth was observed to stop in batch cultures, indicating the bacteria reached its 
stationary stage. Figure 4.2 demonstrates the growth curve of E.coli at control conditions in comparison 
to samples where cinnamaldehyde was added in sub-lethal concentrations. At sub-lethal concentrations of 
cinnamaldehyde, the rate of bacterial growth was observed to decrease during the lag phase, which was 
prolonged for 6 hours in comparison to the control culture; following this period, bacteria cultures were 
observed to achieve stable growth after adaptation to the new environment. 
As described in the Experimental section, cinnamaldehyde was also added to bacteria culture at different 
incubation time points. In the case of bacteria treated with cinnamaldehyde at lethal concentrations (above 
MIC), immediately after cell incubation, no bacteria were observed to appear on the agar gel plating 
during growth, indicating that at the established concentrations, cinnamaldehyde completely inhibited 
bacterial growth. Cinnamaldehyde, as an antibacterial agent containing an aldehyde group in its structure 
conjugated to a carbon double bond with a highly electronegative arrangement, interferes with biological 
processes involving electron transfers. It covalently binds with nitrogen-containing structures such as 
DNA and proteins via their amine groups, thus extinguishing the metabolic functions of E.coli [251]. The 
polarity of this bond makes the carbon atom electrophilic and reactive to nucleophiles such as primary 
amines; it also reacts with oxygen-, sulfur-, or nitrogen-centered nucleophiles, resulting in carbamates, 
thiocarbamates, or thiourea derivatives, respectively, under mild conditions. To monitor the metabolic 
stress response of E.coli exposed to cinnamaldehyde, samples treated with different conditions were taken 
from different stages of the growth curve for analysis, followed by subsequent analysis of changes in 
metabolic profiling between treated and control E.coli samples.  	  
4.3.2 E.coli metabolic profiling (different phases) 
Metabolite profiling of E.coli during different growth stages was performed using untargeted LC-MS 
analysis. According to the obtained results, the highest numbers of features were obtained during the 
exponential phase of the control samples: 83722 and 77382 features in positive and negative modes, 
respectively. The features of all chromatographic peaks were extracted for the discovery of discriminative 
metabolites during bacteria growth. A total of 500 unique metabolites were detected after a comparison of 
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features against metabolite candidates available from the METLIN database. As multiple hits were 
observed for some metabolites, a final list of 300 metabolites was proposed.  	  
	  
Figure 4.1 Investigation of MIC of cinnamaldehyde on E.coli (105 CFU ml-1) growth. E.coli growth stopped for the 
105 CFU ml-1 via treating the system by cinnamaldehyde above 500 mg L-1-biological replicates 3 times for each 
point. 	  
The trends in the obtained metabolite profiles were observed to change at different growth phases, as 
shown in Figure 4.3. For instance, levels of amino acids such as phenylalanine or serine were observed to 
increase during the lag phase, and then decrease during the log phase, while for other amino acids, such as 
threonine, isoleucine, and valine, values were observed to increase gradually during all phases. Increased 
levels of most amino acids during the stationary phase may suggest an enhancement in enzymatic activity 
related to protein degradation. Changes in the lipid composition of bacteria were also observed during 
E.coli growth, especially for fatty acids and phospholipids; throughout the E. coli growth cycle, levels of 
saturated fatty acids such as myristic acid and palmitic acid were observed to increase, while levels of 
unsaturated fatty acids such as palmitoleic acid were observed to decrease. Moreover, increases in 
cyclopropane fatty acids such as cis-9,10 methylene hexadecanoic acid, and 11-R 12-S methylene 
octadecanoic acid were observed to occur during the E.coli growth cycle; further validating previous 
findings by Kates et al. reported the accumulation of cyclopropane fatty acids as a result of 
microorganism growth such as Serratia marcescens, Lactobacillus sp., and E.coli [254].  
In the present work, levels of phospholipids such as phosphatydil glycerol (PGs) were also observed to 
decrease, while phosphatidylethanolamine acid (PEs) levels correspondingly decreased. Previous work 
has indicated that the observed decrease in unsaturated fatty acids during the growth cycle of E.coli could 
be attributed to their conversion to cyclopropane fatty acids, while the observed decrease in PGs levels 
may be connected to their conversion to cardiolipin. Cardiolipin is involved in the transfer of 
phosphatidyl functional groups from one PG to the hydroxyl group of another PG [255]. It is likely that 
the observed metabolic alterations are linked to bacteria adaptation to new media conditions due to the 
increase in bacteria numbers during growth. 	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Figure 4.2 E.coli growth curves for control sample, and cinnmaldehyde treated bacteria at sublethal concentration. 
Comparison between two curves demonstrates delay in lag phase and exponential phase of E.coli growth. 
 
4.3.3 Identification of discriminant metabolites in cinnamaldehyde treated bacteria during 
E.coli growth 
To characterize the metabolic response of E.coli to cinnamaldehyde as an antibacterial agent, 
comparisons of signal abundance in control versus treated groups were conducted for cinnamaldehyde at 
two different concentrations, below and above the minimum inhibitory concentration (MIC=500 mg L-1), 
100 mg L-1 and 2000 mg L-1, respectively. For this purpose, different types of experiments were designed 
so as to evaluate results in terms of different errors (biological or nonbiological), as well as explain 
significant biological differences with higher confidence. Biological replicates were prepared for E.coli 
samples grown and treated under the same conditions in different 96-well plates and in different days so 
as to monitor possible biological variability. Moreover, technical replicates were performed in order to 
determine experimental error attributed to the analytical techniques employed (SPME, MS, and LC 
methods). The obtained results indicated a variation of less than 10% RSD for the technical analytical 
approach, while PCA score plots were used to demonstrate variability in biological replicates. PCA score 
plots showed clear separation between extractions performed for treated E.coli groups and controls, as 
well as extractions conducted between different incubation times, in addition to good clustering of QC 
samples for both positive and negative ionization modes. Two principal components explain 64% of the 
variance; PC1 51% and PC2 13% for positive ESI, and PC1 45% and PC2 12% for a total negative ESI of 
57%. 	  
Further characterization of the differences between groups was performed using the PLS model. For PCA, 
the PLS plot demonstrated clear separation between treated and control bacteria at different growth time 
points. S-plots obtained from OPLS analysis provided retention times, exact masses, and fragmentation 
patterns that were used for identification of discriminating metabolites. 
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Trends in time-dependent metabolite profiles were observed for both concentrations of cinnamaldehyde. 
Metabolic variations for both immediate cinnamaldehyde addition, and cinnamaldehyde addition to 
growing cultures at different time intervals were also investigated.  
Figure 4.4 presents metabolic profiles of bacteria affected by cinnamaldehyde at 100 mg L-1, while Figure 
4.5 presents a list of metabolite changes after 12 hours of bacteria incubation in the presence of 
cinnamaldehyde (added to growing media immediately after incubation, concentration below MIC) as 
compared with control results (non-treated E. coli). Results showed an increase in levels of amino acids 
for samples treated with cinnamaldehyde at MIC, while levels of metabolites related to the TCA cycle 
such as fumaric acid, malic acid, and glucose 6-phosphate were observed to decrease, indicating down-
regulation of TCA cycle metabolism. Levels of saturated fatty acids were observed to increase while 
unsaturated fatty acid levels were observed to decrease, resulting in prolonged bacteria life time likely 
attributed to increasing cell membrane fluidity in stress conditions. An increase in levels of cyclopropane 
fatty acids such as cis-9,10 methylene hexadecanoic acid, and 11-R 12-S methylene octadecanoic acid 
was observed to occur in relation to cinnamaldehyde addition. Karkas et al. reported that at severe 
environmental conditions, small amounts of cyclopropane fatty acids were produced to protect the double 
bound of fatty acids from oxidation [256]. Other studies have also shown an increase in these metabolites 
as a function of bacteria growth at high temperature conditions [257,258]. In the present work, the 
observed increase in cyclopropane fatty acids by cinnamaldehyde addition could support the evidence of 
bacteria adaptation to newly introduced harsh conditions. 
In addition, increases in levels of N-methylated amino acids such as proline were observed to occur. 
E.coli responds to cinnamaldehyde addition as a stress factor by adjusting its membrane composition 
through the production of N-methylated amino acids such as proline, which function to maintain cell 
turgor by osmotic regulation and redox metabolism to eliminate excess amounts of reactive oxygen 
species (Figure 4,5). N-methylated amino acids produced by a new class of genes called osm (osmotic 
tolerance) were introduced as potent osmoprotectants and anti-stress activity regulators against 
dehydration in bacteria by Le Rudulier et al [259]. The potential of these metabolites in the presence of 
naturally occurring compounds in bacteria environment was confirmed through the introduction of 
cinnamaldehyde in growing bacteria. The cell membrane is the first target of cinnamaldhyde, as this 
compound can change membrane permeability as well as protein functions embedded inside the 
membrane. Lambert et al. and Burt et al. reported that in the presence of sub-lethal concentrations of 
naturally occurring antibacterial agents, bacteria reacts by overexpressing stress-response proteins to 
repair damaged proteins; however, at lethal concentrations, this response is unable to prevent cell death 
[260,261]. 
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4.3.4 Potential biomarkers in the case of E.coli treated by cinnamaldehyde above MIC 
 No bacteria growth was observed for bacteria cultures treated with cinnamaldehyde above MIC 
immediately after incubation (t=0). Growing bacteria cultures treated with cinnamaldehyde above MIC 
every 3 hours after inoculation were sampled every 60 minutes following cinnamaldehyde addition. PCA 
score plots (Figure 4.6 and Figure 4.7) showed clear separation between treated E.coli groups and 
controls, as well as good clustering of QC samples for both positive and negative ionization modes. 
Pooled quality control (QC) samples were analyzed following introduction of every set of 15 samples. In 
the PCA score plots, the QC samples are tightly located in the middle, demonstrating good reproducibility 
of analysis for this metabolomics study. Metabolic profiling of E.coli before perturbation at different time 
points demonstrated significant metabolic changes. Furthermore, the metabolic profiles of bacteria treated 
by cinnamaldehyde under MIC showed significant differentiation from samples treated with sequential 
addition of cinnamaldehyde levels above MIC threshold. Individual clusters were found to contain 
samples corresponding to different time points and different cinnamaldehyde dosing regimens, 
demonstrating that different pathways of bacterial metabolome are affected by application of 
cinnamaldehyde at different stages of E. coli growth. 
A total of 32 up- and 27 down-regulated metabolites were detected (p-value < 0.0001) for samples dosed 
with cinnamaldehyde above MIC treatment levels. The list of identified compounds is provided in Table 
4.1. Data analysis demonstrated that cinnamaldehyde addition above MIC inhibited the metabolism of 
E.coli via different mechanisms, such as inhibition of enzyme-catalyzed reactions, inhibition of cell 
membrane synthesis following cell lysis and cell death, inhibition of protein synthesis, and protein 
disruption, which cause disruption of essential enzymatic synthesis, as well as interaction with plasma 
membranes, consequently affecting membrane permeability as well as metabolism inhibition. 
Comparisons of profiles yielded significant differentiation in the metabolic pathways of bacteria treated 
with cinnamaldehyde. Based on the obtained results, it can be concluded that introduction of lethal doses 
of cinnamaldehyde disrupts different metabolic pathways such as fatty acids, phospholipids, amino acids, 
peptides, glycolysis, as well as the TCA cycle, which is discussed in the following section. To the best of 
this author’s knowledge, this is the first time that some of the observed changes in the metabolic pathway 
of E.coli as a function of cinnamaldehyde dosing are reported in the literature. 
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Figure 4.3 Statistically significant changed metabolites (p<0.001) during E.coli growth (control samples) as a ratio 
of peak area of interest time point and peak area of 0h. Error bars are related to biological replicates.  
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Figure 4.4 Statistically significant metabolite changes (p<0.001) during E.coli growth curve as a ratio of peak area 
of interest time point and peak area of 0h for cinnamaldehyde treated E.coli (under MIC). Error bars are related to 
biological replicates. 	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Figure 4.5 Comparison of statistically significant metabolic change (p<0.001) between control E.coli, and 
cinnamaldehyde (under MIC) treated E.coli at t=12 hours after incubation, error bars are related to biological 
replicates. 
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Figure 4.6 PCA score plot_positive ESI mode: E.coli bacteria during growth curve at # hours after bacteria 
incubation in meida and treatment by cinnamaldehyde above MIC at # hours: CC#, control bacteria during growth 
curve at # hours after incubation: C#. (Experimental points are related to biological replicates). 	  
	  
Figure 4.7 PCA score plot_negative ESI mode: E.coli bacteria during growth curve at # hours after bacteria 
incubation in meida and treatment by cinnamaldehyde above MIC at # hours: CC#, control bacteria during growth 
curve at # hours after incubation: C#. (Experimental points are related to biological replicates). 
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Table 4.1 Statistically significant differentiated metabolites between cinnamadehyde treated bacteria above MIC 
added every 3 hours after incubation and control E.coli sample (metabolites confirmed by retention time and 
fragmentation pattern matching with commercially available standards are highlighted in bold font) 
(Regulation:éê ; Up-regulated:é ; Down-regulated: ê)   
Metabolite Chemical 
formula 
METLIN 
ID 
Class P value mz é
ê 
Adduct ppm 
Betaine aldehyde	   C5H11NO 
 
278 Alkylamines 0.00062 
 
102.0910 ê M+ H 
 
-2.9 
Carnitine C7H15NO3 63461 Alkylamines 4.45447e-6 162.1131 é M+ H 4.3 
Indole-3-acetaldehyde oxime	   C10H10N2O 63562 Amino Acids 
and Derivatives 
2.36999e-8 175.0871 ê M+H 3.4 
N(6)-[(Indol-3-yl)acetyl]-L-
lysine	  
C16H21N3O3 66141 Amino Acids 
and Derivatives 
5.95920e-7 304.1660 ê M+H 1.6 
Glycine betaine	   C5H11NO2 287 Amino Acids 
and Derivatives 
7.81195e-7 118.0866 ê M+H 3.3 
2-hydroxymethylserine	   C4H9NO4 65894 Amino Acids 
and Derivatives 
2.15173e-7 136.0610 é M+ H 4.4 
N2-(D-1-Carboxyethyl)-L-
lysine	  
C9H18N2O4 63467 Amino Acids 
and Derivatives 
9.61847e-6 219.1331 é M+H -3.6 
Phenylacetylglycine	   C10H11NO3 4237 Amino Acids 
and Derivatives 
6.60221e-7 194.0815 é M+H 1.7 
5-methoxytryptophan	   C12H14N2O3 103475 Amino Acids 
and Derivatives 
2.47692e-6 257.0901 é M+Na 1.9 
Phenylalanylproline	   C14H18N2O3 23997 Amino Acids 
and Derivatives 
0.00002 
 
263.1393 é M+H 
 
1.1 
3-(Phosphoacetylamido) 
alanine	  
C5H11N2O7P 66116 Amino Acids 
and Derivatives 
0.00001 280.9932 é M+K -1.1 
  Proline C5H9NO2 
 
29 Amino acids 
and derivatives 
0.00003 116.0710 é M+H 3.4 
Aspartic acid C4H7NO4 
 
15 Amino acids 
and derivatives 
0.00001 134.0448 é M+H 0 
Glutamic acid C5H9NO4 
 
19 Amino acids 
and derivatives 
1.4215e-6 148.0604 é M+H 0 
Phenylalanine C9H11NO2 
 
28 Amino acids 
and derivatives 
2.2586e-7 166.0868 é M+H 3.6 
Histidine C6H9N3O2 
 
21 Amino acids 
and derivatives 
0.00005 156.0769 é M+H 1.2 
Arginine C6H14N4O2 
 
13 Amino acids 
and derivatives 
5.0953e-7 175.1189 é M+H 0 
Tryptophan C11H12N2O2 
 
33 Amino acids 
and derivatives 
0.000014 205.0972 é M+H 0 
Methionine C5H11NO2S 
 
26 Amino acids 
and derivatives 
1.16363e-6 150.0584 ê M+H 0 
Valine C5H11NO2 
 
35 Amino acids 
and derivatives 
0.000036 118.0864 é M+H 1.7 
Isoleucine C6H13NO2 
 
23 Amino acids 
and derivatives 
6.53741e-8 132.1020 é M+H 0.7 
  Cysteine C3H7NO2S 
 
3757 Amino acids 
and derivatives 
0.000071 122.0275 é M+H 4.1 
Threonine C4H9NO3 32 Amino acids 
and derivatives 
0.000033 120.0656 é M+H 0.8 
Glutamine	   C5H10N2O3 18 Amino acids 
and derivatives 
4.66183e-6 147.0771 é M+H 4.7 
Lysine C6H14N2O2 71200 Amino Acids 
and Derivatives 
3.52559e-9 147.1129 é M+H 0.7 
Galactosyl 
4-hydroxyproline 
C10H16O 
 
86214 Carboxylic acid 
and derivatives 
1.457687e-6 153.1281 é M+H 
 
4.6 
Phytic acid	   C6H18O24P6 
 
4238 
 
Cyclic alcohols 
and derivatives 
0.00047 
 
698.8250 
 
ê M+K 0.8 
myo-inositol 3-triphosphate	   C6H13O9P 359 Cyclic alcohols 
and derivatives 
3.83342e-6 261.0372 ê M+ H 
 
1 
8-Methylnonenoate C10H17O2 62842 Fatty Acids and 
Conjugates 
1.55983e-10 170.1304 ê M+H 1.8 
7-oxo-11E-Tetradecenoic acid C14H24O3 45868 Fatty Acids and 
Conjugates 
1.65801e-6 241.1804 ê M+H 2.5 
Fumarylacetic acid C6H6O5 45910 Fatty Acids and 
Conjugates 
1.27344e-6 181.0101 ê M+Na -3.3 
	   99 
6,8,10,12-pentadecatetraenal C15H22O 91269 Fatty Acids and 
Conjugates 
6.71761e-6 241.1563 ê M+ Na 
 
0 
9,10-dihydroxy-12-
octadecenoic acid 
C18H34O4 35501 Fatty Acids and 
Conjugates 
9.52547e-7 337.2351 ê M+Na 0.6 
3,5,7-Trimethyl-undecatetraene C14H22 
 
97470 
 
Fatty Acids and 
Conjugates 
0.00024 
 
191.1793 
 
ê M+H -0.5 
Hexadecatetraenoic acid C16H24O2 
 
34835 
 
Fatty Acids and 
Conjugates 
0.00055 
 
249.1845 
 
ê M+H -1.6 
13-Hexadecenoic acid C16H30O2 34927 Fatty Acids and 
Conjugates 
6.3251e-6 277.2145 ê M+Na 2.8 
Dodecadienoic acid C12H20O2 
 
34896 
 
Fatty Acids and 
Conjugates 
0.00160 
 
197.1534 
 
ê M+H 
 
-1.0 
α-hydroxy myristic acid C14H28O3 35391 Fatty Acids and 
Conjugates 
3.27691e-7 267.1955 ê M+Na 9.3 
Myristoyl-EA C16H33NO2 46563 Fatty Acids and 
Conjugates 
0.00001 310.2136 ê M+K -1.9 
2-hydroxy capric acid C10H20O3 
 
35411 
 
Fatty Acids and 
Conjugates 
0.00071 
 
187.1338 
 
ê M-H -0.7 
9,12-hexadecadienoic acid 
 
C16H28O2 
 
34787 
 
Fatty acids and 
conjugates 
0.00086 
 
251.2010 ê M-H 2 
6-Tridecene C13H26 97873 Fatty Acids and 
Conjugates 
7.33244e-7 181.1955 ê M-H -3.3 
4-keto lauric acid C12H22O3 
 
35733 Fatty Acids and 
Conjugates 
0.00038 
 
215.1644 
 
é M+H 1.4 
2-keto palmitic acid C16H30O3 
 
35744 
 
Fatty Acids and 
Conjugates 
0.00005 269.2117 é M-H 
 
-1.8 
2,6 dimethylheptanoyl 
carnitine 
C16H31NO4 58391 Fatty Acid 
Esters 
5.44908e-6 324.2151 ê M+ Na 1.8 
9,12-hexadecadienoic acid 
 
C16H28O2 
 
34787 
 
Fatty acyls 0.00086 
 
251.2012 ê M-H -1.6 
Hexadecanoic acid C16H32O2 
 
187 
 
Fatty acyls 0.00086 
 
255.2324 é M-H -1.9 
Pentadecatetraenal C15H22O 91269 Fatty aldehydes 6.71761e-6 217.1591 ê M-H -2.7 
Dodecanamide C12H25NO 
 
36671 
 
Fatty amides 0.00029 
 
200.2013 é M+ H 
 
2.4 
1-nonaDecanol C19H40O 26349 Fatty alcohols 5.83294e-7 283.2999 ê M-H -2.4 
PA(13:0/0:0) C16H33O7P 3886 Glycerophospho
lipids 
1.36265e-8 367.1884 é M-H -1.9 
PA(P-
16:0/20:5(5Z,8Z,11Z,14Z,17Z)
) 
C39H67O7P 82262 Glycerophospho
lipids 
6.21982e-7 717.4254 é M+K -2.8 
PE(18:0/12:0)[U] C35H70NO8P 
 
40423 
 
Glycerophospho
lipids 
0.00027 
 
664.4898 
 
é M+H 
 
-1.9 
LysoPE(0:0/15:0) C20H42NO7P 62289 Glycerophospho
lipids 
0.00018 440.2765 é M+H -1.4 
Lysophosphatidylserine  C24H48NO9P 
 
34531 
 
Glycerophospho
lipids 
0.00005 
 
525.3062 
 
é M+ -0.8 
Agmatine C5H14N4 3523 Guanidines 3.88392e-6 131.1286 ê M+H -3.8 
2-Hydroxydecanedioic acid 
 
C10H18O5 
 
5413 Hydroxy acids 
and derivatives 
 
1.6437e-7 257.0792 é M+K 
 
-3.2 
4-hydroxyindole C8H7NO 34514 Indols 2.36999e-8 134.0605 ê M+ H -3.7 
Methylindole C9H9N 
 
5453 
 
Indols 0.00009 
 
132.0806 
 
ê M+H 
 
-1.5 
Guanine C5H5N5O 
 
315 Imizopyrimidin
es 
2.11405e-9 152.0572 ê M+Na 3.9 
Creatinine 
 
C4H7N3O 
 
8 Lactams 0.00234 
 
114.0662 
 
ê M+H 
 
0 
Glucose C6H12O6 3755 Monosaccharide
s 
6.07467e-6 203.0531 é M+Na 2.4 
Glutamyl-hydroxyproline C10H11N5O5 69076 Peptides 6.80448e-8 282.0821 é M+H -3.8 
Prolylhydroxyproline C10H16N2O4 58518 Peptides 6.76841e-6 229.1190 é M+H 3.4 
Tyrosyl-alanine C12H16N2O4 85991 Peptides 1.67676e-9 253.1174 é M+H -3.1 
Riboflavin (Vitamin B2) C17H20N4O6 
 
233 
 
Pteridines and 
derivatievs 
0.00008 
 
377.1460 é M+H 
 
1.3 
Cyclic CMP C9H12N3O7P 3436 Pyrimidine 
nucleotides 
7.08504e-6 306.0481 é M+H 1.3 
Hexylglutathione C16H29N3O6S 24067 --------------- 0.00060 392.1854 é M+H 1.2 
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N-decanoyl-L-Homoserine 
lactone 
C14H25NO3 45310 --------------- 9.41730e-7 256.1923 ê M+H -6.2 
N-tetradecanoyl-L-
homoserine lactone 
C18H33NO3 64716 --------------- 9.46201e-7 310.2375 ê M-H -3.9 
 
4.3.4.1 Changes in membrane lipids 
Results related to comparisons of extractions conducted at different time points of the E.coli growth curve 
using two concentration levels of cinnamaldehyde indicated significant differences between the growth 
curve course and the obtained metabolite profiles. Of note, the metabolic profile of lipids has been 
observed to significantly differ under different stress conditions. The cytoplasmic membrane of E.coli 
consists of phospholipids containing three fatty acids: palmitic (hexadecanoic) acid as a saturated fatty 
acid, as well palmitoleic (hexadecenoic) acid and cis-vaccenic (cis-11-octadecenoic) acid as unsaturated 
fatty acids [262]. The concurrent changes in unsaturated fatty acid concentration levels, in conjunction 
with the observed decrease in saturated fatty acid levels in under-MIC cinnamaldehyde-treated cultures, 
can be attributed as principal factors related to changes in the obtained lipid profile; levels of palmitic 
acid and docosanoic acid, saturated fatty acids, were observed to decrease, while an increase in the level 
of palmitoleic acid, an unsaturated fatty acid, was observed to occur. A metabolic pathway investigation 
indicated that at sub-lethal concentrations of cinnamaldehyde, the enzyme desaturase caused an increase 
in membrane fluidity by promoting changes in saturated fatty acids to unsaturated fatty acids. In the 
presence of stress conditions, cells maintain membrane fluidity by recruiting unsaturated fatty acids as 
membrane phospholipids. Desaturase enzyme produces saturated fatty acids by transferring two hydrogen 
atoms to oxygen, allowing microorganisms to remain alive longer through the maintenance of membrane 
structure and function [263]. The consequent increase in bacteria resistance due to this adaptation can be 
clearly observed through a comparison between the growth curves of E.coli treated with sub-lethal 
cinnamaldehyde concentrations and E.coli control groups. However, E.coli response to cinnamaldehyde 
was noted to differ at lethal cinnamaldehyde concentrations. In this condition, levels and the chain length 
of metabolites such as unsaturated fatty acids 8-methylnonenoate, 7-oxo-11E-tetradecenoic acid, 7-oxo-
11E-tetradecenoic acid, fumarylacetic acid, 6,8,10,12-pentadecatetraenal, 9,10-dihydroxy-12-
octadecenoic acid, 3,5,7-Trimethyl-undecatetraene, hexadecatetraenoic acid, dodecadienoic acid and their 
chain length, in addition to hydroxyl fatty acids such as α-hydroxy myristic acid, Myristoyl-EA, and 2-
hydroxy capric acid were observed to decrease, while saturated fatty acid concentration of 2-keto palmitic 
acid were observed to increase concurrently. The observed phenomenon can be attributed to the effect of 
cinnamaldehyde on enzymes involved in fatty acid synthesis, such as fatty acid enzymes that cause an 
increase in cis isomers, and multicomponent membrane desaturase enzymes, which produce unsaturated 
fatty acids by creating double bonds in saturated acyl chains through the elimination and subsequent 
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transfer of hydrogen atoms to oxygen. According to scanning electron microscopy (SEM) observations 
conducted by Pasqua et al., damage to the cell membrane due to cinnamaldehyde treatment is 
accompanied by alterations in fatty acid profiles. The decrease in membrane fluidity caused by changes in 
metabolic lipid profiles through the enhancement of unsaturated fatty acids is one of the literature-
reported effects of cinnamaldehyde applications on bacterial cultures [262]. Damage to the cell membrane 
causes leakage of macromolecules and cell lysis as well [264-266]. Under these conditions, the membrane 
does not function properly due to reduced fluidity, and the reduced flexibility of proteins causes improper 
functions. Previous studies reported a decrease in respiratory activity as well as cytoplasmic material 
coagulation accompanied by increasing cell membrane rigidity [263,267,268]. In addition, the newly 
determined change in the metabolic pathway of cinnamaldehyde-treated E.coli, observed by significant 
up-regulation in lysophosphatidylserine, could be related to phospholipase or carboxylic ester hydrolase 
inactivation, which could be attributed to the interaction of cinnamaldehyde by the above-mentioned 
enzymes. The chromatogram and corresponding masses assigned as adducts of some lipids are presented 
in Figure 4.8. 
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Figure 4.8 Chromatograms and corresponding mass spectra indicating masses assigned as adducts of α-hydroxy 
myristic acid (A, B), 4-keto lauric acid (C, D), palmitic acid (E,F) 
 
 
4.3.4.2 Changes in amino acids 
The observed increase in levels of amino acids and peptides such as lysine, tyrosyl-alanine, glutamyl-
hydroxyproline, 2-hydroxymethylserine, N(6)-[(Indol-3-yl)acetyl] lysine, phenylacetylglycine, lysopine, 
histidine, 5-methoxytryptophan, phenylalanylproline, 3-(Phosphoacetylamido)alanine, threonine, 
glutamine, and prolylhydroxyproline could be attributed to protein denaturing and inhibition of protein 
synthesis, which is caused by a halt in the synthesis of essential enzymes as a result of the addition of 
cinnamaldehyde. On the other hand, a comparison of changes in metabolite levels between 
cinnamaldehyde-treated bacteria and control bacteria demonstrated that this compound can perturb 
enzyme-catalyzed reactions such as glutathione, arginine decarboxylase, and histidine decarboxylase. For 
example, increases in riboflavin and histidine could be attributed to the interruption of histidine 
decarboxylase action. Conversely, a decrease in the agmatine metabolite may be caused by the inhibition 
of arginine decarboxylase by cinnamaldehyde. Cinnamaldehyde has been reported as an inhibitor for 
enzymes such as histidine decarboxylase by Wendakoon et al [269], while Auger et al. reported that 
arginine is decarboxylated by arginine decarboxylase to agmatine [270]. For the presently introduced 
work, the obtained results demonstrated that this blockage in the abovementioned pathway can be 
achieved with the addition of cinnamaldehyde. The chromatogram and corresponding masses assigned as 
adducts of some amino acids are presented in Figure 4.9. 
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Figure 4.9 Chromatograms and corresponding mass spectra indicating masses assigned as adducts of lysine (A, B), 
isoleucine (C, D), methionine (E, F), proline (G, H), histidine (I, J) 	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4.3.4.3 Inhibition of glycolysis pathway 
The obtained results indicated that cinnamaldehyde can act to perturb the citrate metabolic pathway, 
consequently influencing enzymes involved in ATP synthesis. Accumulation of glucose indicates 
disruption of this metabolic pathway in bacteria affected by cinnamaldehyde. Moreover, the observed 
increase in glucose, which is an initial metabolite in the glycolysis pathway, indicates an interruption in 
the action of the enzymes involved in this pathway or decrease in ATP as the source of energy. In support 
of findings presented by Gill et al., which indicate that cinnamaldehyde diffusion to the cell periplasm 
induces a decrease in ATPase activity in the cell membrane [271,272], the currently presented results 
related to down-regulated and up-regulated metabolites in pathways involved in ATPase confirm the 
effect of cinnamaldehyde on the activity of this enzyme. Picone et al. observed that the inability of cells to 
metabolize glucose leads to loss of their viability [273]. The observed up-regulation of glucose, which is 
assigned to inhibit the glycolysis pathway, in cinnamaldehyde-treated samples indicates that this 
naturally-occurring agent has potential as a possible candidate for cancer treatments. Most cancer cells 
uptake glucose in the glycolysis pathway in order to use ATP generation as an energy source; 
accordingly, the development of compounds as glycolytic inhibitors could be introduced as a new class of 
anticancer agents and therapeutic applications [274]. 
4.3.4.4 Changes in other metabolites 
It seems that cinnamaldehyde affects CMP kinase activity through interruption of the phosphorylation 
mechanism due to cyclic CMP enhancement. Accumulation of carnitine accompanied by down-regulation 
of glycine betaine could be directly linked to inhibition of various catabolic enzymes such as carnitine 
dehydrogenase. The carnitine pathway may play more than one role in cell function; in addition to 
generation of an osmoprotectant (glycine betaine), carnitine may play a role in the generation of an 
external electron acceptor in anaerobic respiration. Moreover, glycine betaine levels were observed to 
decrease in E.coli under administration of above-MIC cinnamaldehyde levels, suggesting that 
cinnamaldehyde may impair the glycine betaine pathway in which choline dehydrogenase is involved. 
Strϕm et al. introduced glycine betaine as an osmoprotectant in E.coli under stress conditions induced by 
addition of salt and exposure to cold [275]. In the present study, the observed results indicated that under 
administration of cinnamaldehyde above MIC levels, this metabolite was unable to preserve cell turgor. 
Other down-regulated metabolites such as myo-inositol 3-triphosphate and phytic acid were also indicated 
as discriminant compounds for the present study. Phytase (myo-inositol hexakisphosphate 
phosphohydrolase) is classified as a phosphatase enzyme that catalyzes phytic acid hydrolysis as a source 
of phosphorous [276,277]. This type of change in metabolome profile infers inhibition of phytase activity 
in cinnamaldehyde-treated sample. This study indicated that cinnamaldehyde could stop enzymatic 
activity while concurrently blocking the nitrogen or carbonyl terminal of proteins through covalent bonds. 
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Another enzyme inferred to be inhibited due to cinnamaldehyde addition in growing bacteria media is 
glutathione S-transferase, known to catalyze the addition of glutathione thiol groups to suitable 
electrophilic species. This enzyme is responsible for producing reduced glutathione by catalyzing the 
conjugation of electrophilic compounds. Up-regulation of hexylglutathione due to cinnamaldehyde 
addition to bacteria media inhibits S-hexyl glutathione activity as an inhibitor for the glutathione S-
transferase function. Kanai et al. reported three distinct types of glutathione S-transferase from E.coli with 
defensive characteristics against oxidative stress (hydrogen peroxide) [278]. The presented research work 
demonstrated that cinnamaldehyde influences glutathione S-transferase activity; the same observation has 
been previously reported in the literature for E.coli treated by hydrogen peroxide, showing that 
cinnamaldehyde acts as an oxidative agent. The chromatogram and corresponding masses assigned as 
adducts of some of differenciate metabolites between control and treated samples are presented in Figure 
4.10. 
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Figure 4.10 Chromatograms and corresponding mass spectra indicating masses assigned as adducts of Glycine 
betaine (A, B), cyclic CMP (C, D), hexylglutathione (E, F). 
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4.3.4.5 Anti-quorum sensing activity 
Quorum sensing, defined as cell to cell signaling, is the phenomena in which bacteria secrets auto-
inducers; when these compounds reach their threshold level, their interaction with transcriptional 
regulators affects gene expression [279]. Enzymatic degradation of signaling molecules inhibits biofilm 
formation in systematic and local infections, pathogenicity, and antibiotic resistance. In this study, the 
significant down-regulation observed in N-decanoyl-L-Homoserine lactone and N-tetradecanoyl-L-
Homoserine lactone levels can be attributed to an inhibition in the ability of E.coli to form biofilms in 
cinnamaldehyde-treated media. Accordingly, cinnamaldehyde can be considered as a potential agent that 
interrupts biofilm generation by decreasing production of homoserine lactone as an auto-inducer; 
consequently, the inhibition of quorum sensing signals reduces the problem of resistance and virulance. 
Urbanowski et al. previously suggested cinnamaldehyde or one of its metabolites as an antagonist to auto-
inducer receptor binding [280]; the observed changes in the metabolic profile of E.coli obtained in the 
currently presented work further support their results.  
The abovementioned changes in metabolic pathways as a function of cinnamaldehyde administration on 
E.coli bacteria cultures provide concrete evidence to support the potential of cinnamaldehyde as a potent 
antibacterial agent. The chromatogram and corresponding masses assigned as adducts of metabolites 
between control and treated samples are presented in Figure 4.11. 
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 Figure 4. 11 Chromatograms and corresponding mass spectra indicating masses assigned as adducts of 
N-tetradecanoyl-L-homoserine lactone (A, B), N-decanoyl-L-Homoserine lactone (C, D). 
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4.4 Conclusions and future directions 
In this research, the developed SPME-UPLC-MS based metabolomics coupled with statistical analysis 
presented in Chapter 3 was successfully applied for in vivo bacteria metabolomics. Metabolites with a 
wide variety of chemical and physical properties were extracted directly from E.coli culture using a newly 
developed extractive phase without the need of prior sample preparation steps. The presented procedure 
helps provide a comprehensive platform for determination of statistically significant differentiated 
metabolites between E.coli treated with cinnamaldehyde as a model antibacterial agent and matched 
control samples, detection of potential biomarkers involved in metabolic pathways, and time-resolved 
analysis. Satisfactory separation was observed between samples extracted prior and during different E.coli 
growth curve time points, and differentiation was noted between modes of treatment of cinnamaldehyde. 
Metabolic profile variations in different stages of the E.coli growth curve were investigated, 
demonstrating that the developed method was able to provide clear metabolic profile separations between 
various time points of E.coli growth. Metabolic stress response profiles of E.coli demonstrated different 
metabolic profiles as a function of administrated cinnamaldehyde levels. Potential biomarkers were 
identified for bacteria treated by cinnamaldehyde, which was further confirmed to affect metabolic 
pathways related to TCA cycle, fatty acids, glycolysis, amino acid metabolism, cell membrane, and 
protein synthesis. In addition, new biochemical pathways, which disrupt metabolism in bacteria treated by 
cinnamaldehyde, were introduced. The proposed approach may offer additional opportunities to food 
microbiologists for evaluation of metabolic pathways involved in growth and survival of pathogens in 
foods, food processing environments, as well as humans. 	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Chapter 5 
Use of SPME-LC/MS with chemometrics and multivariate analysis 
towards metabolome characterization of clove oil as an antibacterial 
agent on E.coli  
 
5.1 Introduction 
Essential oils, biosynthesized and extracted from aromatic plants, are widely used in medicine, as well as 
in the food and fragrance industries due to their antimicrobial characteristics. Their defensive properties 
stem from their antibacterial, antiviral, insecticidal, antiparasitic, antifungal, and antioxidant activities 
[281-286]. Among the essential oils, terpenes, terpenoids, phenol-derived aromatic components, and 
aliphatic constituents have been shown to obstruct or deter the growth of bacteria, yeast, and mould 
through membrane and cytoplasm disruption [287-289].  
Three thousands essential oils are currently known; of these, approximately 300 are applied commercially 
in the fragrance industry [281]. Among these naturally-occurring compounds, oxygenated terpenoids such 
as alcohols and phenolic terpenes have demonstrated the highest antimicrobial potential [281,290,291]. In 
related work, Smith-Palmer et al. applied 21 plant essential oils as antibacterial agents against five food-
borne pathogens (Campylobacter jejuni, Salmonella enteridis, E.coli, Staphylococcus aureus and Listeria 
monocytogenes); their findings indicated that oils derived from bay, cinnamon, clove, and thyme yielded 
the highest bactericidal effect [292]. These oils have various constituents; for instance, clove bud oil is 
composed of eugenol (76.8%), eugenyl acetate (9.5%) and β-caryophyllene (6.0%) [293]. The 
interactions between these different constituents lead to synergistic, antagonistic, indifference, or additive 
effects [294,295]. Due to these properties, essential oils are utilized in food and drug discovery industries 
to control the proliferation of food-borne bacteria and pathogenic microorganisms [296,297]. When the 
sum of individual effects related to individual components is equal to the combined effect, an additive 
effect will be observed, whereas an antagonistic effect is observed when the effect of each constituent is 
lower than the effect of a mixture of them. When the effect of a mixture is more than that of each 
component, it is defined as a synergistic effect, and when no interactions take place between constituents, 
this property is called indifference [298-300].  
The mechanisms of action of these naturally-occurring compounds against pathogens are still vague, 
especially at the metabolic level. As the metabolism of living systems alters in response to environmental 
stress, metabolomics aims to provide complementary information to genomics, transcriptomics, and 
proteomics [301]. In studies of mechanisms of action of living systems, scientists seek to determine 
specific reactions that occur as responses to specific stimuli. To do so, scientists must study variations 
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between two samples under different conditions; for this purpose, global analysis of all metabolites in a 
given system is employed to discover potential biomarkers of specific reactions [302]. The global 
metabolomics platform includes different steps: sample preparation, instrumental analysis, and data 
analysis. Determinations of significant metabolite changes are attainable using bioinformatics software. 
Analytical instrumentation platforms such as LC/MS, GC/MS, and NMR are widely used in global 
metabolomics studies. Of these, NMR is a nondestructive method with relatively low intensity; even in 
cases where this method is coupled to LC in order to reduce matrix complexity and increase metabolic 
coverage, NMR is unable to determine more than approximately 100 metabolites [231]. LC/MS provides 
the most comprehensive metabolomics coverage in comparison to GC/MS and NMR. In order to increase 
sensitivity for LC/MS and provide wider metabolome coverage, as well as eliminate ion suppression and 
ion enhancement effects, a wide range of research has been focused on sample preparation techniques. In 
metabolomics, an ideal sample preparation technique should be nonselective, reproducible, simple, and 
fast, in addition to allowing for high-through applications and the integration of a metabolism-quenching 
step [303]. SPME, as one of the recently emerging techniques utilized in sample preparation for 
metabolomics studies, covers all of the abovementioned characteristics needed in an ideal sample 
preparation method [28,143,159]. 
In the current study, an experimental design was applied to optimize effective factors for SPME method 
development. The experimental design was employed to extract the highest amount of information within 
the lowest number of experimental run-throughs. This allowed for the identification of optimum values 
related to each factor while decreasing analysis time and expenses [304,305]. In most previous works 
done with SPME, univariate optimization methods were applied to study important variables influencing 
extraction; variables were examined individually and in sequence, with all other factors kept constant. In 
this traditional method, after the completion of univariate SPME method development, some SPME 
parameters required double-checking, followed by repetition of corresponding optimization experiments. 
In contrast, multivariate designs offer simultaneous variation of several control variables, consequently 
decreasing the number of experiments needed for method development. Moreover, multivariate designs 
indicate probable variable interactions that are not detectable by classical experimental designs [305]. 
 In the current study, a multivariate experimental design was applied to identify the following influential 
variables: desorption solvent type, extraction time, wash time, and desorption time in the 96-blade SPME 
system. The optimized method was then applied to assess the effect of clove bud oil and its major 
constituents on growing E.coli metabolome under the same experimental conditions, using a two-level 
full factorial design. Next, the metabolic profile of antibacterial agent-treated cells and control cells were 
generated by optimized SPME-LC/MS and subjected to multivariate data analysis. These metabolic 
patterns produced clear separations on a PLS-DA analysis that are related to up-regulated and down-
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regulated metabolites. This multivariate experimental design at optimized SPME conditions was also 
applied to investigate the interaction effect of different major components of clove bud oil on E.coli 
growth.  
5.2 Experimental part 
5.2.1 Chemical and materials 
LC-MS grade solvents and LC-MS grade formic acid (1 mL glass ampules) were obtained from Fisher 
Scientific (Ottawa, Canada). Polypropylene deep 96-well plates (Nunc) and easily modified polystyrene–
divinylbenzene (Macherey-Nagel) particles were purchased from VWR International (Mississauga, 
Canada). All metabolites, peptone, yeast extract, NaCl, clove bud oil, eugenol, eugenyl acetate, and 
caryophyllene were purchased from Sigma–Aldrich. E.coli BL21 strain was kindly donated by Professor 
John Brennan’s lab at McMaster University (Hamilton, Ontario, Canada). The Concept 96-SPME-blade 
unit and robotic Concept 96 autosampler were purchased from Professional Analytical Systems (PAS) 
Technology (Magdala, Germany) for SPME sample preparation. 
 
5.2.2 Metabolite Standard Mixture Preparation  
A standard mixture of metabolites with a wide range of polarities, such as amino acids, amines, organic 
acids, sugars, nucleosides, and small peptides (Table 5.1) was prepared for optimization of SPME 
conditions using multivariate analysis. Stock standard solutions were prepared in water/methanol/ethanol, 
kept frozen (-30°C), protected from light, and prepared fresh weekly. Extractions were conducted from a 
spiked standard 1 µg/mL stock solution and added to LB media. Organic solvent content for all extraction 
standards was maintained at 1% (v/v). For instrument calibration, working standard solutions with known 
concentrations of metabolites were prepared by dilution of the stock standard with a desorption solvent. 
 
5.2.3 Bacterial strain and antibacterial activity evaluation 
Frozen cultures of E.coli BL12 were streaked on an LB agar media plate (10 g trypton; 5 g yeast extract; 
5 g NaCl; 15 g Agar in 1 L nanopure water), and incubated overnight at 37°C. One isolated colony was 
re-streaked on LB Agar media and incubated at 37°C for 24 h. Following, one isolated colony was 
inoculated into 5 mL of LB media (10 g trypton; 5 g yeast extract; 5 g NaCl in 1 L nanopure water), then 
incubated at 37°C for 24 h under agitation at 125 rpm. The microbial broth was then serially diluted in 
fresh media. The resulting 107 colony-forming units (CFU/mL) were utilized for the whole study.  
Using GC/MS, the major components of clove bud oil were identified as eugenol (76.8%), eugenyl 
acetate (9.5%) and β-caryophyllene (6.0%). The MIC threshold for clove oil was identified through 
addition of different amounts of clove oil to the same E.coli culture, followed by incubation at 37°C for 
16 hours; results indicated that 10 µL was the MIC for clove oil for a 107 CFU/mL E.coli culture.  
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To evaluate the antibacterial activity of each constituent of clove oil against E.coli, different amounts of 
eugenol (8 µL), eugenyl acetate (1 µL) and β-caryophyllene (0.6 µL) were separately added to the same 
concentration of bacteria in different cell tubes, and bacteria growth was encouraged by incubating at 
37°C for 16 hours at 125 rpm. Next, 100µL of each grown culture were streaked on separate agar plates, 
and then incubated at 37°C overnight. In the case of eugenol, no bacteria growth occurred, but growth did 
occur for cultures treated with eugenyl acetate and caryophyllene. 
The two-level full factorial design, developed to be compatible with Statistica software, was applied to 
evaluate the effect of different constituents of clove bud oil on E.coli’s metabolic profile as well as to 
investigate the synergistic effect of the clove oil constituents. In this part of the currently presented study, 
all experiments were done in triplicate apart from the central points, which were replicated four times. 
	  
5.2.4 Coating preparation for 96-blade SPME and automated SPME procedure for high 
throughput analysis 
In the present study, extraction was done using a 96-blade SPME system coated by PS-DVB-WAX:HLB 
50:50 [w/w] as stationary phase for a stainless steel blade conducted by the robotic concept 96-
autosampler provided by PAS Technology. Coating preparation procedures as well as information related 
to the concept 96-autosampler are reported in Chapter 3, which also provides a comprehensive study 
related to the suitability of the abovementioned coating for metabolomics.  
The 96-blade SPME platform is comprised of four different steps: preconditioning, extraction, wash, and 
desorption. A triangular design and a central composite design (CCD) were applied for variable 
optimization. This triangular design was used for desorption solvent optimization, while CCD was used 
for optimum extraction and desorption time, as well as for optimization of wash time for each step of the 
96-blade SPME method. The sums, geometric means, and averages of peak areas were investigated as 
responses for optimization. The Statistica computer program was used for this experimental design. 
Fibres were pre-conditioned for 1 hour in 1 mL ethanol:water 70:30 (v/v). Next, extractions were 
conducted from 1 mL culture (control and antibacterial agent treated) set in sterile 96-well plates for 2 h 
(1000 rpm agitation speed, 2.5 mm amplitude). A 20s wash step in water was performed after the 
extraction step so as to remove proteins, salt, and particulates from the coating surfaces. Afterwards, 
desorption was carried out for 90 min in 1 mL of acetonitrile/water 1:1 (v/v) as the optimized desorption 
solvent obtained by CCD. Final extracts were kept in -80°C until analysis. 
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Table 5.1 Physicochemical properties of metabolites included in standard metabolite mixture. 
Analyte Formula Molecular Weight pKa Log P 
3-hydroxybutyric acid (HBA) C4H8O3 104.1 4.41 -0.47 
Adenine C5H5N5 135.1 4.15 -0.09 
Adenosine C10H13N5O4 267.2 NA -1.05 
Adenosine diphosphate (ADP) C10H15N5O10P2 427.2 NA -2.64 
Adenosine monophosphate (AMP) C10H14N5O7P 347.2 NA -1.68 
Adenosine triphosphate (ATP) C10H16N5O13P3 507.2 NA -3.61 
β-Estradiol C18H24O2 272.4 NA 4.01 
β-NAD C21H27N7O14P2 663.4 NA -3.68 
Cholic acid C24H40O5 408.6 4.98 2.02 
Choline C5H14NO+ 104.1 NA -5.16 
Citric acid C6H8O7 192.1 2.79 -1.64 
Fructose C6H12O6 180.2 12.1 -1.55 
Fumaric acid C4H4O4 116.1 3.03 0.46 
Glucose C6H12O6 180.2 12.9 -3.24 
Glucose 6-phosphate C6H13O9P 260.1 1.11 -3.79 
Glutamic acid C5H9NO4 147.1 2.23 -3.69 
Glutathione (oxidized) C20H32N6O12S2 612.6 NA -7.89 
Glutathione (reduced) C10H17N3O6S 307.3 NA -5.41 
Histamine C5H9N3 111.1 9.8 -0.7 
Histidine C6H9N3O2 155.2 2.76 -3.32 
Linoleic acid C18H32O2 280.4 4.77 7.05 
Lysine C6H14N2O2 146.2 3.12 -3.05 
Maleic acid C4H4O4 116.1 1.83 -0.48 
Nicotinamide C6H6N2O 122.1 3.35 -0.37 
Phenylalanine C9H11NO2 165.2 1.24 -1.38 
Protoporphyrin IX C34H34N4O4 562.7 NA 7.43 
Pyruvic acid C3H4O3 88.1 2.45 -1.24 
Riboflavin C17H20N4O6 376.4 10.2 -1.46 
Ribose-5-phosphate C5H11O8P 230.1 NA -2.65 
Sucrose C12H22O11 342.3 12.6 -3.7 
Taurocholic acid C26H45NO7S 515.7 NA 0.01 
Tryptophan C11H12N2O2 204.2 7.38 -1.06 
Uridine diphosphate glucose 
(UDPG)  
C15H24N2O17P2 566.3 NA -5.8 
 
 
5.2.5 Metabolic profile for bacteria affected by clove oil and its major constituents 
UHPLC-ESI-MS analysis 
Separation was carried out on a Kinetex pentafluorophenyl coreshell column (1.7 µm, 2.1 mm × 10 mm) 
(Phenomenex, Torrance, CA, USA) with a guard filter (SecurityGuard ULTRA Cartridges UHPLC PFP 
for 2.1 mm). The column temperature was maintained at 25°C, and gradient mobile phase conditions 
were composed of phase A (water containing 0.1% formic acid) and phase B (acetonitrile with 0.1% 
formic acid) set to the following conditions: 0-1 min 90% A; 1-9 min 90-10% A; 9-12 min 10% A; 12-16 
min 10-90% A. Total run time was 16 min per sample. The injection volume for this method was 10 µL. 
Samples were stored under refrigeration (4°C) in the autosampler while waiting for injection, and injected 
in a randomized fashion. A QC sample was run periodically to verify instrument performance. Injection 
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of control samples and antibacterial-treated samples was done alternatively. Blank and QC samples were 
injected after every set of 15 injections so as to avoid cross contamination as well as verify instrument 
performance. The used QC sample was prepared by mixing 10 µL of each sample into one combined 
sample.  
The MS system was operated using an accurate mass Exactive benchtop Orbitrap system (Thermo, San 
Jose, California, USA) in both negative and positive electrospray ionization (ESI) modes and 100-1000 
m/z mass range. Optimum values for sheath gas (arbitrary units), auxiliary gas (arbitrary units), ESI 
voltage (kV), capillary voltage (V), capillary temperature (°C), and tube lens voltage (V) were set at 40, 
25, 4.0, 27.5, 275, and 100 for positive ESI mode, and 50, 25, -2.7, -67.5, 325, and -85 for negative ESI 
mode, respectively. External instrument mass calibrations were performed every 24 h, and found to be 
within 2 ppm for all ions. Separated metabolites were analyzed using Xcalibur software version 2.1 
(Thermo) by isolating the extracted ion chromatograms (XIC), using a 5 ppm window around the accurate 
mass.	  
 
5.2.6 Metabolite identification, data mining, and statistical analysis  
An Exactive Orbitrap detector was used, providing high mass resolution and sensitivity. Raw data 
obtained with Xcalibur software (.raw) was converted to (mzXML) with MS conversion software. The 
converted data was then processed with a web-based platform called XCMS online (Scripps Center for 
Metabolomics, California, USA). The processing of metabolomics data by XCMS Online is divided into 
three stages: data upload, parameter selection, and result interpretation. Samples for each group to be 
compared in mzXML format were uploaded through Java applet. Parameters related to UPLC/Orbitrap 
were set, and data processing was conducted after job submission. The output is a table containing 
retention times, m/z values, and intensity of features, accompanied by some statistical values as well as 
some graphical features. XCMS identifies features whose relative intensity differs between sample 
groups, determining p-values as well as fold changes. The software carried out mass spectral peak 
deconvolution, alignment, peak picking (feature detection), and ion annotation on the list of features in 
order to identify the detected isotopes, adducts, and in-source fragment ions. Multivariate data analysis 
was used by SIMCA-P+ software (Umetrics, NJ, USA) for statistical analyses. Log transformation and 
pareto scales prior to PCA were done to differentiate between control samples and treated ones. 
Orthogonal Projections to Latent Structures Data analysis (OPLS-DA) was performed on obtained data, 
and the resulting S-plots were applied towards further modeling to investigate biomarkers produced in 
bacteria culture treated by antibacterial agents. Metabolite identities were specified based on their 
accurate mass, retention time, comparison of fragmentation data with authentic standards, and METLIN 
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databases within 5 ppm. In order to identify important metabolic pathways, and biological interpretation, 
the KEGG database was used.  
5.3 Results and discussion 
5.3.1 Optimization of SPME parameters 
When utilizing the 96-blade SPME-LC/MS, the SPME method development procedure needs to be 
conducted efficiently, as the effectiveness of the resulting analyte pre-concentration depends on many 
parameters, such as coating type, choice of stationary phase for the 96-blade system, extraction 
conditions, desorption conditions, and wash conditions. 
In order to achieve the most efficient desorption of analytes with a wide range of polarities and physical-
chemical properties from the surface of the coating, the optimum desorption solvent was investigated. A 
triangular design was carried out to determine the influence of different desorption solvents and their 
interactions on the recovery of the 96-blade SPME method. Acetonitrile, water, methanol, and their 
combination (100% acetonitrile, 100% water, 100% methanol, acetonitrile:water 1:1 (v/v), 
acetonitrile:methanol 1:1 (v/v), methanol:water 1:1 (v/v), , and acetonitrile:methanol:water 1:1:1 (v/v/v)) 
were applied using the triangular design. The sum, average, and geometric mean of peak areas obtained 
from the computer program were then compared to identify the optimum responses. Figure 5.1 
demonstrates the results of this triangular design process. 
An evaluation of results indicated that based on the average and sum of the detector responses to each 
metabolite, acetonitrile:water 1:1 (v/v) was the optimum desorption solvent composition for the study, 
while based on plots obtained versus the geometric mean, acetonitrile:water:methanol 5:4:1 (v/v/v) was 
the optimum desorption solvent composition. The central tendency of a set of measurement results is 
typically found by calculating the arithmetic mean (𝑋) and, less commonly, the median or geometric 
mean. The mean is an estimate of the true value as long as there is no systematic error. In the absence of 
systematic error, the mean approaches the true value (µ) as the number of measurements (n) 
increases. Finally, 1 mL of acetonitrile:water 1:1 (v/ v) at 1500 rpm was chosen as the optimized 
desorption solvent in this study for the extraction of targeted metabolites with logP from -7 to +7 spiked 
in LB media. The response, based on the sum of the peak areas, is one of the most useful parameters for 
the optimization of SPME conditions, and therefore was used as the endpoint in this study to evaluate the 
significance of each of the aforementioned factors. 
To optimize the time for each stage of the 96-blade SPME procedure, CCD was applied to obtain the 
optimum time that provided the highest extraction recovery. Minimum and maximum values of time for 
each step were arbitrarily selected to cover the wide range of experimental conditions. Plots were 
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evaluated based on three statistical definitions; however, the optimum condition was chosen based on 
results obtained from the sum of peak areas. 
The experimental variables that were evaluated included extraction time (15–120 min), wash time (0–120 
s) and desorption time (15–120 min), all using the optimized desorption solvent.  
A CCD with a central point (17 runs in total) was performed to determine the optimized time for each 
step of the extraction, wash, and desorption, and their interactions on the 96-blade SPME system. The 
CCD matrix and the surface response are presented in Table 5.2 and Figure 5.2, respectively. The 
sensitivity of the method was significantly improved by applying the method at optimum times for each 
step. The optimized conditions obtained from utilization of the CCD matrix and response surface 
methodology indicated that a 120 min extraction time, 30 seconds as wash time, and 90 min desorption 
time provided the highest extraction recovery for all targeted metabolites.  
 
Table 5.2 Central composite design matrix used to obtain optimum extraction, wash, and desorption time for a set of 
targeted metabolites using PS-DVB-WAX:HLB 50:50 (w:w). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.2 Interaction between clove oil components using full factorial design 
After the evaluation of optimum conditions for the 96-blade SPME system, a full factorial design was 
applied to identify the most important constituent of clove bud oil in stopping E.coli metabolism, as well 
as potential interactions between its major components. Based on observations done to evaluate the 
inhibitory effect of clove oil, its antibacterial activity is due to the major components eugenol, eugenyl 
acetate, and caryophyllene. To determine the effect of the most important constituent of clove bud oil in 
terms of antibacterial activity and potential variable interactions, a two-level full factorial design, 23, was  
Experiment # Extraction time (min) Wash time (second) Desorption time (min) 
    1 36.3 24.3 36.3 
2 36.3 95.7 98.8 
3 98.8 95.7 36.3 
4 98.8 24.3 98.8 
5 67.5 60.0 67.5 
6 36.3 96.7 36.3 
7 36.3 24.3 98.8 
8 98.8 24.3 36.3 
9 98.8 95.7 98.8 
10 67.5 60.0 67.5 
11 15.2 60.0 67.5 
12 119.7 60.0 67.5 
13 67.5 60.0 15.2 
14 67.5 60.0 119.7 
15 67.5 0 67.5 
16 67.5 119.7 67.5 
17 67.5 60.0 67.5 
	   121 
 
	  
	  
Figure 5.1 Triangular design and desirability plots for desorption solvent optimization applying geometric mean 
(geomean), sum, and average of analytical signal vs. desorption solvents. Each angle is related to one desorption 
solvent, the middle of triangle side is the mixtre of desorption solvent at the angle of each side. The mixture of all 
three solvents represents the center of triangles. 	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Figure 5.2 Response surface plot for analytical signal vs. extraction time, desorption time and wash time (min) for 
extraction from spiked analytes in LB media (100 µg mL-1) resulted from central composite design in order to obtain 
optimum time for extraction, wash, and desorption steps in 96-blade SPME. 	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Table 5.3 Full factorial design matrix for investigation of the effects of different clove oil constituents on E.coli 
metabolic profile (Eugenol: 8 µL, eugenyl acetate: 1 µL and β-caryophyllene: 0.6 µL Carryophelene). 
Exp# Eugenol Eugenyl acetate β-Caryophyllene 
1 -1 -1 -1 
2 +1 -1 -1 
3 -1 +1 -1 
4 +1 +1 -1 
5 -1 -1 +1 
6 +1 -1 +1 
7 -1 +1 +1 
8 +1 +1 +1 
 
 
 
 
 
 
 
 
 
 
 
 
 	  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Pareto chart plots based on average, geomean, and sum of peak areas obtained from 96-blade SPME 
coupled to LC-MS related to metabolites whose peak areas were increased by addition of antibacterial agents. 
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Figure 5.3 Pareto chart plots based on average, geomean, and sum of peak areas obtained from 96-blade SPME 
coupled to LC-MS related to metabolites whose peak areas were decreased by addition of antibacterial agents.  	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carried out. Table 5.3 shows the number of different possible conditions in this full factorial design 
experiment. The effect of any two factors was evaluated separately, as well as the effects of all three 
factors. Another experiment (experiment 9) was conducted by adding 10 µL clove oil. All experiments 
were done in triplicate. Metabolic profiling for each set of experiments was provided; the variable effects 
and interactions are summarized in the Pareto charts illustrated in Figure 5.3 and Figure 5.4. Metabolites 
were classified into two groups: Group A (Figure 5.3), comprised of metabolites whose peak areas were 
increased by addition of antibacterial agents, demonstrated as up-regulated metabolites in Table 5.4, and 
Group B (Figure 5.4), comprised of metabolites whose peak areas were reduced with the addition of 
antibacterial agents, demonstrated as down-regulated metabolites in Table 5.4. The plots were 
accomplished by integrating and evaluating the obtained peak areas, corresponding to about 300 extracted 
metabolites from growing E.coli treated by the naturally-occurring antibacterial agents under study. These 
metabolites had various retention times and polarity characteristics selected from the LC chromatogram. 
The responses were evaluated based on the sum, average, and geomean of peak areas. The obtained 
Pareto chart showed the response of the bacteria system to each clove oil constituent and their 
combinations; an evaluation of results showed that addition of antibacterial agents result in an increase 
(Group A) or decrease (Group B) in analytical signal. Of these constituents, eugenol, the major compound 
of clove bud oil, was found to possess the strongest antibacterial activity at the 95% confidence level, 
while other individually applied constituents (in the same volume ratio) did not indicate an antibacterial 
effect on E.coli growth at the 95% confidence level. The Pareto charts demonstrated no significant 
interactions between the constituents (at the 0.05 level). 
 
5.3.3 Metabolic profiling of E.coli under different clove oil constituents as antibacterial 
agents  
In this part of the study, the effects of clove oil and its constituents on the E.coli bacteria metabolic profile 
were investigated. Considering that clove oil is a mixture of different active agent components, the effects 
of each component as well as their interactions were evaluated in the context of nine batches of 
experiments designed by full factorial design. PCA score plots (Figures 5.4 and 5.5) demonstrate 
separation of clusters related to each set of experiments in positive and negative electrospray ionization 
modes, respectively. There is no variation between clusters related to experiments #1, #3, #5, and #7 in 
PC1, while for experiments #2, #4, #5, #6, #8, and #9, in which eugenol is present, the related clusters 
were separated in PC1. Results obtained from the Pareto chart plotting demonstrated that eugenol is the 
most effective antibacterial component of clove bud oil when these constituents are analyzed 
comparatively while maintaining the weight ratio in which they occur in this essential oil 
(76.8%/9.5%/6%) for eugenol, eugenyl acetate, and caryophellene, respectively. 
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 Figure 5.4 PCA score plot obtained from full factorial design for different types of treatments by various 
clove oil constituents (based on Table 5.3, exp 9 is clove oil treated bacteria)-positive ESI mode. 
 
 
Figure 5.5 PCA score plot obtained from full factorial design for different types of treatments by various clove oil 
constituents (based on Table 5.3, exp 9 is clove oil treated bacteria)-negative ESI mode. 
 
Results demonstrated a variation in the identified metabolites (a decrease or increase in relative 
	  
	  
	  	  	  	  	  
	  	  
Exp#1 
Exp#5 
Exp#7 Exp#3 
QC 
Exp#2 
Exp#4 
Exp#6 
Exp#8 
Exp#9 
	  
	  
	  
	  
	  	  	  	  	  
	  
	  
Exp#1 
Exp#5 
Exp#9 
Exp#3 
QC 
Exp#2 
Exp#4 
Exp#6 
Exp#8 
Exp#7 
	  
	   127 
chromatographic areas) depending on the application of different compositions of antibacterial agents. 
Figure 5.6 and Figure 5.7 show the chromatogram related to E.coli extract in both positive and negative 
ionization modes, respectively. Figures 5.8 and 5.9 demonstrate chromatograms of E.coli treated by clove 
oil in both positive and negative ionization modes, respectively. The output of XCMS Online provides an 
overview of experimental results that can be assessed as a quality control mechanism (Figure 5.10). 
Nonlinear methods were used by XCMS Online to compensate for retention time drifts between samples 
(Figure 5.10). Figures 5.10-A and 5.10-B indicate an overlay of all total ion chromatograms (TICs) before 
and after retention time correction, respectively. Figure 5.10-C indicates the retention time deviation 
versus retention time in different analyzed samples. After retention time correction, all TICs should be in 
alignment. Figure 5.10-D is a cloud plot demonstrating dysregulated features to represent ions whose 
intensities are varied between sample groups according to statistical thresholds. Down-regulated features 
in these treated samples are the circles on the bottom of the plot (red bulbs), while up-regulated ones are 
circles on the top (green bulbs). Feature size demonstrates the fold change of features, and the color 
intensity represents the p-value. The program provides a feature table revealing detailed information for 
each individual feature, including statistics and extracted ion chromatograms, spectrum details and 
putative METLIN assignments. 
About 10,000 features were detected in this study in both electrospray ionization modes, of which almost 
60% of the peaks show a significant change of area size due to treatment with antibacterial agents (clove 
oil and eugenol). 
This discrimination in the metabolic profile of E.coli was not observed when eugenyl acetate and 
caryophellene were applied as antibacterial agents. Based on the results, different compounds produced 
unique metabolic profiles on the bacteria profiles. In this study, a lethal concentration of clove oil was 
applied for 107 CFU mL-1 of bacteria. The amount of eugenol in clove oil for this amount of bacteria 
based on the composition of eugenol in clove oil prohibited bacteria growth. However, the amounts of 
eugenyl acetate and caryophyllene present in clove oil were shown to be insufficient to stop bacteria 
metabolism. Thus, the hydroxyl group present in eugenol has an effective role in the prevention of 
bacterial growth. Table 5.4 demonstrates the dysregulated metabolites in clove oil and eugenol treatment 
samples using XCMS software. Eugenol and eugenyl acetate belong to the phenylpropenes, as they have 
a six-carbon aromatic phenol group and a three-carbon propene tail from cinnamic acid produced during 
the first step of phenylpropanoid biosynthesis. Most antibacterial activity of phenylpropenes is related to 
the free hydroxyl group in the structure of this class [306,307]. The type and number of substitutions on 
the aromatic ring are important in the antibacterial activity of phenylpropenes [306,308]. These 
compounds in plants can disrupt the metabolism of bacterial cells by forming hydrogen bonds through 
interaction with proteins [309]. Caryophyllene is a natural bicyclic sesquiterpene (C15H24) from the 
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terpenes family, produced from a combination of several isoprene units (C5H8).  
In eugenol, the presence of a phenolic group is responsible for its antibacterial phenomenon. Sakaguchi et 
al. reported amine formation interruption by E. aerogenes via enzyme inhibition [310,269]. The 
antibacterial activity showed that clove oil and eugenol exhibited stronger activities than β-caryophyllene 
on tested oral bacteria. The antibacterial activity of eugenyl acetate is less than that of eugenol, as there is 
no free hydroxyl group in its structure. Moreover, the clove oil and eugenol showed strong activity 
against periodontopathogenic bacteria [311]. Koutsoudaki et al. reported low or absent antibacterial 
activity for a group of terpenses as well as for caryophyllene against E.coli [312]. 
 
Figure 5.6 Chromatogram of E.coli extract by PS-DVB-WAX:HLB 50:50 (w:w) – positive ESI mode. 
 
 
Figure 5.7 Chromatogram of E.coli extract by PS-DVB-WAX:HLB 50:50 (w:w) – negative ESI mode. 
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Figure 5.8 Chromatogram of extract from E.coli treated by clove oil by PS-DVB-WAX:HLB 50:50 (w:w) – positive 
ESI mode. 
 
 
Figure 5.9 Chromatogram of extract from E.coli treated by clove oil by PS-DVB-WAX:HLB 50:50 (w:w) – 
negative ESI mode. 
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Figure 5.10 XCMS online output. A: total ion chromatograms (TICs) before (Figure 5.10-A) and after (Figure 5.10-
B) retention time correction. Figure 5.10-C: the retention time deviation versus retention time in different analyzed 
samples. Figure 5.10-D: cloud plot: down-regulated (red bulbs) and up-regulated (green bulbs) features in E.coli 
sample treated by eugenol. 
 
5.3.3.1 Effect on the fatty acid Profile of the E.coli cell membrane 
Cellular responses to stress include adjustments of the membrane system, modifications of the membrane 
architecture, and changes in cell cycles and cell division. The cell membrane is the first target of 
antibacterial agents in this study, as these compounds can change its permeability and the functions of 
proteins embedded inside. Because of the hydrophobicity of these compounds, they can easily diffuse 
inside the cell from the membrane and disrupt the membrane via changes in the fatty acid balances. Cells 
adapt to the new environment in order to survive through changes in the ratio of iso and anteiso-branched 
fatty acids and unsaturated fatty acids to saturated fatty acids, and also by changing their fatty acid chain 
length [313]. The change in degree of saturation in fatty acids is applied by desaturase enzyme by adding 
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or removing two hydrogens to or from the acid’s double bond [263]. 
In this current research, when antibacterial agents such as carryophellene and eugenyl acetate were 
applied under minimum inhibitory concentration, the percentage of unsaturated fatty acids increased to 
enhance cell membrane fluidity, whereas in experiments where the antibacterial agents were applied 
above the MIC (clove oil and eugenol), an increase in the amount of saturated fatty acids caused loss of 
membrane fluidity and enhancement in its rigidity. As demonstrated in Table 5.3, the levels of the 
unsaturated fatty acids octadecadienoic acid, 9-hydroperoxy-10E,12-octadecadienoic acid, dodecadienoic 
acid, tridecadienoic acid, 2Z-dodecenedioic acid, decatetraenedioic acid, tridecadienoic acid, nonadienoic 
acid, and 4,7,10-hexadecatrienoic acid were observed to decrease, while the level of myristic acid alkyne, 
as a saturated fatty acid, was observed to increase. Short and medium length levels of organic acids such 
as adipic and pimelic acids also increased.  
 On the other hand, in the case of caryophyllene and eugenyl acetate, the levels of unsaturated fatty acids 
such as 2-methyl-dodecanedioic acid, 12S-hydroxy-5Z,8E,10E-heptadecatrienoic acid, myristoleic acid, 
tetradecadienoic acid, tridecadienoic acid, and 9-oxo-2,4,5,7-decatetraenoic acid, increased. 
Di Pasque et al. perceived that treatment of E. coli O157:H7 ATCC 43888 with sub-lethal concentrations 
of thymol, lomonene, eugenol, carvacrol, and cinnamaldehyde increased the levels of saturated fatty acids 
such as myristic (C14), palmitic (C16), and stearic (C18) acids, while levels of unsaturated acids such as 
unsaturated oleic (C18:1 cis), linoleaidic (C18:2 trans), and linolenic (C18:3 cis) acids were observed to 
decrease as a result of treatment [262]. 
5.3.3.2 Action on proteins 
Another target of eugenol and clove oil is the proteins that the hydroxyl group in eugenol binds  to and 
prevents from functioning as enzymes [310]. Up-regulation or down-regulation of various metabolites 
involved in specific metabolic pathways in the treated sample demonstrated the change in the 
microorganism’s metabolism in antibacterial environments caused by the change in enzymatic functions. 
For example, down regulation of cadaverine, one of the amines produced by biodegredative 
decarboxylases [314], accompanied by up-regulation of lysine in a sample treated with clove oil and 
eugenol, demonstrated the inhibition of lysine decarboxylase [315]. Wendakoon et al. observed that 
eugenol and cinnamaldehyde, as the most-effective species with inhibitory action towards the activity of 
the amino acid decarboxylase of a crude extract of Enterobacter aerogenes, prevented production of 
poisonous metabolites such as cadaverine, histamine, putescine, and tryamine [269]. In addition, the 
down-regulation of the glucose level in treated samples represents amylase down-regulation. This enzyme 
catalyzes the hydrolysis of long chain carbohydrates into simple sugars such as glucose. Thoroski et al. 
observed that the production of enzymes such as alpha-amylase and protease was inhibited or reduced in 
Bacillus subtilis when the concentration of eugenol was increased from 0.0 to 0.04% v/v [316]. This 
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phenomenon may delay glucose utilization in the glycolysis pathway, and consequently, clove oil has 
been suggested as a cancer care drug. Based on the Warburg effect, glycolysis is enhanced in most cancer 
cells to generate ATP as a main source of energy production. Consequently, targeting the glycolytic 
pathway may kill malignant cells and have a broad therapeutic effect [274]. Another pathway of interest 
is that for dGTP synthesis. Increased guanosine levels accompanied by decreased guanine levels could 
stop the salvage of guanine and guanosine, the metabolites at the beginning of the dGTP synthesis 
pathway, which could be attributed to inhibition of guanosine phosphorylase function.  
5.3.3.3 Anti-quorum sensing activity 
When the number of bacteria reaches a particular threshold during growth, intercellular communication, 
called quorum sensing (QS), will organize the interaction among bacteria. QS controls virulence factor 
expression, bioluminescence, sporulation, biofilm formation, and mating. Genes involved in the 
expression of QS produce the prompt of chemical-signaling molecules called autoinducers. Autoinducers 
are produced until the number of bacteria reaches their maximum threshold [317]. Researchers have 
introduced essential oils as nontoxic inhibitors of QS without strain resistance [318]. Various mechanisms 
are involved in QS inhibition, such as the inhibition of acyl homoserine lactones as autoinducers, 
inhibition of acyl homoserine lactone transport, and inhibition of targets downstream of the acyl 
homoserine lactone receptor binding [319]. In the present study, the level of homoserine lactone 
decreased in the clove oil- and eugenol-treated samples, demonstrating that these compounds are potential 
QC inhibitors that prevent biofilm formation. Previously, Khan et al. observed the QS inhibitory effect of 
clove oil [320]. 
Further interpretation of the observed changes will require a more comprehensive investigation and 
interpretation of biochemical pathways of E.coli growing under clove oil treatment.  
Chromatograms and corresponding mass spectra indicating masses assigned as adducts of some important 
metabolites are shown in Figure 5.11. 	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Figure 5. 11 Chromatograms and corresponding mass spectra indicating masses assigned as adducts of Guanine (A, 
B); 2',3' cyclic CMP (C, D); Adenosine (E, F); Histidine (G, H); Tryptophan (I, J), cGMP (K, L). 
	   136 
Table 5.4 Dysregulated metabolites in E.coli samples treated by clove oil and eugenol obtained from XCMS online 
and full factorial design. 
Metabolite Adduct mz METLIN 
ID 
ppm Chemical 
Formula 
Regulation 
p-value 
Amino Acids and Derivatives 
Proline [M+H]+ 116.0707 
 
58150 
 
0.8 C5H9NO2 Up 
6.64574e-6 
Asparagine [M+H]+ 133.0608 
 
65674 0 C4H8N2O3 Up 
7.37334e-6 
Tryptophan [M+H]+ 205.0966 
 
33 2 C11H12N2O2 Up 
0.00345 
N-Hydroxy-L-tryptophan [M+H]+ 221.0920 
 
73314 
 
0 C11H12N2O3 Up 
9.57623e-6 
Glutamate [M+2Na-
H]+ 
148.0604 
 
3761 0 C5H9NO4 Up 
6.45342e-5 
Valine [M+H]+ 118.0864 
 
71199 
 
0.8 C5H11NO2 Up 
0.00008 
Tyrosine 
 
[M+NH4]
+ 
 
199.1078 
 
58353 
 
0 C9H11NO3 Down 
0.00019 
Homoarginine [M+H]+ 189.1343 
 
5640 
 
-1.6 C7H16N4O2 Down 
0.00019 
Homoglutamine [M+H]+ 161.0920 
 
3281 
 
0 C6H12N2O3 Up 
0.00021 
Serine [M+H]+ 106.0501 
 
63419 2.8 C3H7NO3 Up 
0.00001 
Glutamate [M+H]+ 148.0604 
 
3761 
 
0 C5H9NO4 Up 
0.00014 
Citrulline 
Nα-Acetyl-L-arginine 
[M+ACN
+H]+ 
[M+H]+ 
217.1295 
 
16 
 
0 C6H13N3O3 Down 
0.00014 
Tyrosine [M+NH4]
+ 
 
199.1078 58353 4.6 C9H11NO3 Up 
0.00002 
Histidine [M+2Na-
H]+ 
200.0403 
 
65529 -1.5 C6H9N3O2 Down 
0.00005 
Aspartic acid 
 
[M+H]+ 
 
134.0448 
 
63097 0 C4H7NO4 Up 
0.00003 
N6-Acetyl-N6-hydroxy-L-
lysine 
[M+H]+ 205.1182 
 
63465 
 
0 C8H16N2O4 Up 
0.00007 
N-Hydroxy-L-tryptophan [M+H]+ 221.0921 
 
73314 
 
0 C11H12N2O3 Up 
0.00007 
Threonine [M+H]+ 120.0656 
 
32 0 C4H9NO3 Up 
0.00007 
Azolines 
Creatinine 
 
[M+ACN
+H]+ 
155.0927 
 
8 0 C4H7N3O 
 
Up 
9.74675e-6 
 
Benzene and Substituted Derivatives 
Phoxim 
 
[M+2Na-
H]+ 
343.0254 
 
72530 
 
1.6 C12H15N2O3
PS 
 
Up 
0.00227 
Carbohydrates and carbohydrate conjugates 
Acetylmannosamine [M+H]+ 222.0973 
 
3357 0.5 C8H15NO6 Up 
0.00002 
Glucose [M+Na]+ 203.0527 63118 0.5 C6H12O6 Down 
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 0.00004 
Sucrose [M+H-
H2O]+ 
325.1129 
 
137 
 
-1.5 C12H22O11 Up 
1.17474e-6 
 
Glucosaminide [M+H-
2H2O]+ 
466.2041 
 
7043 
 
1.1 C18H35N3O1
3 
Down 
0.00003 
Carboxylic Acids and Derivatives 
 
N-Acetylcystathionine 
 
[M+H-
H2O]+ 
247.0748 
 
6656 
 
1.6 C9H16N2O5
S 
 
Down 
1.48854e-6 
Lysopine 
 
[M+H]+ 219.1340 
 
89468 
 
0 C9H18N2O4 
 
Up 
0.00368 
Adipic acid 
 
[M+Na]+ 
 
169.0468 
 
115 -1.7 C6H10O4 
 
Down 
0.00055 
 
Cystine 
 
[M+H]+ 241.0310 
 
63635 
 
0.4 C6H12N2O4
S2 
 
Up 
0.00153 
Glutathione [M+H]+ 308.0909 
 
44 
 
0.3 C10H17N3O6
S 
Down 
0.00033 
N-Acetylcadaverine [M+H]+ 145.1336 6592 0.7 C7H16N2O Down 
0.00026 
γ-Glutamyl-γ-
aminobutyraldehyde 
[M+H]+ 217.1183 63481 0 C9H16N2O4 Up 
0.00119 
Diaminopimelic acid [M+H]+ 191.1027 352 0.5 C7H14N2O4 Up 
0.00342 
Homocitrulline 
 
[M] + 189.1116 
 
46 
 
1.5 C7H15N3O3 Down 
3.84520e-6 
Glutathione [M+H]+ 308.0909 44 -0.3 C10H17N3O6
S 
Down 
 
Diazines 
Cytosine [M+H]+ 112.0507 
 
283 
 
1.7 C4H5N3O Up 
0.00016 
Fatty Acids and Conjugates 
tridecadienoic acid [M+H-
H2O]+ 
193.1589 
 
34909 
 
-1.5 C13H22O2 Down 
0.00001 
2-keto valeric acid 
 
[M+ACN
+H]+ 
158.0811 
 
3243 
 
0 C5H8O3 
 
Down 
0.00245 
2E,4E-dodecadienoic acid 
(unsaturated) 
[M+H]+ 197.1538 
 
34895 
 
-1.0 C12H20O2 Down 
0.00011 
4,7,10-hexadecatrienoic acid 
(unsaturated) 
[M+H]+ 251.2007 
 
34809 
 
0.8 C16H26O2 Down 
0.00010 
dihydroxy-stearic acid 
(saturated) 
[M+Na]+ 
 
339.2509 45832 
 
1.2 C18H36O4 
 
Up 
0.00001 
nonadienoic acid 
(unsaturated) 
[M+NH4]
+ 
172.1332 35103 0 C9H14O2 Down 
0.00024 
hydroxypalmitic acid 
(saturated) 
[M-H]- 
 
271.2265 
 
45829 -4.7 C16H32O3 
 
Up 
0.0001 
Isodecenoic acid 
(unsaturated) 
[M+H]+ 171.1380 
 
34722 
 
0 C10H18O2 Up 
0.00015 
tridecadienoic acid 
(unsaturated) 
[M+H-
H2O]+ 
193.1588 34909 2.1 C13H22O2 Down 
193.1588 
dodecadienoic acid 
(unsaturated) 
[M+H]+ 197.1538 
 
34895 -1.3 C12H20O2 Down 
0.00004 
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Myristoleic acid 
(unsaturated) 
[M+H]+ 227.2007 
 
6424 
 
0.8 C14H26O2 Down 
0.00496 
Myristic Acid Alkyne [M+H-
H2O]+ 
207.1745 
 
35248 
 
-1.9 C14H24O2 Up 
0.00190 
Decatetraenedioic acid [M+NH4]
+ 
212.0918 74898 0.5 C10H10O4 Down 
0.00168 
Fatty acyls 
Octyl acetate [M+K]+ 
 
211.1095 
 
46196 0 C10H20O2 Down 
0.00001 
Caproic acid 
 
[M+K]+ 
 
155.0469 
 
111 0 C6H12O2 
 
Down 
7.38651e-6 
 
2-Tridecene-4,6,8-triyn-1-ol [M+H]+ 187.1119 87296 1.1 C13H14O Up 
0.00306 
Fatty aldehydes 
2,4,7-tridecatrienal [M+H]+ 193.1589 
 
75353 1.5 C13H20O Up 
Tetradecadienal [M+H]+ 209.1902 
 
46461 
 
1.4 C14H24O Down 
0.00007 
Glycerols 
Glycyrol 
 
[M+ACN
+H]+ 
 
408.1434 71470 -1.6 C21H18O6 Up 
0.00085 
Glycerolipids 
1-Octylglycerol [M+K]+ 243.1357 
 
46620 0 C11H24O3 Down 
Glyceryl 5-hydroxydecanoate [M+Na]+ 285.1669 88341 -1.1 C13H26O5 Down 
0.00301 
Glycerophosphoglycerols 
PE(P-
18:0/22:6(4Z,7Z,10Z,13Z,16
Z,19Z)) 
[M+H-
H2O]+ 
758.5489 
 
46708 
 
0 C45H78NO7
P 
 
Down 
0.00220 
 
PA(13:0/20:5(5Z,8Z,11Z,14Z
,17Z)) 
[M+] 652.4114 
 
81251 
 
-1.5 C36H61O8P 
 
Up 
0.00001 
PE(O-20:0/0:0) M+2Na-H 540.3392 77700 -1.5 C25H54NO6
P 
Down 
0.00219 
Imidazopyrimidines 
Adenine [M+H]+ 136.0618 
 
85 0 C5H5N5 Up 
0.00005 
Guanine [M+H]+ 
 
152.0568 
 
315 
 
1.3 C5H5N5O Down 
4.68891e-6 
 
6-Thiouric acid [M+NH4]
+ 
202.0393 718 0 C5H4N4O2S Up 
0.00197 
Hypoxanthine [M+H]+ 137.0458 83 0 C5H4N4O Down 
0.00110 
Indoles and Derivatives 
3-Methylindole [M+H]+ 132.0809 
 
5453 1.5 C9H9N Up 
8.91649e-7 
Indole [M+H]+ 118.0653 
 
286 
 
1.6 C8H7N Up 
0.00145 
Lactams 
Homoserine lactone [M+K]+ 
 
140.0108 
 
65863 0 C4H7NO2 Down 
8.96060e-6 
Lineolic acid and derivatives 
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octadecadienoic acid [M]+ 312.2300 
 
35348 
 
0 C18H32O4 Down 
0.00002 
9-hydroperoxy-10E,12-
octadecadienoic acid 
[M]+ 312.2300 
 
35348 0 C18H32O4 Down 
0.0000054 
Prenol lipids 
2-Hexaprenyl-3-methyl-6-
methoxy-1,4-benzoquinol 
[M]+ 562.4379 62813 -1.2 C38H58O3 Down 
0.00028 
Purine Nucleosides and Analogues 
Adenosine [M+H]+ 268.1039 
 
86 
 
-0.4 C10H13N5O4 Up 
0.00029 
Guanosine [M+H]+ 284.0988 
 
87 -0.4 C10H13N5O5 Up 
0.00006 
Deoxyguanosine 
Adenosine 
[M+ACN
+H]+ 
309.1304 3395 -0.6 C10H13N5O4 Up 
0.00241 
cGMP [M+H]+ 346.0541 3485 1.7 C10H12N5O7
P 
Up 
0.00106 
Isopentenyl adenosine [M+H]+ 336.1666 64086 0 C15H21N5O4 Up 
0.00103 
Xanthine [M+H]+ 153.0407 
 
82 0 C5H4N4O2 Down 
0.0000053 
1-Methyladenosine [M+H]+ 282.1196 6888 0 C11H15N5O4 Up 
0.00027 
Pyrenes 
Pyrene [M+ACN
+H]+ 
244.1121 69974 0 C16H10 Up 
0.00048 
Pyridines and Derivatives 
Nicotinic acid (Niacin) [M+H]+ 124.0394 
 
240 
 
0.7 C6H5NO2 Down 
2.46054e-6 
Pyridoxamine 
 
[M+ACN
+H]+ 
210.1238 
 
238 0.4 C8H12N2O2 
 
Down 
0.00210 
Pyridoxal (Vitamin B6) 
 
[M+ACN
+H]+ 
209.0921 
 
2203 
 
0 C8H9NO3 
 
Down 
0.00266 
Pyrimidine Nucleosides and Analogues 
Cytidine diphosphate choline [M+H]+ 489.1142 
 
3581 -0.8 C14H26N4O1
1P2 
Up 
0.00004 
2',3'-Cyclic UMP [M+H]+ 307.0325 
 
3438 
 
0 C9H11N2O8
P 
Up 
1.55770e-8 
2',3' cyclic CMP [M+H]+ 306.0481 
 
62429 
 
1.3 C9H12N3O7
P 
Down 
1.92863e-7 
Quaternary ammonium salts 
Choline [M+ACN
+H]+ 
145.1336 56 0.6 C5H13NO Down 
0.00026 
 
5.4 Conclusions and future directions 
In this study, a 96-blade SPME-LC/MS method was developed using multivariate design, and applied to 
evaluate the synergistic effect of different major components of clove oil as antibacterial agents against 
E.coli. In contrast to traditional univariate optimization methodology applied in previous studies, 
multivariate experimental design assists in the optimization of important parameters affecting extraction 
recovery, taking into account their interactions as well. SPME provided clear separation between E.coli 
samples treated by clove oil major components, and the mechanism of antibacterial action of the naturally 
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occurring compounds suggested different metabolic pathways for samples treated with the active agents. 
Based on the obtained results, eugenol, as the major component of clove oil, clearly confirmed its 
characterization as an antimicrobial agent, while no synergistic effect was observed between the 
constituents of clove oil in the actual weight percent in which they appear in this oil. This study can be 
applied towards the utilization of antibacterial agents and reduce the antibacterial agent consumption in 
order to access to a particular antibacterial effect and health purposes. This study provided a better 
understanding of the metabolic responses of E.coli to clove oil and its major components, while 
demonstrating the SPME-LC-MS-based metabolomics platform as a superior technique for the study of 
complex biosystems, using E.coli as a model organism. Evaluation of the discriminatant metabolites in 
treated samples confirmed that eugenol is a lead candidate for further development as an active agent in 
anti-cancer treatments due to its ability to cause glycolysis inhibition of E.coli as a model organism. An 
investigation of metabolic profiles between treated and control E.coli samples demonstrated that this 
compound can stop E.coli metabolism by binding to proteins as well as through membrane disruption. 
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Chapter 6 
Targeted and untargeted apple metabolomics with SPME-LC/MS 
 
6.1 Introduction 
The apple is an important fruit source for human consumption.	  The quality of apples is defined based on 
their appearance, sweetness, acidity, firmness, color, and potential health benefits [321]. Sweetness is 
related to their sugar and sugar alcohol content. Organic acids and complex cell wall polymers determine 
the fruit acidity and firmness, respectively. Fruit color is related to the composition of carotenoids and 
anthocynins in the peel, while polyphenolic metabolites and triterpenes provide potential health benefits 
[322-328]. Commercially, apples are kept at temperatures of -1 to 4°C without suffering abrupt damage, 
but after weeks or months of storage in such temperatures, chilling stress related to coldness can cause 
browning disorders or superficial scalds attributed to damage happening in the upper hypodermal layers 
associated with changes in fruit metabolism [329-331]. Ethylene, a naturally occurring plant hormone, 
assists in the maturation process of fruits through enzyme production, which breaks down starches and 
cell walls, causing fruit softness and sweetness. Physiological disorders such as superficial scald, soft 
scald, core flush, and greasiness develop during storage and are linked to fruit maturity. The shelf life of 
apples may be enhanced by controlling ethylene production, as considerable evidence indicates that 
ethylene leads to scald progress [332]. Better insight into the processes involved in this phenomenon will 
help suppliers better predict the maximum shelf life of apple products, achieve nutritional stability, and 
enhance market value. 
Various methods are applied to chemically control ethylene biosynthesis; for instance, in the horticulture 
industry, ethylene inhibitors such as diazocyclopentadiene, 1-methylcyclopropane (1-MCP), and 
aminoethoxyvinylglycine (AVG) are widely used to reduce physiological apple disorders such as 
superficial scald and soft scald, which may result from storage and other types of stress that induce 
ethylene production by influencing ethylene biosynthesis, as well as other metabolic pathways [333,334]. 
Apple ripening involves complicated biological processes characterized by conversions in the 
transcriptome, proteome, and metabolome. Untargeted metabolomics is able to differentiate metabolites 
altered by ecological conditions or genotypes [335]. Metabolomic analyses consist of a sequence of steps, 
including sample preparation, metabolite extraction, separation, detection, and data treatment. As the 
nature of compounds of interest is mostly unknown, a reliable method is needed to extract as many 
metabolites as possible from apple samples [336]. 
Various studies have reported on the metabolic pathways involved in superficial scald or browning 
disorders that affect apple samples during storage; however, providing a comprehensive picture of 
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metabolism alteration requires a reproducible technique that is indiscriminating towards metabolites 
extraction, fast enough to inhibit metabolite degradation or loss, accompanied by a metabolism quenching 
stage, and that provides identification of a wide variety of metabolites [337-345]. Sampling and sample 
preparation should provide a good representative of the sample under study. Various chemical and 
physical properties of metabolites, as well as their high turnover rates, make metabolite extraction a 
challenging undertaking. Matrix complexity and metabolite loss are the most important issues faced in 
metabolomics performance. A powerful extraction technique should provide extraction of metabolites 
from interferences, and bring the metabolome concentration up to detectable levels for instrumental 
techniques. A number of metabolite extraction techniques are used in plant metabolomics, such as LLE, 
solid–liquid extraction (SLE), SPE, and accelerated solvent extraction. In the case of LLE and SLE, the 
type of solvent being used can cause metabolite discrimination as well as metabolite modification and 
degradation [336].  
SPE, another technique used to remove the matrix of samples such as proteins and salts, provides efficient 
sample clean up and metabolite enrichment. SPE is widely used in plant and food metabolomics; 
however, cartridge clogging is probable during extraction. Also, due to the large volumes of solvent that 
are used in this technique, non-adsorbent analytes are retained in the void volume. In contrast, according 
to the guidelines related to green chemistry goals, the latest trend favors miniaturized sample preparation 
techniques, and decreases or eliminates solvent consumption [346,347]. Thin film SPME, using an open 
bed device, provides several benefits over other techniques, making it a powerful candidate for 
metabolomics research: it is easily automated, uses small sample volumes, consumes small amounts of 
organic solvent, is a fast sample preparation technique, and, depending on the choice of coating, SPME is 
capable of extracting a wide polarity range of metabolites [346,348]. MS and NMR are two analytical 
platforms extensively used in plant metabolomics. NMR has low sensitivity and lower resolving power in 
comparison to MS, allowing for the detection of low abundance metabolites. MS provides more complex 
spectra, especially in the case of complex matrices [348]. Efficient sample preparation and 
chromatographic techniques reduce the enhancement of matrix effects in MS-based metabolomics [346] 
SPME coupled to GC/MS has been successfully utilized as a sample preparation technique for plant 
metabolomics, especially in the identification of volatiles and semi-volatiles, although the technique is 
unsuitable for nonvolatile determinations without derivatization, which is associated with numerous 
difficulties and artifacts in chromatograms [349-361]. SPME-LC/MS can be applied to cover the 
identification of metabolites unidentifiable by SPME-GC/MS. In the literature, to the best of this author’s 
knowledge, no reports are available on applications of SPME-LC/MS for plant and food metabolomics. 
The objective of the presently introduced work was the development of a high-throughput 96-blade 
SPME-LC/MS technique for the extraction of a broad range of metabolites from apple samples that could 
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be applied without the need of laborious sample pretreatment steps. Once developed, the 96-blade SPME-
LC/MS was applied for untargeted metabolic profiling of “Honeycrisp” apples subjected to cold storage. 
PLS has been used to characterize changes in the metabolic profiles of apples during storage under a 
controlled atmosphere, applying AVG, and disorder development. Primary and secondary metabolic 
pathway alterations in apple samples were investigated, as were the metabolite variations following 
various time points of cold storage (4 and 8 months). The results demonstrate extensive changes in the 
metabolism of samples involving multiple pathways as a function of the stress generated by cold storage. 
6.2 Experimental part 
6.2.1 Metabolite standard mixture preparation  
Standard mixtures of metabolites covering a wide range of polarities such as amino acids, sugars, 
nucleosides, and flavonoids, listed in Table 6.1, were prepared for SPME method development. Stock 
standard solutions were prepared in water/methanol, kept frozen (-30°C), and protected from light. 
Extractions were conducted from spiked standards prepared from 1 µg/mL of stock solution into a citrate 
buffer (pH=3.5), while keeping the organic solvent content of all extraction standards at 1% (v/v). The 
citrate buffer was prepared using the proper molar ratios of sodium citrate and citric acid in 1 L of water, 
and the pH levels of the buffers were adjusted to 3.5 based on the acidity of the Honeycrisp apple samples 
analyzed in this study. For instrument calibration, working standard solutions with known concentrations 
of metabolites were prepared by dilution of the stock standard with desorption solvent. 
 
Table 6.1 Physicochemical properties of metabolites included in standard metabolite mixture. 
Analyte Formula 
 
Molecular Weight (MW) Log P 
 
Glucose C6H12O6 180.1559 -2.9 
Mannitol C6H14O6 182.1718 -3.7 
Sucrose C12H22O11 342.2965 -4.5 
Caffeic acid C9H8O4 180.1574 1.5 
Catechin hydrate C15H14O6 290.2681 1.8 
Naringenin C15H12O5 272.2528 2.8 
t-resveratrol C14H12O3 228.2433 3.4 
Taxifolin C15H12O7 304.25 1.8 
Aspartic acid C4H7NO4 133.1027 -3.5 
Glutamic acid C5H9NO4 147.1293 -3.2 
Isoleucine C6H13NO2 131.1729 -1.5 
Leucine C6H13NO2 131.1729 -1.6 
Methionine C5H11NO2S 149.211 -2.2 
Phenylalanine C9H11NO2 165.1891 -1.2 
Proline C5H9NO2 115.1305 -2.9 
Serine C3H7NO3 105.0926 -3.9 
Tryptophan C11H12N2O2 204.2252 -1.1 
Tyrosine C9H11NO3 181.1885 -1.5 
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6.2.2 Sampling and sample preparation for metabolomics study 
‘Honeycrisp’ apples (with a diameter of approximately 6-7 cm), were harvested on September 14, 2010, 
at 20°C, from a mature commercial orchard in Simcoe (Norfolk County), Ontario, Canada. Post-harvest 
conditions differed for apple samples. The first group refers to time point zero; for instance, HC-0 
represents apples collected and brought to the lab, and kept on ice until preparation without storage. Time 
point one refers to apples kept at 3°C air storage conditions until January. This group, subdivided, 
experienced four types of conditions: HC-1 samples did not have any disorder, while HC-1-SC-D, HC-1-
SC-D-R, and HC-1-SC-S samples demonstrated soft scalding. The HC-1-SC-D-R samples were air stored 
at 3°C, with AVG applied to inhibit ethylene production. HC-2 represents time point two, for apple 
samples air-stored at 3°C for 8 months after harvesting. Table 6.2 reviews the sample conditions. 
The sampling process is summarized as follows. Immediately after harvesting, a metabolism-quenching 
step was performed by soaking the fruit in liquid nitrogen; the apples were then stored in dry ice (-70°C) 
during transportation to the laboratory. In the laboratory, individual fruits were rinsed with distilled water 
and dried with Kim Wipes, followed by apple core removal and slicing of the frozen fruit randomly from 
all possible sides of the fruit cortex. One hundred grams of disrupted frozen apple tissue was submitted to 
250 mL of saturated sodium chloride solution (providing an additional metabolism-quenching step, 
terminating enzymatic activity, and decreasing aqueous solubility, leading to potential enhancement of 
SPME enrichment factors for selected compounds), followed by 1.5 min homogenization. Subsequently, 
an additional 250 mL aliquot of nanopure water was added to the homogenate, followed by introduction 
of an additional 1 min homogenization period. This last step was performed to enhance the release of 
metabolites during extraction and decrease matrix effects. The final homogenate was transferred into 20 
mL vials (protected from light) and stored in a freezer at –30°C until the time of analysis, upon which 
they were thawed individually in a temperature-controlled water bath maintained at 30°C for 20 min.  
 
Table 6.2 Apple samples under study at different treatment conditions.  
 
# of samples                Treatment                   Disorder                          Sample code                            Comments	  
             
        5                            None                                       No                                        HC-0                       Harvest and brought to lab 
 
        2                     Air storage 3°C                yes, soft scalding                            HC-1-SC-D                 Kept in storage for 4 months 
 
        4                    Air storage 3°C               Extensive soft scalding                  HC-1-SC-D-R              Kept in storage for 4 months 
                              Applied AVG to 
                               inhibit ethylene       
 
        1                    Air storage 3°C                    yes, soft scalding                          HC-1-SC-S               Kept in storage for 4 months 
 
        9                    Air storage 3°C                               No                                            HC-1                   Kept in storage for 4months 
 
       11                   Air storage 3°C                               No                                            HC-2                   Kept in storage for 8 months 	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6.2.3 Automated SPME procedure for high throughput analysis 
1.5 mL portions of thawed homogenate were transferred into 96-well plates, and a concept 96- 
autosampler was used for extraction. The Concept 96-blade SPME device and autosampler were provided 
by Professional Analytical System (PAS) Technology (Magdala, Germany). The Concept 96 autosampler 
includes three integrated arms to hold, move, and place the 96-blade SPME device into the 96-well plates, 
as well as four orbital agitators, which are allocated to agitate the 96-well plates at a defined speed. All 
arms and agitators are fully controlled by the Concept software, which enables automatic performance of 
preconditioning, extraction, wash, and desorption steps. The time of extraction was set at equilibrium for 
all compounds. The extraction was performed for 2 h (1000 rpm agitation speed, 2.5 mm amplitude). A 
1.5 mL sample was used for the extraction, and this volume was precisely controlled throughout the entire 
study. A fast 20 s wash step in water +0.1% formic acid was carried out after extraction from apple 
samples in order to remove any particulates and macromolecules from the surface of the coating. 
Afterwards, desorption was performed for 120 min in 1.5 mL of methanol: acetonitrile: water 40:40:20 
(v/v/v) with + 0.1% formic acid as the optimized desorption solvent (1500 rpm agitation speed, 1 mm 
amplitude).  
 
6.2.4 Preparation of the coating for 96-blade SPME system 
C18, PS-DVB-WAX, HLB, PBA, Si-RP-WCX, Strata X, as well as the lab made Si-IL, HILIC, and Diol, 
in addition to the mixed coatings PS-DVB-WAX: HLB 50:50 [w/w], PS-DVB-WAX: HLB 80:20 [w/w], 
and PS-DVB-WAX: Si-IL 80:20 [w/w)] were prepared and used in the currently presented study. 
Instructions regarding the coating preparation procedure have already been reported in Chapter 2 and 
Chapter 3 [137,222]. In brief, different SPE particles and synthesized lab-made particles were 
immobilized on the surface of stainless steel blades, using a spraying technique to affix a polyacrilonitile 
solution as a binder, at approximately the same thickness (80µL).  
 
6.2.5 LC-MS analysis by a benchtop Orbitrap instrument for targeted and untargeted 
analysis 
Separation was carried out on a Kinetex PFP column [100×2.1mm, 1.7µm] (Phenomenex, Torrance, CA, 
USA) with a guard filter (SecurityGuard ULTRA Cartridges UHPLC PFP for 2.1 mm). The column 
temperature was maintained at 25°C, and the gradient mobile phase conditions consisted of phase A 
(water containing 0.1% formic acid) and phase B (acetonitrile with 0.1% formic acid) set to the following 
conditions: 0-1 min 90% A; 1-9 min 90-10% A; 9-12 min 10% A; 12-16 min 10-90% A. Injection of each 
apple sample was followed by injection of control samples. Blank samples and QC samples were injected 
after every set of 15 sample injections so as to avoid cross contamination and verify instrument 
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performance. This QC sample was prepared by mixing a 10µL part of each sample into one sample. The 
injection volume for all methods was 10 µL. Samples were stored and refrigerated (4°C) on the 
autosampler while waiting for injection.  
The MS system was operated using an accurate mass Exactive benchtop Orbitrap system (Thermo, San 
Jose, California, USA) in both negative and positive electrospray ionization (ESI) modes and a 100-1000 
m/z mass range. The optimum values for sheath gas (arbitrary units), auxiliary gas (arbitrary units), ESI 
voltage (kV), capillary voltage (V), capillary temperature (°C), and tube lens voltage (V) were set at 40, 
25, 4.0, 27.5, 275, and 100 for positive ESI mode, and 50, 25, -2.7, -67.5, 325, and -85 for negative ESI 
mode respectively. External instrument mass calibrations were performed every 24 h, and found to be 
within 2 ppm for all ions. Separated metabolites were analyzed using Xcalibur software, version 2.1 
(Thermo) by isolating the extracted ion chromatograms (XIC), using a 5 ppm window around the accurate 
mass.	  
	  
6.2.6 Metabolite identification, data mining, and statistical analysis  
The raw data obtained with Xcalibur software (.raw) was converted to (mzXML) with the MS conversion 
software. The converted data was then processed with the XCMS R-package (Scripps Center for 
Metabolomics, California, USA). The resulting output is a table containing retention times, m/z, and 
intensity of features [142]. Mass spectral peak deconvolution, alignment, and peak picking (feature 
detection) were done by R software. The CAMERA R-package (Bioconductor Version 2.10) was applied 
to provide ion annotation on the list of features so as to identify detected isotopes, adducts, and in-source 
fragments ions. An Exactive Orbitrap detector was used in this study, providing high mass resolution and 
sensitivity. Multivariate data analysis was used by the SIMCA-P+ software (Umetrics, NJ, USA) for 
statistical analyses. Log transformation and pareto scaling prior to PLS were done to identify the 
differentiation between control and treated samples. OPLS-DA was performed on obtained data, and the 
resulting S-plots were applied towards further modeling to investigate markers with statistical relevance 
of variation (p < 0.05) related to storage stress and soft scald evidence. Metabolite identities were 
specified based on their accurate mass, retention time, comparison of fragmentation data with authentic 
standards, and METLIN databases within 5 ppm. In order to assign metabolites to metabolic pathways, 
the KEGG database (http://www.genome.jp/kegg) and the Plant Metabolic Network 
(http://www.plantcyc.org) were used. 
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6.3 Results and discussion 
6.3.1 Targeted analysis for development of SPME-LC-MS analysis 
6.3.1.1 Optimization of SPME parameters 
Twelve different types of stationary phases with different polarities and functional groups (C18, PS-
DVB-WAX, HLB, PBA, Si-RP-WCX, Strata X, Si-IL, HILIC, Diol, PS-DVB-WAX: HLB 50:50 [w/w], 
PS-DVB-WAX: HLB 80:20 [w/w], and PS-DVB-WAX: Si-IL 80:20 [w/w)]) were evaluated as the 
stationary phase for the 96-blade SPME system with thin film geometry for the extraction of targeted 
metabolites ranging -4.5 < Log P < 3.4 from the citrate buffer and apple matrices. PS-DVB-WAX, HLB, 
IL, and the coating prepared with a mixture of these particles provided the highest absolute extraction 
recoveries. In all cases, RSD% was below 15%, except for Diol and Strata X, whose coatings stripped off 
from the stainless steel blades in the case of real samples due to the complexity of the matrix (RSD up to 
40%). Detailed descriptions of the chemical characteristics and properties of these coatings are provided 
in Chapter 3. 
6.3.1.2 Preconditioning 
The preconditioning step was optimized for each set of coatings, with data obtained for polar coatings 
indicating that longer preconditioning times were needed in comparison to nonpolar coatings as 
metabolites were extracted from the aqueous phase. A 2-hour extraction time was determined for 
preconditioning in methanol/water 50:50 (v/v), with agitation set by the concept software chosen to 
prepare the surface coatings for extraction. 
 
6.3.1.2 Extraction 
The extraction time profiles of targeted metabolites in the citrate buffer (pH=3.5) and apple samples 
(pH=3.5) were evaluated for all coatings. Polar metabolites reach equilibrium more slowly on blades with 
nonpolar coatings than nonpolar metabolites, whereas for polar coatings, equilibrium is reached earlier. 
An evaluation of extraction time profiles indicated higher equilibrium extraction times for real samples. 
All metabolites in the apple matrices reached equilibrium in 2 hours. Therefore, 2-hours extraction times 
were used for the entire study, with 1000 rpm agitation.  
 
6.3.1.3 Wash 
To reduce the transfer of macromolecules, salts, and particulates from the apple matrix, a wash step was 
applied after extraction; however, this step needed to be optimized, as it is possible to lose polar 
metabolites during this step. After optimization, results indicated that a 20 s wash in 1 mL water + 0.1% 
formic acid helped decrease possible matrix effects while reducing metabolite loss for the most polar 
targeted metabolites to less than 10%. 
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6.3.1.4 Desorption 
To increase the desorption of extracted metabolites from the surface of coatings, as well as decrease 
carryover, two parameters were optimized for desorption solvent: the type of desorption solvent, and 
desorption time. Results demonstrated that for different coatings, different types of optimized desorption 
solvent and the desorption time were needed for optimization, although a 1.5 mL methanol: acetonitrile: 
water 40:40:20 (v/v/v) at 1500 rpm agitation speed (1 mm amplitude) for 2 hours provided a high 
extraction efficiency for HLB with the least percent of carryover (less than 1%). Analysis of a second 
desorption was not needed for this coating in the case of real samples. While the PS-DVB-WAX coating 
provided the highest extraction efficiency, under optimized desorption conditions, it showed high 
carryover, and this phenomenon was observed as well for the coating prepared with a mixture of particles 
in the presence of PS-DVB-WAX for metabolomics studies. Considering the large number of samples to 
be processed and the advantages associated with reusing the coatings without sacrificing time and cost, 
the HLB coating was chosen for the metabolomics part of this study. Figure 6.1 demonstrates a 
comparison of 96-blade SPME coatings in terms of extraction efficiency and selectivity for representative 
targeted metabolites extracted from apple samples. 
 
6.3.2 Metabolite identification 
Approximately 8000 features were detected using XCMS R-package and CAMERA R-package for both 
negative and positive ionization modes. Figure 6.2 and Figure 6.3 show chromatograms of metabolites 
extracted using the HLB coating in positive and negative ionization modes, respectively. The METLIN 
database was used to match the obtained m/z values with a mass tolerance window of 5 ppm, resulting in 
a database of about 500 metabolites. The application of HLB 96-blade SPME covered extraction of a 
broad range of metabolites from apple matrices in a single experiment run, while UPLC/MS provided 
analysis of the extracted metabolites, including sugars, fatty acids, amino acids and peptides, sugar 
alcohols, organic acids, prenol lipids, glycerophospholipid, flavonoid, sphingolipids, ethers, 
proanthocyanidins, hydrolyzable tannins, steroids and steroid derivatives, thiamines, glycosyl 
compounds, fatty acids and conjugates, cinnamic acid derivatives, phenols and derivatives, fatty amides, 
cyclic alcohols and derivatives, alkyl glycosides, isoindoles and derivatives, pyrrolidines, fatty adehydes, 
furans, pyrans, indols, pyridines and derivatives, and acetals. Table 6.3 demonstrates the metabolites 
extracted from apple samples using the HLB coating. Traditionally, metabolomics focuses on individual 
metabolites or a specific class of metabolites; however, in this study, comprehensive metabolite analysis 
was possible with a single SPME coating, without further sample pretreatment. The SPME-LC/MS 
method was used for characterization of different apple samples based on quality attributes. PLS score 
plots as statistical tools were employed for classification purposes. OPLS plots showed good 
differentiation between different clusters of apple samples and QC. PLS-DA analyses and S-plots were 
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applied to distinguish components of interest and potential markers for storage conditions of apple 
samples. Results showed metabolic divergence in response to storage duration after 4 and 8 months, in 
comparison to apple samples without storage. There were also differences in the metabolic profiles of 
apple samples with evidence of scald. 
Figures 6.4 and 6.5 demonstrate PCA score plots related to different apple samples. SPME demonstrated 
a correlation between different stored apple samples with scald evidence as well. Clear separation of 
clusters of each set of apple samples demonstrated that specific metabolites correlate directly with apple 
quality traits; their growth during storage as well as scald development is produced by changes in 
different classes of metabolites such as phenolics, anthocyanines, amino acids, lipids, and carbohydrates. 
Variability in apple samples is most likely attributable to environmental stresses, genetic variation, and 
virus expression [362]. Figure 6.6 demonstrates the metabolic changes of extracted metabolites in 
different evaluated apple samples. Plants alter their metabolism in various ways, including in the 
production of compatible solutes that are able to stabilize proteins and cellular structures and to preserve 
cell turgor by osmotic adjustment, and by altering the redox metabolism to remove excess levels of 
reactive oxygen species and re-establish the cellular redox balance. The most observed dysregulations in 
various classes of metabolites are summarized next.  
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Figure 6.1 The comparison of 96-blade SPME coatings in terms of extraction efficiency and selectivity for 
representative targeted metabolites extracted from apple samples. 
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Figure 6.2 Chromatogram of extracted metabolites from apple samples (HC-0) using 96-blade HLB SPME-LC/MS, 
positive ESI mode. 
 	  
	  
Figure 6.3 Chromatogram of extracted metabolites from apple samples (HC-0) using 96-blade HLB SPME-LC/MS, 
positive ESI mode. 
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Figure 6.4 PCA score plot showing clustering of the apple samples collected under different storage conditions 
(positive ESI mode). 
 	  
	  
Figure 6.5 PCA score plot showing clustering of the apple samples collected under different storage conditions 
(negative ESI mode). 
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6.3.2.1 Changes in amino acids and peptides 
Stored apple samples had higher levels of amino acids and peptides such as proline, leucine, tyrosine, 
beta-hydroxyarginine, N-formyl-L-glutamate, tryptophan, homomethionine, homoserine, homoglutamine, 
phenylalanine, galactosyl 4-hydroxyproline, and cinnamoylglycine, as well as a large number of peptides 
(Figure 6.6). This increase could be related to enhanced amino acid production or decreased protein 
synthesis due to a lower amino acid consumption rate, which consequently enhances amino acid 
accumulation, or to protein breakdown causing cell damage.  
Accumulation of amino acids in plants exposed to abiotic stress has been reported previously [363-369]. 
Amino acids are building blocks of proteins, and important in many metabolic networks that control 
growth and adaptation to environmental stresses. Their biosynthesis is regulated by a complex network 
involving both nitrogen and carbon metabolic pathways, such as nitrate reduction occurring beside carbon 
oxidation. The enhancement of amino acid levels in stored apple samples has been thought to reflect an 
increase in nitrogen recycling processes, with amino acids being involved as a carbon source in TCA 
cycles [370,371]. One of the amino acids upregulated in apple samples during storage condition is 
proline. This metabolite has been reported to be a reactive oxygen species scavenger and osmolyte 
stabilizer that protects cells from stress damages [372-375]; its levels rise in response to different 
environmental stresses such as drought, high salinity, and exposure to heavy metals [376-379]. 
6.3.2.2 Changes in organic acids 
Results demonstrated decreased levels of citric acid, malic acid, and glyoxylic acid, and increases in 
succinic acid levels during storage. Previous studies reported upregulation of TCA intermediates in 
response to temperature or drought stress [380-382]. Malic acid is the major organic acid in apples and 
one of the TCA intermediates, tasked with controlling respiration and flavor component during cold 
storage. Levels of malic acid were observed to decrease in relation to increased storage time after 4 and 8 
months of storage. Ackermann et al. observed a decrease in levels of malic acid and citric acid during 
ripening and storage of apple samples [383]. In addition, the level of glyoxylic acid was also observed to 
decrease during storage as well as in the case of apple samples with evidence of scald. This compound is 
an intermediate of the glyoxylate cycle that enables plants to convert fatty acids into carbohydrates, which 
are osmoprotectant metabolites [384].  
6.3.2.3 Changes in secondary metabolism 
Significantly higher levels of polyphenols were noted for stored samples, and may be associated with the 
release of polyphenol oxidase from chloroplast [385]. However, as scald proceeds, both simple phenol 
and flavonoid concentrations decrease; in this study, flavonoid levels, such as those of coumaric acid, 
catechine, quercetin 3-sambubioside-3'-glucoside, catechin 7-O-alpha-L-rhamnopyranoside, quercetin 3'-
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xyloside, myricitrin, quercetin 7-galactoside, quercetin 3-rhamnoside-7-glucoside, 5,7,2',4'-Tetrahydroxy-
3,6,5'-trimethoxyflavone, 7,8-dimethoxyflavanone, (±)-catechin, quercetin, 8-methy caffeine, 
epigallocatechin 3-O-caffeate, kaempferol 3-p-coumarate, epiafzelechin 3-O-beta-D-allopyranoside, were 
observed to decrease in samples with scald evidence. Browning reactions in the apple surface attributed to 
scald are associated with polyphenols attached to proteins. Previous studies observed a correlation 
between high-levels of phenolic compounds in apple peel and less scald development after storage 
[386,387]. 
6.3.2.4 Changes in sugar metabolism  
Stored carbohydrates such as starch are metabolized to soluble sugars under stress conditions to protect 
the apple membrane’s cell structure and proteins from stress damage. Adjustment of sugar contents has 
also been recognized using the OPLS model. Levels of pentose sugars such as glucose increased with 
increased storage time, while sucrose was observed to decrease due to hydrolysis of sucrose to glucose 
during storage. Previous studies introduced the release of hexose sugars from fructans, which achieved 
osmotic adjustment and membrane stabilization in freezing and dehydration conditions [388]. The level of 
sorbitol, as a sugar alcohol, increased in stored apple samples over time; sorbitols, as major sugar alcohol 
constituents in apples, cause fruit sweetness enhancement. Stoop et al. distinguished a correlation between 
the accumulation of straight chain polyols, including mannitol and sorbitol, and stress tolerance in several 
plant species [389]. Fidler et al. observed a relation between increase in sorbitol and browning in scald 
apple samples [390]. Evidence of level increases in other alkyl glycosides such as (R)-1-O-b-D-
glucopyranosyl-1,3-octanediol, heptanol glucoside, (R)-1-O-b-D-glucopyranosyl-1,3-octanediol, citrusin 
E, (R)-1-O-b-D-glucopyranosyl-1,3-octanediol, 1-(beta-D-glucopyranosyloxy)-3-octanone, and (R)-1-O-
[b-D-glucopyranosyl-(1->6)-b-D-glucopyranoside]-1,3-octanediol was also demonstrated in the current 
study. Lee et al. reported that an enhanced concentration of disaccharides such as galactose-beta-1,4-
xylose is associated with cell wall breakdown, as xylose is the major component of xyloglucan [391,392]. 
6.3.2.5 Changes in lipid metabolism 
Up-regulation of glycerophospholipids was observed in the stored apple samples; however, their levels 
were noted to decrease in apple samples with scald evidence. On the other hand, in most cases, the level 
of fatty acids and conjugates in all samples increased. Enhancement in the levels of acylated steryl 
glucosides and steryl esters indicated membrane integrity alteration. Conversion of unsaturated fatty acids 
to saturated fatty acyl functional groups of alkyl glycosides due to the transfer of apple samples from low 
temperature storage conditions to ambient temperature has been noted in the case of apple samples with 
scald. Brackmann et al. observed increased amounts of fatty acids in air-stored apple samples [393]. 
Inositol, which is the precursor for phosphatidylinositol, was noted to increase in stored apple samples, 
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indicating alterations in cell metabolism. Loewus et al. reported elevation of this metabolite in response to 
cell membrane alteration and lipid membrane modification, as a result of chilling or oxidative stress 
[394]. Concentrations of phytosterol metabolites such as provitamin D6 and stigmasterol (6S,9R-
dihydroxy-4,7E-megastigmadien-3-one 9-[apiosyl-(1->6)-glucoside]) conjugated in peel tissue were 
found to increase in scald apple samples. Phytosterols are integral units of plant membrane, modifying 
membrane fluidity and permeability [395]. Rudell et al. observed that the degree of phytosterol 
conjugation is correlated with ripening and chilling stress [396]. Picchioni et al. reported the constant 
level of conjugation in stigmasterols during ripening in cold storage [397]. Moreover, the level of abscisic 
acid increased during storage and decreased in apple samples with scald evidence. Abscisic acid is an 
isoprenoid plant hormone classified as a prenol lipid. It quickly accumulates in plants due to 
environmental stress [398-400].  
The metabolic pathways of apples in cold storage conditions changed through the activation of free 
radicals, antioxidant enzymes, ethylene production, and α-farnesene synthesis. As in storage conditions, 
as fruits continue ripening, the level of metabolites changes. For example, esters with various functional 
groups are produced by glycolysis or β-oxidation of fatty acids [401]. An evaluation of the obtained 
results revealed an association between ripening and scald produced by chilling stress. Based on previous 
reports, AVG [402] delays ethylene production, so α-farnesene and its products will be reduced initially; 
however, their levels increase during storage. In the current study, batches of apple samples treated with 
AVG were noted to demonstrate signs of scald development after 4 months of storage. 
Storage stress activates many processes in which free radicals, antioxidants, ethylene, farnesal,     and α-
conjugated trienols are involved. Our study demonstrated that the concentration of α-conjugated trienols 
such as 3Z,6E,8E-Dodecatrien-1-ol in scald samples increased in stored apple samples. Moreover, 6-
methyl-5-hepten-2-one, as the byproduct of free radicals, which produces cell damage resulting from the 
reaction of conjugated trienols, was noted to increase in the same samples as well. These metabolites are 
directly associated with scald symptoms; however, the evidence of their enhancement was observed even 
in the case of stored samples without scald symptoms. Meigh et al. observed increases in α-farnesene 
early in storage and subsequent decreases during further storage time [403]. On the other hand, Huelin et 
al. reported enhancement in conjugated trienes during storage [404]. They observed a correlation between 
conjugated triene levels and scald development that was confirmed by the present study.	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Figure 6.6 Metabolic profile of extracted metabolites from apple samples using 96-blade HLB SPME-LC/MS at 
different storage conditions. 
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Table 6. 3 Metabolite extracted from apple samples using 96-blade HLB SPME-LC/MS. 
Metabolite Exact Mass Chemical 
formula 
Adduct METLIN 
ID 
ppm 
Alkyl Glycosides 
(R)-1-O-b-D-glucopyranosyl-1,3-
octanediol 
331.1727 
 
C14H28O7 
 
[M+Na]+ 86223 0 
(R)-1-O-b-D-glucopyranosyl-1,3-
octanediol 
309.1909 
 
C14H28O7 
 
[M+H]+ 
 
86223 0.6 
Citrusin E 
 
373.1489 
 
C17H24O9 
 
[M+H]+ 
 
93825 
 
-1.1 
(R)-1-O-b-D-glucopyranosyl-1,3-
octanediol 
309.1907 
 
C14H28O7 [M+H]+ 
 
86223 0 
1-(beta-D-Glucopyranosyloxy)-3-
octanone 
329.1576 C14H26O7 [M+Na]+ 87578 1.8 
(R)-1-O-[b-D-Glucopyranosyl-(1->6)-
b-D-glucopyranoside]-1,3-octanediol 
471.2441 C20H38O12 [M+H]+ 88721 -1.1 
Acetals 
Acetal R 209.1536 
 
C13H20O2 [M+H]+ 91838 0 
Amino acids and conjugates 
Acetyl-L-tyrosine 223.0844 C11H13NO4 [M]+ 5827 0 
beta-Hydroxyarginine 235.0783 C6H14N4O3 [M+2Na-H]+ 72279 2.5 
Leucine 173.1284 
 
C6H13NO2 [M+ACN+H]+ 64934 
 
0 
N-Formyl-L-glutamate 220.0192 
 
C6H9NO5 
 
[M+2Na-H]+ 3769 
 
0 
Tryptophan 249.0615 C11H12N2O2 [M+2Na-H]+ 65364 2.0 
Homomethionine 227.0829 
 
C6H13NO2S 
 
[M+ACN+Na]+ 64484 
 
2.2 
Pentahomomethionine 220.1364 
 
C10H21NO2S [M+H]+ 64511 
 
-0.5 
1-
(Malonylamino)cyclopropanecarboxyli
c acid 
226.0112 
 
C7H9NO5 
 
[M+K]+ 
 
87876 
 
0 
N-Malonyltryptophan 
 
313.0795 
 
C14H14N2O5 
 
[M+Na]+ 
 
94069 
 
0 
Proline 116.0710 C5H9NO2 
 
[M+H]+ 
 
29 3.4 
Benzopyrans 
Coumarin 147.0441 
 
C9H6O2 
 
[M+H]+ 
 
3525 
 
0 
Benzopyridines 
Isoquinoline 130.0652 
 
C9H7N 
 
[M+H]+ 44763 0.7 
Carbonyl Compounds 
6-Nonenal 
 
158.1539 
 
C9H16O 
 
[M+NH4]+ 87316 
 
0 
Octanal 
 
129.1275 
 
C8H16O 
 
[M+H]+ 6033 
 
-1.5 
Carboxylic Acids and Derivatives 
Glyoxylic acid 
 
118.9716 
 
C2H2O3 
 
[M+2Na-H]+ 64613 
 
0 
Malic acid 
 
178.9920 
 
C4H6O5 
 
[M+2Na-H]+ 118 -3.3 
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Acetylputrescine 
 
131.1185 
 
C6H14N2O 
 
[M+H]+ 
 
3252 
 
5.3 
Procaine hydrochloride 
 
295.1184 
 
C13H21ClN2O2 
 
[M+Na]+ 
 
66759 
 
0.3 
Citric acid 
 
236.9981 
 
C6H8O7 
 
[M+2Na-H]+ 124 0 
Cinnamic acid and derivatives 
      
Methyl 3,4,5-trimethoxycinnamate 
 
275.0890 
 
C13H16O5 
 
[M+Na]+ 
 
93223 
 
0 
Coumaric acid 147.0449 
 
C9H8O3 
 
[M+H-H2O]+ 305 
 
-2.0 
 
Cinnamaldehydes 
Cinnamaldehyde 
 
133.0648 
 
C9H8O 
 
[M+H]+ 
 
6931 0 
Cyclic Alcohols and Derivatives 
Chlorogenic Acid 377.0843 
 
C16H18O9 
 
[M+Na]+ 
 
3498 0 
5Z-Caffeoylquinic acid 355.1031 C16H18O9 
 
[M+H]+ 95165 2.2 
Disaccharides 
Galactose-beta-1,4-xylose 295.1023 
 
C11H20O10 
 
[M+H-H2O]+ 62416 
 
-2.0 
 
cis-Mulberroside A 
 
591.1684 
 
C26H32O14 
 
[M+Na]+ 
 
87898 
 
0 
3-Hexenyl b-primeveroside 
 
417.1730 
 
C17H30O10 
 
[M+Na]+ 
 
87866 
 
-0.2 
Sucrose 381.0791 
 
C12H22O11 [M+K]+ 137 -0.5 
1-Hexanol arabinosylglucoside 
 
419.1888 
 
C17H32O10 
 
[M+Na]+ 
 
87865 
 
0 
3-Hexenyl b-primeveroside 
 
395.1912 C17H30O10 
 
[M+H]+ 
 
87866 
 
0 
Docosanoids 
4,5-epoxy-17R-hydroxy-
6E,8E,10Z,13Z,15E19Z-
docosahexaenoic acid 
421.2349 C25H34O4 
 
[M+Na]+ 75237 
 
0 
Eicosanoids 
10-F2-dihomo-IsoP 419.2768 C23H40O5 [M+Na]+ 96931 
 
0 
Fatty Acids and Conjugates 
2-hydroxy capric acid 
 
211.1304 
 
C10H20O3 
 
[M+Na]+ 
 
35411 
 
0 
Pentadecanedioic acid 273.2059 
 
C15H28O4 
 
[M+H]+ 
 
35977 
 
-1.5 
3,12-dihydroxy-pentadecanoic acid 
 
297.2035 
 
C15H30O4 
 
[M+Na]+ 
 
74562 
 
-0.3 
6,8-dihydroxy-octanoic acid 
 
177.1121 
 
C8H16O4 
 
[M+H]+ 
 
74602 
 
0 
2E,8E-dodecadienoic acid 214.1802 
 
C12H20O2 
 
[M+NH4]+ 34897 
 
0 
14-keto pentadecanoic acid 
 
239.2014 
 
C15H28O3 [M+H-H2O]+ 
 
35743 
 
1.2 
6,8-dihydroxy-octanoic acid 159.1021 C8H16O4 [M+H-H2O]+ 74602 0 
	   163 
     
4-keto pentadecanoic acid 239.2014 
 
C15H28O3 
 
[M+H-H2O]+ 
 
35741 
 
1 
Fatty Aldehydes 
Stearaldehyde 
 
291.2682 
 
C18H36O 
 
[M+Na]+ 6658 8.2 
Fatty Acid Esters 
9-oxo-2,4,5,7-decatetraenoic acid 
 
179.0703 
 
C10H10O3 
 
[M+H]+ 74724 
 
0 
Propionyl-CoA 
 
823.1384 
 
C24H40N7O17P3S 
 
[M+] 442 -3.6 
2-methylene dodecanoic acid 
 
213.1848 
 
C13H24O2 
 
[M+H]+ 
 
34573 -0.5 
Fatty esters 
Tridecatrienyl acetate 237.1849 
 
C15H24O2 
 
[M+H]+ 
 
46270 0 
Fatty Acyls 
Octane-1,2-diol 147.1384 C8H18O2 [M+H]+ 
 
46044 3.3 
10-amino-decanoic acid 
 
188.1645 
 
C10H21NO2 
 
[M+H]+ 
 
74855 
 
0 
4-oxo-9Z,11Z,13E,15E-
octadecatetraenoic acid 
291.1952 
 
C18H26O3 
 
[M+H]+ 
 
74765 
 
-0.2 
Octyl acetate 173.1536 
 
C10H20O2 
 
[M+H]+ 
 
46196 
 
0 
6,8-dihydroxy-octanoic acid 159.1021 
 
C8H16O4 
 
[M+H-H2O]+ 
 
74602 
 
0 
Fatty Alcohols  
Decen-1-ol 
 
198.1852 
 
C10H20O 
 
[M+ACN+H]+ 46092 
 
0 
Octane-1,2-diol 
 
147.1385 C8H18O2 
 
[M+H]+ 
 
46044 4.1 
(3R,7R)-1,3,7-Octanetriol 
 
185.1148 C8H18O3 
 
[M+Na]+ 89425 
 
0 
1,3,7-Octanetriol 
 
163.1327 
 
C8H18O3 
 
[M+H]+ 
 
89425 
 
-0.6 
2,5-Octadien-1-ol 
 
109.1017 
 
C8H14O 
 
[M+H-H2O]+ 
 
94689 
 
3 
Sorbitol 
 
183.0863 
 
C6H14O6 
 
[M+H]+ 
 
143 0 
Dioctyl hexanedioate 
 
371.3164 C22H42O4 
 
[M+H]+ 
 
95990 -2.4 
Fatty Amides 
Linoleoyl Ethanolamide 
 
362.2468 C20H37NO2 
 
[M+K]+ 
 
3718 
 
3.5 
(Z)-6-Tetradecene-1,3-diyne-5,8-diol 259.1109 C14H20O2 
 
[M+K]+ 
 
93602 
 
5.8 
13E-Docosenamide 338.3417 C22H43NO 
 
[M+H]+ 85041 
 
0 
N-stearoyl valine 384.3472 C23H45NO3 
 
[M+H]+ 
 
75504 
 
0 
Flavonoids 
Quercetin 3-sambubioside-3'-glucoside 
 
781.1798 
 
C32H38O21 
 
[M+Na]+ 
 
50545 
 
0 
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Catechin 7-O-alpha-L-
rhamnopyranoside 
 
459.1262 
 
C21H24O10 
 
[M+Na]+ 
 
47244 
 
0 
Quercetin 3'-xyloside 
 
457.0741 C20H18O11 
 
[M+Na]+ 
 
50598 
 
0 
Myricitrin 
 
465.1028 
 
C21H20O12 
 
[M+H]+ 
 
50852 
 
0 
Quercetin 7-galactoside 
 
487.0847 
 
C21H20O12 
 
[M+Na]+ 
 
50594 
 
0 
Quercetin 3-rhamnoside-7-glucoside 
 
611.1606 
 
C27H30O16 
 
[M+H]+ 
 
50615 
 
0 
5,7,2',4'-Tetrahydroxy-3,6,5'-
trimethoxyflavone 
 
399.0693 
 
C18H16O9 
 
[M+Na]+ 
 
51465 
 
1.8 
7,8-Dimethoxyflavanone 
 
307.0941 
 
C17H16O4 
 
[M+Na]+ 
 
52580 
 
0 
(±)-Catechin 
 
291.0868 C15H14O6 
 
[M+H]+ 
 
3419 
 
1.7 
Quercetin 
 
303.0504 C15H10O7 
 
[M+H]+ 
 
409 
 
1.6 
8-Methy caffeine 
 
247.0590 
 
C9H12N4O2 
 
[M+K]+ 
 
84980 
 
-0.4 
Cyanidin 3-glucosyl-(1->6)-[xylosyl-
(1->2)-galactoside] 
 
765.1818 
 
C32H38O20 
 
[M+Na]+ 
 
46866 
 
-4.0 
Kaempferol 3-p-coumarate 
 
433.0932 C24H16O8 
 
[M+H]+ 
 
50408 
 
3.4 
Kaempferol 3-p-coumarate 433.0923 C24H16O8 [M+H]+ 50408 1.4 
Epiafzelechin 3-O-beta-D-
allopyranoside 
475.1001 
 
C21H24O10 
 
[M+K]+ 47242 
 
0 
Glycerolipids 
DG(20:2(11Z,14Z)/14:0/0:0) 575.5039 
 
C37H68O5 
 
[M+H-H2O]+ 
 
88644 
 
0 
Glycerol 1-(5-hydroxydodecanoate) 
 
273.2059 
 
C15H30O5 
 
[M+H-H2O]+ 94704 
 
-2.1 
Glycerophospholipids 
PA(21:0/22:4(7Z,10Z,13Z,16Z)) 
 
794.5833 
 
C46H83O8P 
 
[M]+ 81866 
 
1.0 
PC(O-16:0/O-16:0) 
 
728.5931 
 
C40H84NO6P 
 
[M+Na]+ 
 
40207 
 
4.1 
PC(0:0/7:0) 
 
411.2254 
 
C15H32NO7P 
 
[M+ACN+H]+ 40361 
 
0 
PE(20:4(5Z,8Z,11Z,14Z)/16:0) 
 
740.5225 
 
C41H74NO8P 
 
[M+H]+ 60781 
 
0 
Indoles 
N-Methyltryptamine 
 
197.1049 
 
C11H14N2 
 
[M+Na]+ 
 
63558 
 
0 
Methylindolepyruvate 
 
259.1082 C12H11NO3 
 
[M+ACN+H]+ 86813 
 
1.9 
Neutral glycosphingolipids 
GlcCer(d16:2(4E,6E)/18:0(2OH)) 
 
714.5514 
 
C40H75NO9 
 
[M+H]+ 103318 
 
0 
Monosaccharides 
5-Methylthio-D-ribose 
 
181.0529 
 
C6H12O4S 
 
[M+H]+ 
 
63429 
 
0 
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Glucose 
 
203.0526 
 
C6H12O6 
 
[M+Na]+ 
 
3755 
 
0 
Isoprenoids 
Cymene 
 
163.1481 
 
C12H18 
 
[M+H]+ 
 
85265 
 
0 
Peptides 
Gly-His-OH 
 
338.1095 
 
C13H12N4O6 
 
[M+NH4]+ 
 
65205 
 
0 
Gln Gly Pro Ser 
 
388.1827 C15H25N5O7 
 
[M+H]+ 
 
209734 
 
0.2 
Tyr Lys Thr 
 
428.2504 
 
C19H30N4O6 
 
[M+NH4]+ 19980 
 
0.2 
Ser Gly Phe Pro 
 
429.1745 
 
C19H26N4O6 
 
[M+Na]+ 225571 
 
0 
Pro Leu Pro Asp 
 
463.2163 C20H32N4O7 
 
[M+Na]+ 
 
203321 
 
0 
Pro Lys Lys Ser 
 
476.3191 C20H38N6O6 
 
[M+NH4]+ 
 
202854 
 
0 
Phe Ile Trp 
 
503.2055 C26H32N4O4 
 
[M+K]+ 18310 
 
0 
Met Tyr Cys Cys 
 
541.1220 
 
C20H30N4O6S3 
 
[M+Na]+ 191100 
 
0.2 
Pro Arg 296.2225 C15H26O3 [M+ACN+H]+ 85909 1.6 
Hydroxyprolyl-Tryptophan 
 
359.1709 
 
C16H19N3O4 
 
[M+ACN+H]+ 85780 
 
-1.1 
Phenylpropenes 
4-Hydroxycinnamoylagmatine 
 
299.1478 C14H20N4O2 [M+Na]+ 
 
66195 
 
0 
Prenol Lipids 
Limonene 
 
137.1324 
 
C10H16 
 
[M+H]+ 41063 
 
0 
6-Methyl-5-hepten-2-ol 
 
129.1274 C8H16O 
 
[M+H]+ 44731 
 
-0.8 
Farnesal 
 
203.1794 C15H24O 
 
[M+H-H2O]+ 44756 
 
-1.5 
7-Drimene-11,12,14-triol 255.1950 C15H26O3 [M+H]+ 91869 -1.6 
6S,9R-Dihydroxy-4,7E-
megastigmadien-3-one 9-[apiosyl-(1-
>6)-glucoside] 
541.2255 C24H38O12 
 
[M+Na]+ 
 
86480 
 
0 
Geranylcitronellol 310.3104 
 
C20H36O [M+NH4]+ 46161 
 
0 
Eriojaposide A 
 
503.2487 
 
C24H38O11 
 
[M+H]+ 92803 
 
0.2 
Linalyl propionate 
 
228.1958 C13H22O2 
 
[M+NH4]+ 86966 
 
0 
alhpa-tocopheronolactone 
 
301.1410 
 
C16H22O4 
 
[M+Na]+ 
 
53844 
 
0 
Carvyl propionate 
 
209.1536 C13H20O2 
 
[M+H]+ 
 
92819 
 
0 
3,6,8-dodecatrien-1-ol 
 
198.1852 
 
C12H20O 
 
[M+NH4]+ 36515 
 
0 
Cyclocitral 153.1274 
 
C10H16O 
 
[M+H]+ 95447 
 
0.7 
Proanthocyanidins 
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Procyanidin B5 579.1497 
 
C30H26O12 
 
[M+H]+ 
 
71836 
 
0 
Proanthocyanidin A2 591.1504 C31H26O12 [M+H]+ 68190 1.1 
Purine Nucleotides 
Guanosine monophosphate 
 
427.0751 C10H14N5O8P 
 
[M+ACN+Na]+ 98 3.2 
Inosine-5'-carboxylate 313.0793 C11H12N4O7 
 
[M+H]+ 
 
65946 
 
4.7 
Pyridines and Derivatives 
Pyridoxine (Vitamin B6) 192.0631 
 
C8H11NO3 [M+Na]+ 
 
6307 
 
0 
Sphingolipids 
GlcCer(d18:2/16:0) 697.5481 
 
C40H75NO8 
 
[M]+ 83808 
 
-1.5 
N-(2R-Hydroxytricosanoyl)-2S-amino-
1,3S,4R-octadecanetriol 
670.6345 
 
C41H83NO5 
 
[M+H]+ 
 
90755 0.1 
Styrenes 
Caffeoylputrescine 295.1022 C13H18N2O3 [M+2Na-H]+ 3380 -2.3 
(3xi,6E)-1,7-Diphenyl-6-hepten-3-ol 266.1670 C19H22O [M]+ 86754 0 
Stilbenes 
4-(3-Methyl-1-butenyl)-3,3',4',5-
tetrahydroxystilbene 
313.1439 C19H20O4 
 
[M+H]+ 87088 -1.5 
 
6.4 Conclusions and future directions 
This is the first application of the 96-blade SPME in direct extraction mode coupled to LC-MS for all 
small molecular weight species in apple samples for determinations of the dynamic processes occurring in 
apple samples under storage. The objective of the current research was the successful application of the 
solvent-free and environmentally-friendly SPME sample preparation technique for global metabolomics 
analyses of complex food matrices. In comparison to traditional sample preparation techniques, SPME 
offers a solvent-free procedure, lower sample preparation times, use of small sample sizes, high-
throughput capability, and matrix effect reduction. SPME method development for apple metabolomics 
demonstrated that the type of SPME coating can affect the metabolic profile of apple samples. Sample 
preparation for global metabolite discovery was shown to be performed efficiently, with hundreds of 
features profiled using R software. The developed HLB coating as the stationary phase for the 96-blade 
system provided simultaneous extraction of both polar and hydrophobic compounds in a single run, 
accompanied by high-throughput analysis, while use of the open-bed thin film microextraction afforded 
an increase in sensitivity and reduced extraction time, without any need for further sample pretreatment. 
Chromatographic conditions employed a short gradient, resulting in peak widths < 0.3 min; such 
conditions were useful for both metabolite profiling and for metabolite identification experiments. SPME 
showed good separation between various groups of apple samples in different conditions, and some of the 
most important markers related to browning reactions produced by scald in apple samples were 
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determined. The optimized method can be applied to find changes in metabolite levels due to storage 
disorders of apples. The proposed method not only shows metabolic profiling to be an efficient tool for 
mapping biochemical pathway analysis, but could also be helpful in achieving information regarding 
markers related to chemical phenotypes as well as storage and marketing decisions. Direct immersion 
SPME coupled to LC-MS provides sample characterization for a broad range of metabolites, and in order 
to obtain more a comprehensive metabolic picture of apple samples and potential biomarkers regarding 
storage effect, in future studies, the present results with the results obtained from SPME-GCxGC-TOFMS 
for the same apple samples will provide comprehensive metabolic profile for wide range of metabolite 
comparing both techniques. 	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Chapter 7 
 Summary and future perspectives 
7.1 Summary 
Global metabolomics focuses on the analysis of all metabolites in biological systems; it is applied to 
investigate the metabolic differences between case studies and control samples. Consequently, 
metabolomics can be utilized in biomarker discoveries related to diseases, toxicant exposure, evaluation 
of nutritional status, and drug discovery and development. Among the various analytical chemistry 
techniques, the most comprehensive high-resolution analysis of non-volatiles and semi-volatiles is 
provided by LC-MS. Recent research in this area has shown that many factors, such as sample 
preparation, quantification, column type, and detection technique, as well as peak identification, are 
important factors in determining the quality of metabolomics data. As such, further improvement of 
metabolomics techniques for quantification and qualification need to involve consideration of these 
variables. However, there currently exists a need for sample preparation techniques prior to LC-MS 
analysis that are capable of increasing sensitivity and reducing matrix effects caused by co-elution of 
highly abundant metabolites, salts, and proteins as low abundance metabolites need more sample clean-up 
and preconcentration to be detected.  
The main objective of this study was the development of a high-throughput SPME-LC/MS technique that 
involves a solventless, green, and environmentally-friendly sample preparation methodology for targeted 
and non-targeted metabolome profiling of complex sample matrices. In this work, both polar and apolar 
metabolites from E.coli as a model sample were separated by the UPLC PFP LC column. Exactive 
Orbitrap facilitated high-resolution detection (<5ppm) of mass ions, providing differentiation between 
isobaric compounds with the same nominal mass. Optimization of coating characteristics for extraction of 
metabolites produced by E.coli bacteria as a model organism demonstrated the tested coatings possess 
selectivity to provide extraction of different classes of metabolites with high extraction recoveries. The 
results indicated a relationship exists between the chemistries of the tested coatings, resulting in different 
extraction profiles demonstrating that coatings with various chemical structures extract metabolite with 
different functional groups. For example, the PBA coating, which contains a diol-hydroxyl group in its 
phenylboronic acid structure, can covalently bind with alcohols, nucleotides, and carbohydrates. PS-
DVB-WAX can provide various types of extraction capabilities such as van der waals and π- π 
interactions, as well as hydrogen binding and ionic interactions due to the weak ionic exchange group 
available in its polymer structure, which function to balance the characteristics of this coating for 
extraction of both polar and nonpolar metabolites. Consequently, a large number of classes of metabolites 
can be extracted with this coating. The HLB coating demonstrated similar characteristics; however, this 
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coating was shown to extract a class of lipids with higher extraction recovery. As such, the commercially 
available HLB coating with ionic exchange groups possesses different coating characteristics towards a 
different class of metabolites. It is worth mentioning that pH, ionic strength, and the type of sample 
matrix under study were factors that were shown to potentially influence the final metabolomics results. 
Coatings with alkaline long chains such as C18 were shown to provide high extraction recovery for lipid 
classes, which are nonpolar metabolites that do not contain polar functional groups in their structure. The 
presented results demonstrated that ion exchange phases such as Si-RP-WCX or polar functional groups 
embedded in the chemistry of a coating like Si-IL can change the coating characteristics towards 
extraction of metabolites with higher polarity. In Chapter 3, the use of Heatmap illustrated optimum 
coating characteristics towards the extraction of different classes of metabolites. The results demonstrated 
that each type of coating is specific for extraction of particular classes of metabolites that influence 
metabolic profile. Application of various extractive phases for the 96-blade system utilized for 
metabolomics indicates that the obtained metabolome profile differs depending on the selected coating 
type, an effect similar to the use of different solvents in LLE. Therefore, this study shows that based on 
the type of metabolite classes that are being investigated in a metabolomics study, appropriate coatings 
must be selected.  
In contrast to LLE and SPE, SPME is a non-exhaustive extraction method that eliminates the need for 
metabolism quenching and produces lower MS signal intensities. Therefore SPME is less susceptible to 
matrix effect due to lower extraction recovery and lower intensity of highly intense ions reducing ion 
suppression or enhancement in comparison to traditional technique. In addition, the small amounts of 
extracted metabolites are generally sufficient for quantitative analysis. Clean extract obtained from SPME 
has less problem of obscuring low intensities ions by ion suppression phenomenon. The SPME coatings 
developed in this research have long-term reusability and allow for the extraction of a wide polarity range 
of metabolites. For biocompatible SPME coatings, the addition of a wash step can eliminate particulates, 
salt, and protein retardation on the surface of the coating, allowing the desorption solvent to be free of 
suppressing salt, proteins, and other interferences. In this work, the obtained results demonstrated the 
higher reproducibility of SPME in comparison to LLE for non-biological replicates extraction from the 
same bacteria growth culture (Figure 7.1). This particular set of experiments allowed for a comparison of 
variability within sample preparation and analysis techniques in terms of experimental errors to set 
confidence limits for the significant data. The observed findings can be explained by the ability of the 
SPME method to only extract the free portion of metabolites present in the sample, which allows 
reduction in matrix effects and contributes to lower chromatographic backgrounds. Data nalaysis related 
to statistically siginificant-differentiated metabolites between two clusters in Figure 7.1 between two 
metods demonstrates extraction of phospholipids with high ion abundance in LLE experiment in 
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comparison to SPME. Conversely, during the solvent extraction step of the LLE method, dissolved 
phospholipids and other cellular components can interfere or co-elute with the metabolites of interested 
that are separated at the same retention time, which in turn causes ion suppression. In addition, SPME was 
shown to have higher metobite coverage due to lower ion suppression as well as extract unstable and 
short-lived metabolites (Chapter 3). In short, SPME was shown to be a more sustainable and reproducible 
method by extracting lower amounts of metabolites due to its non-exhaustive characteristics, and 
extraction of free portion of metabolites resulting in producing smaller matrix effects than LLE.  
SPME provides separate clusters for each experiment (Chapter 4, Chapter 5, Chapter 6) as well as good 
instrument performance after a large number of extractions, thus confirming the superior repeatability and 
precision of the method, as well as its ability to provide cleaner extracts, which consequently lead to 
sound analytical results. The obtained results shows that SPME has the potential to act as a one-step 
sample preparation and sample clean-up technique with high method precision for various areas of 
research, including biological, clinical, pharmaceutical, environmental, food, and metabolomics studies. 
In this work, high-throughput instantaneous preparation of up to 96 samples was attained with an average 
of ~1-2 min per sample for equilibrium extraction. However, with the application of an automated, highly 
sensitive 96-blade SPME system, this analysis time can be considerably decreased via pre-equilibrium 
extraction, without sacrificing precision or limiting sensitivity. Performing experiment at lower extraction 
times using the automation technique helps diminish possibility of metabolite transformation or 
degradation happening in longer extraction times. Thin film microextraction, as an open bed extraction 
technique, results in significant enhancement in extraction efficiency, providing faster extractions than 
methods involving commercial SPME fibers, in addition to eliminating common issues experienced in the 
workflow of traditional methods such as SPE, for instance the clogging of packed bed systems.  
 
 
Figure 7.1 Cluster separation and reproducibility of extraction results by SPME and LLE from E.coli bacteria (10-5 
CFU mL-1) for 5 non-biological replicates. 
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Another dimension of the currently reviewed work involved the application of the developed analytical 
technique towards a novel procedure for acquiring semi-quantitative metabolic information from under-
stressed biological systems (Chpater 4, Chapter 5, Chapter6). First, the developed method was applied for 
in vivo DI-SPME sampling of bacteria growing in media, with minimum perturbation and the elimination 
of metabolism-quenching steps and manipulative sample preparation. The global SPME metabolic 
profiles of bacteria treated with different naturally-occurring antibacterial agents indicates that widely 
differing SPME-LC/MS profiles can be obtained depending on the type and amount of antibacterial agent 
added, as well as the time point of the growth phase during which sampling is conducted. The SPME 
method showed good cluster separation between two different antibacterial agents (Figure 7.2) and 
provided metabolite differentiation, demonstrating that the tested essential oils have differing modes of 
action in regards to microorganism metabolism interruption, through interruption of various metabolic 
pathways. To this purpose, different types of experiments were designed in order to evaluate results in 
terms of different errors (biological or nonbiological) and explain significant biological differences with 
higher confidence. Biological replicates were obtained to differentiate between random results and 
statistically significant differences between two groups of samples exposed to different treatments, so as 
to ascertain whether the observed differences represent a true biological difference induced due to 
treatment with the naturally-occurring antibacterial agents. For this series of experiments, the obtained 
SPME profiles were composed of potential biomarkers, which can potentially help in determinations of 
biosynthetic pathways and biological roles of antibacterial agents on E.coli bacteria. However, the 
obtained results are still exploratory in nature; further investigations are needed to properly identify and 
characterize these biomarkers. Cinnamaldehyde and clove oil have likely to be used as active anticancer 
agents based on their potential effect to stop the glycolysis pathway. The obtained results indicate that the 
state-of-the-art 96-blade SPME coupled to LC/MS has the potential to provide metabolic profiling of uni- 
and multicellular living systems under the induction of various environmental stresses.  
The second application of the developed method involved investigations to provide and compare 
metabolic snapshots of stored apple samples (with and without superficial scald) versus healthy apple 
samples. SPME demonstrated good differentiation between sample types and different time points, in 
addition to allowing for identification of potential biomarkers related to disturbed apple metabolism under 
storage conditions. The change in metabolic pathway of apple samples under stress in comparison to the 
control samples help increase the shelflife utilizing particular agent to inhibit the scald progress. 
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Figure 7.2 Cluster differentiation between bacteria treated with clove oil and cinnamaldehyde, with the matched 
control samples. 
7.2 Future perspective 
A future step of this thesis, currently in progress in our laboratory, involves the development and 
evaluation of the full potential of SPME in the field of global metabolite analysis through hyphenation of 
this technique with high-resolution instrumentation, such as HS-SPME GCxGC-ToFMS and 96-blade 
SPME-LC/MS. The goal of these applications is to provide comprehensive metabolic profiles of both 
bacteria and apple samples under environmental stress conditions. Results so far have demonstrated that a 
coupling of the DI-SPME technique to multidimensional LCxLC-MS techniques will result in the 
provision of comprehensive complex sample characterization, high-resolution metabolite separation, and 
single-run profiles of living systems. Miniaturized SPME-LC/MS may also be applied in single cell 
metabolomics studies, allowing for a less invasive technique and providing spatial resolution 
enhancement. Essential oils, which are small molecules of plant origin, are suggested as potential leads 
towards drug design; in-depth investigations of metabolic pathway transformation using comparisons 
between control bacteria and matched treated bacteria samples can assist in the characterization of the 
modes of action of essential oils against pathogens, as well as aid in the discovery of the targets of these 
antibacterial agents. This can in turn allow for the use of these naturally occurring compounds as drugs in 
place of conventional chemicals that increase microorganism resistance. Additionally, the application of 
SPME-LC-MS metabolomics techniques imparts new information into the physiological processes 
controlling superficial scald and ripening processes that affect fruit flavor, appearance, and overall 
quality. Deregulation of different metabolite levels connected with ripening and browning disorders 
suggest changes in various metabolic pathways and biochemical mechanisms taking place in stored apple 
samples. The results introduced to date confirm the currently introduced method as a promising technique 
for the evaluation of adverse growth conditions such as drought, salinity, chilling, freezing, and high 
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temperature, which can cause delayed growth and reduce productivity, or, in extreme cases, even plant 
death. Capturing metabolites with a wide variety of polarities assists in the creation of snapshots of the 
biosynthesis and degradation pathways of the main metabolites associated with stress tolerance, which in 
turn helps to explain the role of metabolites in adapting to severe environments. Finally, SPME-LC-MS 
based metabolomics could provide the data for study of biological systems alongside with proteomics and 
genomics in order to provide a full map of living organism. 
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